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ABSTRACT

Weaver, Cory J. Ph.D., Purdue University, August 2016. The Role of NADPH Oxidases
in Neurite Outgrowth and Zebrafish Neurodevelopment. Major Professor: Daniel M.
Suter.

Nicotinamide adenine dinucleotide phosphate oxidases (NOX) are a family of
enzymes that produce reactive oxygen species (ROS). The first NOX enzyme was
discovered in leukocytes and associated with host defense in the immune system.
Subsequent findings of ROS production in non-immune cells led to the identification of
six additional NOX isoforms, and opened new avenues for research into NOX-mediated
cellular functions. Since then, NOX-derived ROS have been found to be involved in a
tremendous number of cell signaling pathways. Of particular interest is the wellestablished function of NOX-derived ROS in signaling pathways that drive cytoskeletal
rearrangements and motility in several cell types. Our lab is interested in the highly
motile neuronal growth cone that guides axonal growth during neurodevelopment and
regeneration. Others have reported that inhibition of NOX enzymes during development
causes a decrease in the size of some brain areas, and NOX deficiencies in humans are
correlated with diminished cognitive function. Despite the fact that NOX activity is
necessary for some cell motility in non-neuronal cells and a loss of NOX function during
development has impacts on brain structure, it is still unclear what role NOX plays in
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axonal growth and guidance or the establishment of connections in the central nervous
system.
In this series of studies, I investigated the function of NOX enzymes in neurite
outgrowth and neurodevelopment using both in vitro and in vivo approaches. I report that
NOX activity is necessary for the extension of neurites in culture. Inhibition NOX
activity leads to a disorganization of the actin cytoskeleton, a decrease in retrograde flow
and a loss of neurite outgrowth. Using embryonic zebrafish, I showed that four separate
nox genes are expressed broadly throughout the central nervous system during the first
two days of development. Functional studies in zebrafish revealed that NOX inhibition
leads to expansion of the ganglion cell layer in the retina and decrease in the size of the
optic nerve. Subsequent studies using a site-specific, RNA-guided mutagenesis approach
(CRISPR/Cas9) showed that optic nerve thinning resulted from developmental delays
while ganglion cell expansion was a permanent defect caused by the mutation of a
specific NOX isoform, NOX2/CYBB. The targeting of optic nerve axons to the optic
tectum of the midbrain was also disrupted in NOX2/CYBB mutants. These results show
that NOX activity is critical for neurite outgrowth in cultured cells in addition to retinal
development and axon targeting in vivo.

1

CHAPTER 1. INTRODUCTION

1.1 Reactive oxygen species as cellular signals

Reactive oxygen species (ROS) are a class of small, oxygen-containing
compounds that readily react with many classes of biomolecules (Finkel, 2001).
Typically, ROS are associated with the oxidation of free thiol groups in cysteine or
methionine residues (Fomenko et al., 2007; Jones and Go, 2011). Oxidized residues can
readily form inter- or intramolecular disulfide bridges that effect protein structure and
function (Dalle-Donne et al., 2002; Comito et al., 2011). Being promiscuous, ROS do not
discern among targets in the same way as a prototypical ligand. Therefore, oxidation by
ROS must be controlled by other means. One mechanism for controlling oxidation sites is
the creation of reactive cysteines. Under normal physiological conditions, free cysteine
thiols have a pKa ≥ 8 (Finkel, 2011). This means that they will not readily oxidize. In
some cases, protein folding can create a microenvironment wherein the pKa of a cysteine
thiol can reach as low as 4 making it primed for oxidation by ROS (Finkel, 2011).
ROS do not diffuse over great distances within the cell (Finkel, 2011; Lim et al.,
2016). Therefore, another mechanism to control oxidative specificity is to maintain
redox-sensitive targets in close approximation to sources of ROS. One example of this is
protein tyrosine phosphatase (PTP) 1B. Epidermal growth factor (EGF) signaling
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propagates via kinase cascades and PTP-1B acts as a negative regulator of this pathway
by removing phosphate groups from downstream target proteins (Flint et al., 1997). PTP1B is also redox sensitive, and becomes inactive when oxidized (Salmeen et al., 2003). In
addition to the initiation of kinase cascades, EGF binding leads to the production of ROS
at the membrane. Since PTP-1B localizes to the membrane, it becomes oxidized and
inactivated upon EGF binding (Lee et al., 1998; Finkel, 2011). Redox inactivation of
PTP-1B allows EGF signaling to propagate locally to the site of activated EGF receptor
while PTP-1B outside of the local ROS gradient remains active.
A large part of the reason that ROS do not diffuse in cells is the presence of
antioxidants. Cells maintain a battery of antioxidants that serve to regulate the redox
balance including peroxiredoxin, glutathione peroxidase, catalase, thioredoxin,
superoxide dismutase and others (Cerutti et al., 1994; Sarsour et al., 2009). Antioxidants
have been shown to be active components of signaling pathways. In the PTP signaling
pathway detailed above, the local activity of peroxiredoxins would quickly clear ROS,
leading to PTP activation and a loss of kinase-mediated signaling. To counter this,
peroxiredoxin I is inactivated by phosphorylation downstream of the activated EGF
receptor which allows a sustained, local increase in ROS that maintains PTP-1B
inactivation (Woo et al., 2010). Alternatively, antioxidants can act more directly in
signaling pathways. Thioredoxin has been shown to bind and inhibit apoptotic signalregulating kinase 1 (ASK1) (Saitoh et al., 1998). Binding is blocked when thioredoxin is
oxidized by ROS which allows ASK1-mediated apoptotic signaling to proceed. Similar
inhibitory antioxidant binding has been shown to contribute to cardiac hypertrophy via
the regulation of histone deacetylases (Yamamoto et al., 2003; Ago et al., 2008).
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Collectively, these studies show that ROS can act as cellular signals despite their
biochemical promiscuity.

1.2 Sources of ROS and downstream effectors

Having established that ROS act as cellular signals, we should next consider the
sources of ROS and targets of ROS-mediated oxidation. ROS are produced from several
enzymes, but the most significant contributors are a class of enzymes called nicotinamide
dinucleotide phosphate (NADPH) oxidases (NOX) and mitochondria (Wilson and
Gonzalez-Billault, 2015). Functions of mitochondrial ROS in cell signaling have been
extensively reviewed elsewhere (Finkel, 2012; Shadel and Horvath, 2015). NOX-derived
ROS are excellent candidates for cellular signals because NOX enzymes can be localized
to specific sites. Unlike mitochondria, the activity of many NOX enzymes can be
regulated to restrict the production of ROS. These enzymes have been implicated in
various signaling pathways, many of which will be discussed in this and later chapters.
Our lab is interested in the growth and guidance of neuronal growth cones.
Growth cones are actin-rich structures located at the tips of developing axons and
neurites that guide these processes toward their final targets (Levitan and Kaczmarek,
2002). Growth cones can be divided into three domains: the peripheral domain (P), the
transition zone (T) and the central domain (C, Figure 1.1) The peripheral domain is
comprised largely of actin and contains filopodia, long bundles of actin filaments, and
lamellipodia, a meshwork of actin (Figure 1.1). Both filopodia and lamellipodia are
dynamic, adding new actin monomers at the leading edge and depolymerizing actin
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structures at the transition zone. This, along with action of myosins, leads to a constant
retrograde flow of actin from the periphery to the transition zone (Levitan and
Kaczmarek, 2002). Growth cone turning is accomplished by asymmetric changes in actin
dynamics that lead to biased protrusion on one side versus the other. Full turning
responses are accompanied by the extension of the microtubule-rich central domain into
the actin-based protrusions. Growth cone guidance is the fundamental process that
underlies axon outgrowth during neurodevelopment and regeneration. Since growth cone
motility is dependent on the cytoskeleton, it shares basic, cell biological mechanisms with
other cellular functions in motile cells. Therefore, we are most interested in NOX
enzymes as they relate to cell motility, cytoskeletal remodeling, neurodevelopment and
nervous system function.

Figure 1.1: Neuronal growth cones (A) Schematic of cytoskeletal organization in the growth cone.
Microtubules (green) and actin (red) are highly organized in the three domains: peripheral (P), transition
zone (T) and central (C). (B) Aplysia growth cone imaged using DIC optic with the domains labeled. (C)
The same growth cone shown in B labeled for actin and microtubules.

Axon guidance and the subsequent establishment of neuronal connections are
dependent on interpretation of external cues by the neuronal growth cone that cause
turning. These cues include secreted ligands, growth factors, extracellular matrix proteins,
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cell-surface proteins and proteoglycans (O'Donnell et al., 2009; Kolodkin and TessierLavigne, 2011; Masu, 2015). NOX enzymes have been implicated in signaling
downstream from many of these molecules. Specific examples will be discussed in
Chapters 6 and 7 with respect to the results obtained in my experiments. However, the net
result of all the aforementioned signaling pathways is cytoskeletal modification that
drives axon guidance. Given the central importance of the cytoskeleton in axon
outgrowth and neurodevelopment, it is important to understand how redox regulation
impacts the organization and dynamics of actin and microtubules.

1.2.1 Redox regulation of actin

Treatment of monomeric actin with 5-20mM hydrogen peroxide (H2O2) decreases
assembly rates (DalleDonne et al., 1995). The same study found that oxidized actin took
longer to reach equilibrium in vitro and the resulting actin filaments were more fragile
than those derived from non-oxidized monomers. From additional data, the same group
concluded that fragment instability was caused by weaker interactions with actin binding
proteins such as alpha actinin (DalleDonne et al., 1995; Milzani et al., 1997). They then
found that specific methionine residues along with cysteine 374 were the targets of
oxidation, and they identified increased actin oxidation in human patients suffering from
neurodegeneration (Dalle-Donne et al., 2001; Dalle-Donne et al., 2002). In a separate
study, the authors showed that reversible S-glutathionylation of cysteine 374 decreases
actin polymerization rate by subtly altering the conformation of the actin monomer
(Dalle-Donne et al., 2003). Additional studies showed that cysteine 272 was oxidized
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specifically by the addition of hydrogen H2O2, and this oxidation caused a weaker
interaction with cofilin leading to filament instability (Lassing et al., 2007).
In addition to actin, myosin has also been shown to be redox sensitive. Treatment
of skeletal muscle with high doses of H2O2 (5 and 50mM) caused structural changes in
myosin, and decreased actomyosin contractility (Prochniewicz et al., 2008). However, it
should be noted that 50mM H2O2 may not be physiologically relevant, and the authors
did not account for the impact of actin oxidation on contractile responses.
Most published work shows that oxidation via H2O2 reduces actin polymerization.
All of these studies used concentrations of H2O2 in excess of 5mM. Application of 15mM H2O2 to p388DI cell lysates in vitro caused as much as a 50% increase in
polymerized actin (Omann et al., 1994). The authors went on to show that this increase
was not due to a greater number of nucleation events. Another study used endothelial
monolayer wounding assays to show that increased ROS production at the wound margin
correlated with increased actin assembly and faster cell migration (Moldovan et al., 2000).
The authors also used ROS scavengers to demonstrate the necessity of ROS production to
actin assembly in these cells. In endothelial cells, ROS stimulation enhances actin
retrograde flow leading to protrusion and the leading edge of the membrane (Taulet et al.,
2012). Our lab has show that reductions in exogenous ROS lead to decreased actin flow
rates and slower neurite outgrowth in neuronal growth cones (Munnamalai and Suter,
2009). Integrin-based cell adhesions are accompanied by ROS production. One study
showed that ROS in this pathway leads to actin glutathionylation which caused persistent
stress fibers and a lack of cell spreading (Fiaschi et al., 2006). The authors found that this
was due to the stability of the actomyosin complex when actin was oxidized.
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1.2.2 Redox regulation of microtubules

Like many other proteins, monomeric tubulin can be reversibly modified to
regulate microtubule dynamics (Janke, 2014). Unlike actin, much of the literature on
redox regulation of tubulin focuses on reactive nitrogen in lieu of ROS (Landino et al.,
2007; Wilson and Gonzalez-Billault, 2015). Tubulin monomers can undergo Sglutathionylation after oxidation by reactive nitrogen, and the sites of these modifications
have been identified via crystallography (Lowe et al., 2001; Nogales and Zhang, 2016).
Studying the direct oxidation of tubulin in vitro is difficult given the short lifetime of
reactive nitrogen in the conditions necessary for microtubule polymerization. The
challenges and necessary compromises are detailed in other literature (Sparaco et al.,
2006; Wilson and Gonzalez-Billault, 2015), but the central message is how tubulin
oxidation affects microtubule dynamics is still not fully understood.
Oxidation has been shown to impact microtubule dynamics by modifying
microtubule associated proteins (MAPs). H2O2-induced oxidation of cysteines in tau and
MAP2 caused a decrease in microtubule assembly and stability in vitro (Landino et al.,
2004). This effect of this oxidation was reversible suggesting a possible role for redox
regulation of microtubules via MAPs. It has also been shown that MAPs impact the
transport of cargo along microtubules by interacting with specific motor proteins (Dixit et
al., 2008). One study showed that nitrosylation of MAP1B caused neurite retraction by
decreasing microtubule stabilization (Stroissnigg et al., 2007). Neurite retraction was
dependent on dynein suggesting an interaction between MAPs, cytoskeletal motors and
microtubule stability.
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1.3 Linking extracellular signaling to redox control of the cytoskeleton

Many of the studies on redox regulation of the cytoskeleton have used cell-free, in
vitro polymerization assays to determine the impact of oxidation or reduction. Some have
used migrating cells to correlate ROS production with actin dynamics and migration.
However, none of the studies discussed to this point described a signaling pathway that
begins with an extracellular ligand and leads to ROS-mediated changes in the
cytoskeleton that affect motility. In the last decade, studies focused on a protein called
molecules interacting with CasL (Mical) elucidated this type of redox-mediated pathway
that directs the growth of axons in Drosophila.
The structure of Mical was resolved by two different groups around the same time
(Nadella et al., 2005; Siebold et al., 2005). Mical was then shown to be critical for
transduction of semaphorin-plexin-mediated collapse responses in Drosophila neurons
during central nervous system development (Ayoob et al., 2006). Collapsin response
mediator proteins (CRMPs) are necessary for axon turning in response to repulsive
semaphorin cues. Association with CRMP, induced by semaphorin, activated Mical, and
this activity was necessary for axon guidance in vivo (Schmidt et al., 2008). Although
Mical was now firmly established as a mediator of semaphorin-induced axonal guidance,
the link to ROS was still unknown.
In 2010, a study reported that Mical was capable of producing ROS via a
flavoprotein domain (Hung et al., 2010). More importantly, it was found that ROS
production was necessary for semaphorin-induced growth cone collapse, and that Mical
associates directly with f-actin. Additional studies showed that Mical-derived oxidation
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of actin at methionine 44 mediates cytoskeletal collapse and growth cone turning (Hung
et al., 2011). In order to be a useful signaling mechanism, actin oxidation must be
reversible. In 2013, it was found that a reductase enzyme called SelR reduces methionine
44 and restores normal actin polymerization (Hung et al., 2013). In addition to actin,
Mical-derived ROS was also found to activate CRMP via direct oxidation (Morinaka et
al., 2011). Collectively, these studies resolved a complete circuit of redox-mediated
signaling that drives axon guidance.
Most of this work focused on Mical in the Drosophila nervous system, but a
recent study implicated semaphorin-Mical signaling in human melanoma cells. The
authors reported that depletion of Sema6A or Mical1 decreased stress fiber formation and
chemotaxis (Loria et al., 2015). Over expression of either protein caused cells to be more
invasive and have higher growth rates. Beyond cell motility, Mical has also been
implicated in vesicle trafficking via association with Rab proteins (Fukuda et al., 2008).
Mical knockouts lead to disruptions in endoplasmic reticulum to Golgi trafficking and
endocytosis (Fischer et al., 2005; Van Battum et al., 2014). It has been proposed that
Mical-actin interactions are important for trafficking, but it should be noted that these
studies did not address Mical-derived ROS directly. Therefore, it remains unclear
whether or not ROS production is necessary for trafficking.
While there is still more to discover about Mical proteins, the research into
Mical’s role in growth cone guidance is as complete a picture of ROS-mediated axon
guidance as is currently available. Other sources of ROS in cells, like NOX, likely
contribute to the propagation of guidance signals, but this remains to be studied.
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1.4 Introduction of the NOX isoforms

Research into NOX enzymes and redox biology extends as far back as 1908 when
a respiratory burst was observed during the fertilization of sea urchin eggs (Warburg,
1908). From these initial experiments, there emerged a field of study aimed at
characterizing the respiratory burst and identifying the cellular machinery responsible. In
the intervening century, not only was a specific isoform of NOX implicated in the
respiratory burst, but six additional NOX isoforms, each with unique functions, were
characterized. NOX dysfunction was also shown to be the cause of a potentially fatal
immune disease, and knowledge derived from the study of patients was critical for
identifying the genes encoding NOX subunits. In the sections that follow, each NOX
isoform is introduced in the order in which they were discovered. Included is a
description of the enzyme complexes, a brief overview of activation mechanisms and a
review of the known functions with respect to the nervous system.

1.4.1 NOX2

In 1933, a respiratory burst similar to that in sea urchin eggs was observed in
phagocytes (Baldridge and Gerard, 1933). This burst proved clinically significant in
1957 with the discovery of a rare immunological disease. Patients, typically males,
developed severe infections and excessive inflammation often in the form of persistent
granulomas (Berendes et al., 1957). Ten years later, the disease now called chronic
granulomatous disease (CGD) was attributed to a lack of oxidant production at infection
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sites. The decreased ROS production was linked leukocytes, a type of phagocyte
(Baehner and Nathan, 1967; Holmes et al., 1967; Quie et al., 1967). In the mean time,
studies had identified that the respiratory burst in leukocytes produced H2O2, and that
NADPH, not NADP, served as an electron donor for the reaction (Iyer et al., 1961; Rossi
and Zatti, 1964).
Nearly thirty years after the initial identification of CGD, one of the primary
genes responsible was identified and cloned (Royer-Pokora et al., 1986; Teahan et al.,
1987). The gene was located on the X chromosome explaining the predominantly male,
X-linked recessive pattern of CGD inheritance. The gene product was initially called
gp91phox, but is now commonly referred to as NOX2 or CYBB. It quickly became clear
that NOX2 was part of a larger enzyme complex when it was discovered that deficiency
of another gene encoding a protein called p22phox, CYBA, also led to CGD (Dinauer et al.,
1987; Segal, 1987). The gene for p22phox is located on chromosome 16 explaining the
autosomal recessive pattern of inheritance of p22phox-based CGD.
The advent of cell-free systems led to the identification of additional cytosolic
subunits called p47phox, NCF1, and p67phox, NCF2 (Bromberg and Pick, 1985; Nunoi et
al., 1988; Volpp et al., 1988). By 1994, it was established that the small GTPases Rac1/2
were also members of the NOX2 complex (Abo et al., 1991; Knaus et al., 1991; Abo et
al., 1994). Seven years after the initial cloning of the gene encoding NOX2, the final
subunit of the NOX2 complex was identified as p40phox, NCF4 (Wientjes et al., 1993).
NOX2 and p22phox are both transmembrane proteins, and they are tightly
associated within the cell to form the enzymatic core called the flavocytochrome
(Nauseef, 2004). With the exception of NOX5 and DUOX, all NOX isoforms require
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p22phox. Additionally, all NOX isoforms have six transmembrane alpha helices forming a
pseudochannel that shuttles electrons from NADPH in the cytosol to the oxygen acceptor
on the opposite face of the membrane (Kawahara and Lambeth, 2007). Alpha helices III
and IV each contain two histidine residues that are responsible for the binding of heme
cofactors involved in shuttling electrons (Brandes et al., 2014). The composition of the
NOX2 complex and other NOX complexes are shown in Figure 1.1.
Returning specifically to NOX2, ROS production is initiated when the enzyme
complex assembles on a membrane. The complex can be activated in several ways, but
the most commonly described involves the phosphorylation of the scaffolding protein,
p47phox, and the activation of Rac. In the absence of phosphorylation, the autoinhibitory
region (AIR) of p47phox interacts with the phosphoinositide-binding domain, PX, to bury
many of the functional domains (Groemping et al., 2003). This closed conformation
prevents p47phox from acting as a scaffold to bring other proteins to the flavocytochrome.
Upon phosphorylation and release of autoinhibition, p47phox adopts an open conformation
that allows the PX domain to act as a membrane anchor and protein scaffold. (Ago et al.,
2003). Dual Src homology 3 (SH3) domains in p47phox directly bind to the
flavocytochrome via proline-rich regions of p22phox (Nakanishi et al., 1992). p47phox also
interacts with p67phox to bring the latter into close proximity of the NOX2 active site (el
Benna et al., 1994b). p67phox contains an activation domain that significantly increases
the rate of NOX2 electron transfer when aligned to the active site (Han et al., 1998).
Activated Rac translocates to the membrane independently of p47phox, but shows a strong
association with p67phox (Diekmann et al., 1994). In fact, strong activation of Rac is
sufficient to drive p67phox to the membrane (Gorzalczany et al., 2000).
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Owning to its discovery in CGD patient cells, NOX2 is most commonly
associated with functions in phagocytic cells of the immune system. However, NOX2 is
expressed in neurons, microglia, vascular smooth muscle cells, skeletal muscle,
cardiomyocytes, hepatocytes, endothelial cells, hematopoietic stem cells and fibroblasts
(Pagano et al., 1997; Bedard and Krause, 2007; Brown and Griendling, 2009; Nayernia et
al., 2014). NOX2 has been shown to be involved in growth factor signaling, angiogenesis,
cell death and blood pressure regulation (Bedard and Krause, 2007; Brown and
Griendling, 2009). However, it is noteworthy that NOX2 is found in cells of the nervous
system. Accordingly NOX2 has been implicated in nervous system function and
maintenance in a number of ways.
CGD patients were critical in identifying and characterizing NOX2, and
researchers are again turning to patients to understand the full of range of NOX2
functions in the nervous system. CGD patients suffer from mild cognitive deficiencies
including below average IQ scores (Pao et al., 2004; Cole et al., 2013). However, it
should be noted that severe infections in CGD patients often lead to prolonged
hospitalization and social isolation (Chiriaco et al., 2015). The authors of both studies
cited above caution that lack of social and educational exposure may contribute to
cognitive declines. However, NOX2 is expressed in neurons and several neuronal
functions are known so there remains a possibility that the enzyme plays a direct role in
brain development.
In adult mouse brains, there is direct evidence that hippocampal neurons express
NOX2, and that the enzyme plays a significant functional role. One of the first studies on
this topic showed that mice overexpressing superoxide dismutase, a potent antioxidant
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enzyme, do not undergo long-term potentiation (Thiels et al., 2000). In cultured
hippocampal neurons, NOX2 subunits were identified in cell bodies and dendrites via
immunohistochemistry (Tejada-Simon et al., 2005). Further, direct activation of NOX led
to the colocalization of NOX2 regulatory subunits at presynaptic sites. A separate study
found that inhibition of NOX2 leads to polarization defects and decreased neurite
extension in mouse hippocampal neurons (Wilson et al., 2015). The authors confirmed
that NOX2 subunits were localized throughout the cell, and found that several NOX2specific inhibitors caused alterations in the actin cytoskeleton that presumably led to
neurite outgrowth defects. Studies performed on mice lacking either NOX2 or p47phox,
rodent models of CGD, identified impairments in spatial and context dependent-fear
memory formation (Kishida et al., 2006). Both of these behaviors are mediated by the
hippocampus. Additionally, these in vivo experiments showed that NOX2 deficient mice
do not undergo long-term potentiation in hippocampal neurons. All of these studies, taken
together, clearly show the importance of NOX2 in learning and memory processes
mediated by the hippocampus. See Figure 1.1 for a summary of the known roles for
NOX2 in the nervous system.
Neural stem cell potency is dependent on the maintenance of high ROS levels in
progenitors (Le Belle et al., 2011; Wang et al., 2015). Adult hippocampal stem cells rely
on high ROS levels to maintain self-renewal and normal progenitor function. It is perhaps
unsurprising that NOX2 has been identified as a major source of ROS in adult
hippocampal stem cells (Dickinson et al., 2011). Inhibition of NOX2 leads to depletion of
neural progenitors and defective neurogenesis. This may suggest that NOX2 function is
critical for hippocampal development and maintenance in addition to memory and
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learning. It is tempting to speculate that cognitive declines in CGD patients may stem
from NOX2 dysfunction in the hippocampus that impacts memory, learning and/or
neurogenesis. This speculation remains untested, but is worthy of further investigation.
Moving out of the hippocampus, NOX2 has also been found in cerebellar granule
neurons (CGN). CGNs are small, tightly packed neurons that allow for complex coding
of input information. In 2009, a group found that staurosporine-induced apoptotic death
in CGNs was mediated by NOX2 activity (Guemez-Gamboa and Moran, 2009). CGNs
derived from NOX2 knockout mice were less sensitive to staurosporine than wild type
controls. Apoptosis in CGNs can be triggered in multiple ways, and researchers found
that NOX2 was specifically activated by staurosporine and not other apoptotic signals.
This finding indicates that NOX2 is not a general apoptotic signal, but acts in a specific
pathway.
While the previous study implicates NOX2 in cell death, NOX2 has also been
shown to promote the maturation of CGNs (Olguin-Albuerne and Moran, 2015). Using
CGN cultures, authors showed that NOX inhibitors and general antioxidants caused a
decrease in neuronal maturity after three days in vitro. Maturity was measured by
morphology as well as the presence of mature neuronal markers, Tau and MAP2. NOX2
was identified in the growth cones and filopodia of developing CGN neurites, and
colocalized to the sites of H2O2 production. Additionally, the authors described an
increase in ROS at one day in vitro that was critical for CGN survival. CGNs derived
from NOX2 knockout mice displayed short neurites which is consistent with what was
observed in response to NOX inhibitors (Olguin-Albuerne and Moran, 2015).
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NOX2 is also implicated in tissue damage following brain injury. Inflammation
driven by NOX2-derived ROS has been shown to promote tissue damage following
ischemic stroke (Carbone et al., 2014). NOX inhibitors have been shown to ameliorate
the inflammation and tissue damage in laboratory studies. Unfortunately, NOX2 activity
might also directly increase the probability of stroke occurrence by contributing to the
formation of arterial plaques (Sierra et al., 2011). A separate study showed that the
application of a NOX inhibitor, apocynin, attenuated nearly all markers of neural damage
following traumatic brain injury (TBI) in mice (Lu et al., 2014). Apocynin-treated mice
showed a decrease in neuronal apoptosis, blood-brain barrier disruption and cognitive
deficiency. The authors focused on cortical injuries, and found that NOX2 expression
sharply increased immediately following TBI. This may indicate that NOX2 is a marker
of inflammation and damage in cortical cells.
Amyotrophic lateral sclerosis (ALS) is a disease characterized by the progressive
atrophy of motor neurons that eventually leads to a loss of muscle control. As there is no
cure, current treatments focus on slowing disease progression. Rac1, a critical regulator
of NOX function, is known to be involved in cytoskeletal organization in mature neurons.
Through the misregualtion of Rac1, NOX has been implicated in ALS disease
progression (D'Ambrosi et al., 2014). NOX2 has been identified as a key source of
damaging ROS in ALS models (Boillee and Cleveland, 2008). A recent study of human
ALS patients confirmed the experimental results from rodent models. This study showed
that lower levels of endogenous NOX2 activity lead to modest increases in patient
survival (Marrali et al., 2014). This makes NOX2 a promising therapeutic target for
future studies.
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Alzheimer’s disease (AD) is a neurodegenerative condition causing dementia and
memory loss. In the United States, approximately 5 million individuals over the age of 65
have AD (Association, 2014). The disease is characterized by the progressive loss of
neurons due to the formation of extracellular amyloid plaques and intracellular
neurofibrillary tangles (Association, 2014). Compared to non-diseased, age-matched
controls, human cortical sections from AD patients exhibited higher expression of genes
encoding p47phox, p67phox and p40phox, but not NOX2 itself (Ansari and Scheff, 2011).
Further, NOX2 activity correlated well with symptom severity suggesting that ROS
production is a predictor of disease progression. As with the TBI study mentioned earlier,
these experiments focused on cortical tissues from AD patients. In both cases, it is
unclear whether NOX2 contributes to normal cellular function in the cortex or is
expressed only in the diseased state. The answer to this question may shed light on what
role, if any, NOX2 plays in disease onset as opposed to progression. AD patients also
have lesions in the hippocampus leading to memory loss (Association, 2014). Given the
well-established function of NOX2 in the hippocampus, it is possible, although untested,
that NOX2 misregulation contributes to the onset of AD pathology in this brain region.
Although NOX2 activity correlates well with AD severity, mouse models of AD
treated with the NOX inhibitor apocynin were not significantly protected (Dumont et al.,
2011). Inhibitor-treated mice showed no change in the extent of brain lesions or cognitive
declines. Conversely, a previous study showed that genetic NOX2 deficiency in the same
AD mouse model improved cognitive and histopathological symptoms (Park et al., 2008).
Drug administration is less potent than genetic knockouts, and this may explain the
discordant results. However, it should be noted that NOX2 deficient mice also develop
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CGD. This poses serious ethical questions regarding the viability of NOX2 as a target for
gene therapy or other genetic manipulations. Nonetheless, these studies present a paradox
concerning the viability of NOX2 as a target for AD therapies that is worthy of continued
study.

1.4.2 NOX1

Researchers were surprised to find that fibroblasts and neutrophils from CGD
patients were capable of producing a respiratory burst (Emmendorffer et al., 1993). This
clearly showed that ROS production in these cells was not mediated by NOX2. As the
final components of the NOX2 complex were identified in 1993, the search was on for
additional enzymes capable of generating bursts of ROS. In 1999, a homolog of NOX2
called mitogenic oxidase 1 (MOX1, now NOX1) was identified and cloned (Suh et al.,
1999). Cytosolic subunits for the NOX1 complex, NOXO1 and NOXA1, were found four
years later (Banfi et al., 2003; Geiszt et al., 2003).
Similar to p47phox, NOXO1 functions as a scaffold to bring the activation domain
of NOXA1 near to the active site of NOX1. NOXO1 contains similar PX, SH3 and PRR
domains that mediate protein-protein interactions involved in scaffolding. One critical
difference between p47phox and NOXO1 is the absence of the AIR in NOXO1 (Cheng and
Lambeth, 2004). This means that NOXO1 activity is not phosphorylation dependent.
However, NOX1 activity is still dependent on Rac giving the complex some degree of
regulation despite the constitutive activity of NOXO1 (Park et al., 2004; Miyano et al.,
2006; Ueyama et al., 2006). Like p67phox, NOXA1 interacts directly with Rac in addition
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to NOXO1, and contains an activation domain necessary for optimal NOX1 function
(Brandes et al., 2014).

Figure 1.2: Composition of the NOX complexes The active form of each NOX enzyme complex is
shown. The enzyme complexes assemble on the plasma membrane or vesicular membranes. It is unknown
whether NOXA1 and Rac are necessary for NOX3. Misregulation leads to the conditions and/or diseases
listed below each complex, discussed and cited in the text. There have been no functions associated with
NOX3/5 in the nervous system. PX indicates the peroxidase-like domain of DUOX1/2.
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NOX1 is most closely associated with expression in the colon epithelia, but
expression has also been shown in endothelial cells, vascular smooth muscle cells, retinal
pericytes, uterus, placenta and prostate (Cui et al., 2006; Rokutan et al., 2008; Brown and
Griendling, 2009; Sorce and Krause, 2009). NOX1 has been implicated in canonical
Wnt-beta catenin signaling, and hypoxic injury (Kajla et al., 2012; Spencer et al., 2013).
NOX1 is also important for the migration of vascular smooth muscle cells and colon
adenocarcinoma cells suggesting a possible role in cancer metastasis (Schroder et al.,
2007; Sadok et al., 2008; Zimmerman et al., 2011). The enzyme has also been identified
in the nervous system, but the functions of NOX1 are less extensively studied compared
with NOX2.
Parkinson’s disease is a neurodegenerative condition characterized by the loss of
dopaminergic neurons in the substantia nigra which leads to progressively worsening
movement disorders (Jimenez-Shahed, 2016). Current therapies aim to slow progression
of the symptoms, but there is still no cure. Cell culture models revealed that a selective
dopaminergic neuronal toxin, 6-hydroxydopamine (6-HD), causes increased expression
of NOX1 mRNA (Choi et al., 2012). Another study using the same culture model showed
that protein kinase C delta and NOX1 mediate cell death in dopaminergic neurons under
oxidative stress conditions (Cristovao et al., 2013). Knockdown of protein kinase C delta
led to a subsequent decrease in NOX1 activity and increased neuronal survival. In live
rats, injection of 6-HD into the brain also increased NOX1 expression in the substantia
nigra, but the protein was surprisingly localized to the nucleus (Choi et al., 2012).
Accordingly, 6-HD treated rats exhibited oxidative DNA damage and death of
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dopaminergic neurons. Knockdown of NOX1 ameliorated both conditions. Collectively,
these findings portray NOX1 as a potential therapeutic target for Parkinson’s disease.
Inflammation is a common hallmark of many neuropathologies including trauma
to the central nervous system (Ansari and Scheff, 2011; Lu et al., 2014; Marrali et al.,
2014; Zhao et al., 2016). Microglia are responsible for inflammation in the central
nervous system, and are thus often targeted in therapies for brain and spinal cord injury.
Using purified microglia from mice, researchers found that activation via
lipopolysaccharide (LPS) elicits an increase in NOX1 activity which leads to nitric oxide
synthase (NOS) activation and neurotoxicity (Cheret et al., 2008). Both NOX1 and
NOX2 contribute to this process, but NOX1 was necessary for maximum ROS
production. NOX1 knockout mice were protected from LPS-induced neurodegeneration,
and showed decreased NOS activity. As inflammation is a symptom of many
neuropathologies, the discovery of NOX1 in this signaling pathway may be the most
promising therapeutic target yet presented.

1.4.3 NOX3

NOX3 was first identified in 2000 by several independent groups (Kikuchi et al.,
2000; Cheng et al., 2001; Banfi et al., 2004a). p22phox is necessary for activity, but the
additional regulatory subunits of the NOX3 complex are still a matter of some debate. It
is clear that NOXO1 is needed for optimal ROS production, but it may not be essential
for basal NOX3 activity (Bedard and Krause, 2007). NOX3 is highly expressed in the
inner ear, an organ involved in balance control. NOXO1 deficient mice exhibit
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locomotion and balance defects that indicate inner ear dysfunction (Kiss et al., 2006). The
same study went on to link NOXO1 in the inner ear with NOX3 activity. This provides
evidence that NOXO1 is needed for NOX3 activity in vivo. Whether NOXA1 or Rac are
necessary for NOX3 function is currently unclear (Bedard and Krause, 2007).
As stated, NOX3 expression is closely associated with the inner ear, but
additional expression has been identified in a range of human fetal tissues including
kidney and spleen (Cheng et al., 2001). Additionally, NOX3 expression has been found
in human colon epithelial cells (Kikuchi et al., 2000). There is currently no data on
NOX3 expression in the nervous system, and no NOX3-associated functions. However, it
is possible that hearing and balance defects in NOX3 knockouts are caused disruptions in
the connections between the inner ear and nervous system. Additional studies into the
specific mechanisms of NOX3-mediated signaling are needed to address this possibility.

1.4.4 NOX4

The gene encoding NOX4 was originally identified in kidney tissue in the year
2000 (Geiszt et al., 2000; Shiose et al., 2001). NOX4 is unique from other isoforms in
that function is not dependent on any cytosolic subunits (Bedard and Krause, 2007).
NOX4 does interact with p22phox, however, and this interaction is necessary for activity.
The absence of cytosolic subunits led many to speculate that NOX4 is constitutively
active, and this is confirmed in cell free systems (Bedard et al., 2012). However, NOX4 is
comparatively sensitive to cellular conditions such as the presence of free oxygen, and
this may act as a mechanism modulate NOX4 activity (Nisimoto et al., 2014). Activation
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may also be controlled at the level of transcription. Many NOX4-dependent signaling
pathways have been shown to control the expression of NOX4 mRNA (Brandes et al.,
2014).
While details regarding the mechanisms of regulation are still being investigated,
NOX4 has been identified in many cell and tissue types. As mentioned, NOX4 was first
discovered in kidney tissue. Since then NOX4 has been found in neurons, osteoclasts,
vascular smooth muscle cells, hematopoietic stem cells, fibroblasts, keratinocytes,
melanomas and neural crest cells (Bedard and Krause, 2007; Lee et al., 2014). NOX4
activity is involved in vascular smooth muscle cell function, and NOX4 deficient mice
are predisposed for obesity (Lyle et al., 2009; Li et al., 2012a). Adding to the range of
NOX4 functions, the enzyme is also necessary for influenza A replication in lung
epithelia (Amatore et al., 2015).
Damage to peripheral neurons, either by injury or disease, can result in prolonged
pain. This condition is clinically known as neuropathic pain, and approximately 20
million people in the United States have been diagnosed with some form of this condition
(Yawn et al., 2009). A widespread cause of neuropathic pain is peripheral neuropathy,
commonly caused by diabetes or chemotherapy treatment. Additional routine causes of
neuropathic pain include injury, surgical complications or other unknown sources (Yawn
et al., 2009). One group found NOX4 expression in peripheral nerves and dorsal root
ganglia in the mouse. They went on to show that mice lacking NOX4 exhibit a decrease
in peripheral nerve demyelination following nerve injury (Kallenborn-Gerhardt et al.,
2012). The NOX4-deficient mice also display a decrease in behaviors indicative of
neuropathic pain. The study provides evidence that NOX4 may contribute both to the
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extent of nerve injury and to the perception of neuropathic pain in mouse models. Given
the prevalence of neuropathic pain in humans, this is an important discovery that may
lead to improved therapeutic strategies.
The role of NOX2 in cell death following ischemic stroke was presented earlier,
but a separate study found that NOX4 is more important in post-stroke neuroprotection.
The research showed that NOX4 expression is increased in both humans and mice
following ischemia (Kleinschnitz et al., 2010). NOX4 deficient mice, but not those
deficient in NOX1/2, were protected from neuronal apoptosis, and this was specifically
due to the reduction of oxidative stress. The extent of neuroprotection was unaffected by
age. Mice treated with a NOX inhibitor, VAS2870, hours after the onset of ischemic
stroke showed decreased neuronal apoptosis and improved long-term cognitive function
compared to sham-treated controls. This has major clinical significance since viable
therapies for use in humans must be effective even when applied long after the onset of a
stroke (Zhang et al., 2016).
NOX4 contributes to the survival and fate determination of neural crest stem cells
(NCSCs) during development. Cultured NCSCs treated with bone morphogenetic protein
2 (BMP2) differentiate into neurons, and this process is dependent on the production of
ROS (Lee et al., 2014). One group found that NOX4 was expressed in NCSCs, neuronal
differentiation was blocked in NOX4 knockouts (Lee et al., 2014). This effect was
reproduced in cells treated with NOX inhibitors. Strangely, NOX4 deficient mice do not
display any defects in NCSC-derived tissues. The authors note that homozygous NOX4
knockout pups are not born at the expected rate, suggesting NOX4 knockout may be
lethal, and they speculate that molecular compensation might mask the phenotype.
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1.4.5 NOX5

NOX5 was first identified in the testis, spleen and lymph node in 2001 (Banfi et
al., 2001). In lieu of cytosolic subunits, NOX5 relies on direct phosphorylation and
calcium binding for activation (Banfi et al., 2004b). NOX5 contains two EF hand motifs
that cooperatively bind calcium ions to elicit protein function (Bedard et al., 2012).
NOX5 has been shown to interact directly with calmodulin, and calmodulin modulates
the calcium sensitivity of NOX5 (Tirone and Cox, 2007). Additionally, NOX5 can be
phosphorylated at two sites to induce ROS production (Brandes et al., 2014). NOX5
forms a homodimer in order to function, and activity does not require the presence
p22phox like all of the previously described NOX isoforms (Brandes et al., 2014).
In addition to the tissues mentioned above, NOX5 is also expressed in endothelial
cells, vascular smooth muscle cells, pancreas, placenta, ovary, uterus, stomach and
multiple fetal tissue (Bedard and Krause, 2007). NOX5 has been shown to be involved in
thrombin-mediated proliferation in human endothelial cells, and platelet derived growth
factor-mediated proliferation in smooth muscle cells (BelAiba et al., 2007; Jay et al.,
2008). There is currently no known function for NOX5 in the nervous system.

1.4.6 DUOX1/2

Originally called thyroid oxidases, dual oxidases (DUOX1 and DUOX2) were the
last NOX-related isoforms to be identified (Dupuy et al., 1999; De Deken et al., 2000).
Like NOX5, DUOX1/2 are activated by calcium binding to EF hand motifs. The proteins
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are called ‘dual’ oxidases because they contain a large N-terminal peroxidase-like
domain in addition to the flavocytochrome (Lambeth et al., 2007). There is significant
debate regarding the importance of the extracellular peroxidase-like domain, but patients
with mutations in this domain exhibit hypothyroidism (Bedard and Krause, 2007),
suggesting some nominal function. DUOX1/2 are claimed to directly produce H2O2, but
this seems unlikely given the biochemical restraints of the monoelectron reactions of
NOX family members. Rather, some have postulated that superoxide is direct product,
but DUOX1/2 facilitate rapid dismutation into H2O2 (Bedard and Krause, 2007).
DUOX1/2 are expressed, as the original name implies, in the thyroid.
Additionally, they are expressed in the epithelia of the airway and gastrointestinal tract,
testis, uterus, gall bladder, pancreas and cerebellum (Harper et al., 2006; Lambeth et al.,
2007). As mentioned, DUOX2 mutations have been shown to cause hypothyroidism thus
demonstrating function in the thyroid. Additionally, DUOX has been show to be involved
in cytokine-mediated neutrophil recruitment in zebrafish (de Oliveira et al., 2015). There
are no studies of DUOX expression or function in nervous system cells. However,
DUOX activity has tangentially been shown to guide and promote the regeneration of
damaged peripheral nerves in the zebrafish tail (Rieger and Sagasti, 2011). In this study,
peripheral nerves were damaged either by tail clipping or laser nerve ablation. Normally,
new axons completely reinnervate the regenerated tail, and this is accompanied by tissuescale ROS production. The authors found that DUOX knockdown decreased overall axon
outgrowth and caused less extensive reinnervation. Further investigation showed that the
ROS gradient stemmed from DUOX expressed in damaged keratocytes, not from the
neurons themselves. The DUOX-derived ROS created a tissue-scale gradient that acted as
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a cue to guide the newly growing axons. While this study did not provide any evidence
that DUOX has a cell-autonomous role in neurons, it is noteworthy that damaged axons
followed an increasing gradient of ROS in this system. In contrast, most models of axon
regeneration posit that ROS inhibit axon outgrowth. From what is known, overproduction
of ROS by the glial scar acts as an inhibitory signal for axon regrowth, but antioxidant
therapies for brain and spinal cord injuries have been largely unsuccessful (Hall, 2011). It
is possible that low concentrations of ROS might act as positive growth signals while
higher concentrations are inhibitory. This idea is supported by earlier work from our lab
(Munnamalai and Suter, 2009), and extended by my work (Chapter 3).

1.5 Additional roles for NOX in the nervous system

General ROS production was shown to affect neuronal fate determination in
cortical cultures from embryonic rats (Tsatmali et al., 2006). Consistent with what is
known about neuronal precursors in mouse hippocampus (Dickinson et al., 2011),
cortical neurons from embryonic day 15 rats displayed a high level of ROS production
(Tsatmali et al., 2006). ROS levels were found to be reliable predictors of neuronal
subtype, and antioxidant treatments shifted this distribution without affecting cell
survival. Further, the authors reported that ROS production was limited to cortical
progenitors by postnatal day 20. While the study did not specify a source of ROS, the
findings are similar to the pattern of NOX2-derived ROS in the hippocampus described
earlier. Regardless of the source, the current study shows that ROS contributes to fate
determination in cortical neurons.
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Staying with neuronal differentiation, PC12 cells treated with nerve growth factor
(NGF) display neurite outgrowth and the expression of neuron-specific genes such as AP1. NGF stimulation of PC12 cells is accompanied by ROS production and inhibiting this
ROS blocks the adoption of a neural fate (Suzukawa et al., 2000). This study did not
directly prove the involvement of NOX in this process, but the authors did show that a
dominant negative Rac1 also blocks ROS production and neuronal differentiation.
Therefore, it is possible that a Rac1-dependent NOX isoform is involved in the induction
of PC12 cells to a neuronal fate.
NOX activity has also been linked to brain development. The prenatal
administration of apocynin led to gross morphological changes in the rat cerebellum.
ROS production was reduced in the cerebellum of inhibitor-treated rats, and cerebellar
folia were underdeveloped as a result (Coyoy et al., 2013). Accordingly, rats treated with
apocynin showed decreased motor coordination indicative of cerebellar dysfunction.
Recall that NOX2 promotes CGN maturation (Olguin-Albuerne and Moran, 2015). It is
then reasonable to speculate that NOX inhibitor application may lead to the
underdevelopment of the cerebellum by blocking NOX2-mediated CGN maturation.

1.6 Overview of experimental work

Our lab investigates cellular signaling involved in the growth and guidance of
neuronal growth cones. Growth cones are specialized, highly motile structures that direct
axons to their targets by receiving and interpreting extracellular signals. Therefore, axon
guidance and the neuronal connectivity are dependent on the function of growth cones.
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There is very little known about the role of NOX or even ROS in axonal growth and
guidance. However, axon outgrowth and turning are driven by actin and microtubulebased cellular machinery and both of these proteins are redox sensitive. Furthermore,
Mical, another ROS-generating enzyme, mediates axon guidance by direct oxidation of
actin. Finally, signaling pathways that induce cell migration and cytoskeletal
rearrangements in non-neuronal cells require NOX-derived ROS. The basic cellular
machinery that drives motility in these cells is often conserved in growth cones. Our lab
has previously shown that growth cones from cultured Aplysia (Aplysia californica)
neurons are sensitive to changes in ROS. Specifically, we found that application of
antioxidants led to decreased neurite outgrowth, disorganization of the actin cytoskeleton
and slowed actin retrograde flow (Munnamalai and Suter, 2009). The first part of my
study was to determine whether NOX-derived ROS are important for the outgrowth and
overall viability of cultured Aplysia neurons (Chapter 3). In this set of experiments, we
identified a NOX2-like protein in Aplysia neurons and showed that NOX activity is
necessary for proper neurite outgrowth. Additionally, we showed that elements of the
NOX2 complex colocalize with actin and depend on actin for transport.
In vivo, the proper function of growth cones leads to the formation of axon tracts
and the establishment of neuronal connections. In addition to axon guidance, many events
including, but not limited to cell migration, proliferation, stem cell maintenance and
differentiation contribute to the larger process of neurodevelopment. Most of these
cellular functions have been linked to ROS or NOX in non-neuronal cells. With this
knowledge and having shown that NOX is important for neurite outgrowth, I investigated
the impact of NOX on neurodevelopment.

30
Zebrafish (Danio rerio) are ideal for studying vertebrate neurodevelopment due to
their transparent bodies and external fertilization that make them highly compatible with
in vivo imaging. However, many NOX studies use mice and rats since they are
mammalian systems that often translate well to humans. Despite the fact that rodents do
not carry NOX5, the availability of NOX1-4 and DUOX2 knockout mice has contributed
to their popularity (Altenhofer et al., 2012; Bedard et al., 2012). Additionally, it has been
comparatively difficult to generate targeted mutations in zebrafish so the production of
gene knockouts has been rare. However, the advent of site-specific mutagenesis strategies
designed especially for zebrafish has made an already powerful developmental model
even more so (Jao et al., 2013). It is now possible to precisely edit the zebrafish genome
and generate mutant lines using a process that is comparatively simple when measured
against generating genetic mutants in mammals. Therefore, I used zebrafish embryos to
study the role of NOX in neurodevelopment.
I first characterized nox gene expression in the zebrafish nervous system during
the first two days development, a period that coincides with a great deal of
neurodevelopment. Using quantitative PCR and extensive in situ hybridization, I
discovered broad but dynamic expression of nox1, nox2/cybb, nox5 and duox (Chapter 4).
The expression domains were overlapping indicating the simultaneous presence of
multiple nox genes in many tissues. While the results of this study did not provide
information on cell-type specific nox expression, they do show that nox genes are
expressed in the nervous system which may suggest a function.
I then investigated the function of NOX in neurodevelopment (Chapter 5). I found
that optic nerve development was affected by the application of NOX inhibitors. Using
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site-specific mutagenesis (CRISPR/Cas9) I determined that NOX2 (CYBB in zebrafish)
mutants had similar defects in the optic nerve indicating that NOX2/CYBB was
important for development. Finally, I found that NOX2/CYBB homozygous mutants
displayed an expansion of retinal ganglion cells in the eye and mistargeting of axons to
the midbrain.
In summary, the aim of this study was to investigate the role of NOX in axon
outgrowth and neurodevelopmental. I first showed that NOX is expressed in Aplysia
neurons and is important for neurite outgrowth. I then transitioned to in vivo work to
show that nox genes are expressed in the zebrafish nervous system during development.
Finally, I performed functional studies in zebrafish to show that NOX activity is
necessary for retinal development and axon targeting.
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CHAPTER 2. METHODS

2.1 General methods

2.1.1 Zebrafish housing and breeding

All animal work and experimental protocols were approved by the Purdue Animal
Care and Use Committee. Zebrafish (Danio rerio) of the AB or Tg(ath5:GFP) line were
maintained according to standard procedures (Westerfield, 2000; Hensley and Leung,
2010). NOX mutant lines were generated as described in section 2.4.7. To generate
embryos, parental fish were placed into breeding tanks and separated by a clear divider
overnight. The following morning, adults were moved to a new breeding tank with fresh
water, the divider was removed and the breeding basket was tilted to force the parents
into close proximity. Embryos were collected at 15-minute intervals to obtain cohorts of
the same stage. Embryos were maintained in E3 medium at 28°C and staged as described
prior to harvest (Kimmel et al., 1995). Medium was changed daily and dead embryos
were removed to discourage bacterial and fungal growth. Between 12 and 23 hours postfertilization (hpf) embryos used for live imaging, in situ hybridization, immunolabeling
and microangiography were treated with 0.003% N-Phenylthiourea (PTU) (Sigma, St.
Louis, MO) in E3 medium to inhibit melanization (Li et al., 2012b).
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2.1.2 Mounting embryos in 1% low melting point agarose

Agarose for mounting was dissolved in E3 media or 1x PBS depending on the
experiment. For 20 mL, 0.2 g of analytical grade low melting point agarose (Promega,
Madison, WI, Cat. V2111) was added to 20 mL of solvent in an 18 x 150 mm glass
culture tube. The tube was capped with foil to prevent evaporation and placed into a
preheated water bath. The tube was vortexed every 5 minutes until the agarose
completely dissolved. 10 mL aliquots were stored in 15 mL conical tubes at 4°C. Prior to
mounting, an aliquot was microwaved briefly, no more than 10 seconds at a time, and
vortexed until all the agarose had liquefied. It is important not to overheat or open the
tube during heating to prevent molten agarose from escaping. The aliquot was then
equilibrated in a 40°C water bath for 30 minutes prior to use.
For mounting, a yellow pipette tip was cut to create an opening large enough to
accommodate a single embryo. Live embryos were anesthetized in 0.016% Tricaine
methanesulfonate while fixed, immunolabeled samples were not anesthetized, and were
transected posterior to the hindbrain to facilitate mounting. In either case, a single
embryo was collected into the pipette tip. The embryo was carefully deposited into the
tube containing molten agarose, and quickly recollected into the tip along with 20-30 µL
of agarose. The embryo was then placed onto the dish or coverslip in a drop of agarose
and positioned using a pin. Agarose solidifies within 1-2 minutes so embryos were
positioned quickly. Once all samples were solidified, E3 media was added to prevent the
samples from drying.
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2.1.3 Preparation of 7.5% N-Phenylthiourea stock

This recipe is taken from the ZFIN Wiki (https://wiki.zfin.org/display/prot/PTU2). PTU is very toxic so eye shields, gloves and face shields were worn during handling.
0.75 g of PTU powder (Sigma) was dissolved in 10mL of anhydrous DMSO (Sigma).
This stock formulation was chosen because PTU dissolves quickly in DMSO without the
need to heat or stir. PTU stock was then split into 1mL aliquots and stored at 4°C. 40 µL
of 7.5% stock was used per 100 mL of E3 media to obtain a final concentration of
0.003%.

2.1.4 Determination of zebrafish Nox domains

Amino acid sequences for human NOX1 (Q9Y5S8), NOX2 (P04839), NOX5
(Q9Y5S8) and DUOX1 (Q9NRD9) were downloaded and manually annotated using
domain and binding site information from UniProt (http://www.uniprot.org).
Transmembrane helices, calcium binding domains, peroxidase-like domains and substrate
binding domains were mapped to the human amino acid sequences using Vector NTI
version 8.0 (InforMax, Inc. now Thermo Fisher). Corresponding zebrafish protein
sequences were downloaded from GenBank (Nox1, NP_001095857.1; Nox2/Cybb,
NP_956708; Nox5, XP_009296060.1; Duox, BAF33370.1). The sequences for each
domain of the human protein were individually aligned to the full sequence of the
zebrafish protein in Vector NTI. In all cases, the zebrafish sequences retained ≥80%
similarity within domains. Outside of these domains, the sequences varied. Importantly,
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transmembrane helices III and IV retained the critical heme-binding histidine residues
confirming that these sites mapped to the human sequence. Mutant proteins sequences
were predicted by translating the mRNA sequences, determined for each line, using the
Vector NTI. The resulting amino acid sequences were aligned to the wild type sequence
to determine which functional domains were lost. Figure 7.2 shows all of the predicted
domains that remain in the NOX mutant lines generated thus far.

2.2 Methods for Chapter 3

2.2.1 Aplysia bag cell neuronal culture

Aplysia bag cell neurons were plated on coverslips coated with 20µg/ml poly-Llysine (70-150 kDa) as previously described (Lee et al., 2008; Suter, 2011). Cells were
kept in L15 medium (Invitrogen, Carlsbad, CA) supplemented with artificial seawater
(L15-ASW: L15 plus 400 mM NaCl, 10 mM CaCl2, 27 mM MgSO4, 28 mM MgCl2, 4
mM L-glutamine, 50 µg/ml gentamicin, 5 mM HEPES, pH 7.9) overnight at 14o C. All
reagents were from Sigma (St. Louis, MO) unless otherwise specified.

2.2.2 Live cell imaging and neurite outgrowth analysis

For live-cell imaging, a chamber containing Aplysia bag cell neurons cultured for
1 day was prepared as recently described (Lee et al., 2008; Suter, 2011). 0.1% DMSO
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(vehicle control), 5 µM VAS2870 (Enzo Life Sciences, Farmingdale, NY) or 5µM
celastrol (Cayman Chemical, Ann Arbor, MI) dissolved in L15-ASW medium were
sequentially applied to live neurons, while cells were observed with a 60x 1.4 NA oil
objective (plus 1.5x magnification) using a Nikon TE2000 Eclipse microscope (Nikon,
Melville, NY; (Munnamalai and Suter, 2009). An OG590 long-pass red filter (Chroma
Technology Corp., Bellows Falls, VT) was used to eliminate shorter wavelengths harmful
in live cell imaging. Each drug was pre-incubated for 5 min before differential
interference contrast (DIC) time-lapse imaging at 10 second intervals was performed.
VAS2870 and celastrol were applied for a total of 20 min. The drug was then washed out
with fresh L15-ASW. For retrograde flow analysis, three kymographs of DIC time-lapse
sequences were constructed from each growth cone using line scans across the peripheral
(P) domain using MetaMorph 7 software (Molecular Devices, Downingtown, PA).
Retrograde flow rates of individual growth cones were determined by averaging 5
velocity measurements from each kymograph.
Neurite outgrowth experiments were carried out as described previously
(Munnamalai and Suter, 2009). Neurons were imaged in L15-ASW medium 4 hours after
plating using a 10x phase objective. The medium was then replaced with L15-ASW
medium containing 0.05% DMSO or 2.5µM VAS2870 or 1µM celastrol. Cells were then
incubated at 14°C for 24 hours prior to a second round of imaging. Drugs were then
washed out extensively with fresh L15-ASW and cells were incubated at 14°C for an
additional 24 hours prior to the collection of a final set of images. Total neurite length
was calculated by summing the lengths of all neurites per cell. Only cells with total
neurite length of ≥ 50µm were included in the analysis.
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2.2.3 Immunolabeling and fluorescent imaging

After 1d in culture, bag cell neurons were fixed with 3.7% formaldehyde/400mM
sucrose/ASW, pH 7.6 for 20 min at room temperature (RT). Following fixation, cells
were permeabilized with 0.1% saponin in fixation solution for 15 min. After three washes
with PBS/0.01% saponin, cells were incubated with 2 units/ml (1:100) Alexa 488phalloidin (Invitrogen) in PBS/0.01% saponin for 20 min. Following three washes, cells
were blocked with 5% BSA in PBS/0.01% saponin for 30 min. For detection of NOX2,
the rabbit anti-gp91phox antibody R2085 was incubated at 1:500 in blocking solution for
1h. This antibody was raised against a peptide corresponding to AA 548-560 in human
gp91phox (Quinn et al., 1989). For peptide blocking experiments we used the human
NOX2 548-560 peptide KQSISNSESGPRG or the corresponding Aplysia NOX2 peptide
KHCNRFSSSESK (XP_005090645). The NOX2 antibody was diluted at 1:500 in
blocking solution together with the same dilution of either the human or Aplysia peptide
(10 mg/ml stock; Genscript, Piscataway, NJ) over night at 4 C before the antibody was
applied to fixed neurons. A mouse anti-p40phox was used at a 1:200 dilution in blocking
solution for 1 h at RT. This antibody was raised against full length human p40phox (Gauss
et al., 2002). apCAM was detected with the monoclonal antibody 4E8 diluted to 10 µg/ml
in blocking solution (Suter et al., 1998). Following three washes, primary antibodies were
detected by applying either 4 µg/ml Alexa 568 or Alexa 647 labeled goat-anti-rabbit or
mouse secondary antibodies (Invitrogen) in the same blocking solution for 30 min at RT.
Fluorescent images were acquired in 20 mM n-propyl-gallate in PBS/80%
glycerol pH 8.5 on a Nikon TE2000 Eclipse microscope equipped with a 60X 1.4 NA oil
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(plus 1.5x magnification) objective, an X-cite 120 metal halide lamp (EXFO, Mississauga,
Ontario, Canada), appropriate fluorescence filter sets (Chroma, Bellows Falls, VT),
Cascade II cooled CCD camera (Photometrics, Tucson, AZ) and MetaMorph 7 software
(Molecular Devices, Downingtown, PA). Neuronal cell bodies were imaged by acquiring
z-stacks with 10µm intervals on a Zeiss LSM 710 confocal microscope equipped with
488, 568 and 610 nm lasers and appropriate filters.

2.2.4 ROS imaging

For quantitative ROS imaging, we used a hydrogen peroxide (H2O2)-specific
fluorescent dye Peroxyfluor-6 acetoxymethyl ester (PF-6) kindly provided to us by Dr.
Christopher Chang, University of California, Berkeley CA (Dickinson et al., 2011). After
one day in culture, growth cones were incubated for 20 min in the dark with artificial
seawater (ASW) containing 5µM PF-6 (for H2O2 detection) together with 250nM Calcein
Red-Orange AM (Invitrogen), a cell permeable fluorescent dye used as volume marker
for ratiometric imaging (Li et al., 2009). Three washes with ASW were performed to
remove free dye. Pre-treatment images (time 0) were captured using a Nikon TE2000
Eclipse microscope using a 480 nm excitation and 535 nm emission filter for PF-6 and a
575nm excitation and 610nm emission filter for Calcein Red-Orange. The growth cones
were then treated with ASW containing 0.1% DMSO, 0.1 µM phorbol 12,13-dibutyrate
(PDBu; a protein kinase C activator), 5 µM VAS2870 or a combination of PDBu and
VAS for up to 15 min before a second set of images were taken of the same growth cones.
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Average fluorescent intensities of both PF-6 and Calcein Red-Orange signals
were measured in three regions in the growth cone periphery and then backgroundsubtracted using MetaMorph software. Each PF-6 and Calcein Red-Orange growth cone
measurement was then normalized by the average DMSO control value at the same time
point to correct for experimental variability. The DMSO-normalized signals were then
volume-corrected by dividing PF-6 values by the corresponding Calcein Red-Orange
values. Volume-corrected PF-6 signals were calculated as percent changes of H2O2 levels
at specific time points by dividing each value by the time 0 value.

2.2.5 Image Processing, Fluorescence Intensity and Colocalization Analysis

Photoshop CS3 extended (Adobe, San Jose, CA) was used for image processing
and making videos. Canvas X (ACD Systems of America, Inc, Miami, FL) was used for
final figure assembly. For quantification of NOX2 and p40phox signals, the average NOX2
and p40phox fluorescence intensities per unit area was determined in the growth cone P
domain using MetaMorph 7.0. For quantification of p40phox colocalization with NOX2 or
F-actin, each signal was thresholded at the level of the average intensity plus 10% for a
given area. After thresholding, the colocalization analysis function in MetaMorph was
used to determine the % area overlap of p40phox with either NOX2 or F-actin or the %
area overlap of NOX2 with either p40phox or F-actin.
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2.2.6 Statistical Analysis

Quantified data are presented as mean values ± SEM. STATISTICA 10 Academic
software (StatSoft, Inc., Tulsa, OK) was used for statistical data analysis. Significant
differences between two conditions were determined with Student’s t-tests if data showed
normal distribution. Comparison of multiple conditions was performed with a one-way
ANOVA followed by Dunnett’s T3 post-hoc test. Significance levels were labeled as
follows: *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.

2.3 Methods for Chapter 4

2.3.1 Quantitative PCR

Total RNA was isolated from 12, 24, 36 and 48 hpf embryos with TRIzol reagent
(Life Technologies, Carlsbad, CA). 36 and 48 hpf embryos were anesthetized with 0.016%
Tricaine methanesulfonate (Sigma) prior to RNA isolation. First-strand cDNA was
prepared using the polyA primers supplied in the SuperScript®III First-Strand Synthesis
System (Life Technologies). Primer sets against nox1, nox2/cybb, nox5, and duox, β-actin
and ribosomal protein L13a were designed to target exons using ProbeFinder software
(version 2.50, Roche Diagnostics, Indianapolis, IN). See Table 2.1 for a summary of
primer sequences. For each gene and each stage, samples were analyzed in three
independent wells in a single 96-well plate. The experiment was repeated with two
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biological replicates of total RNA isolated from independent cohorts of embryos.
Samples were run in a LightCycler96 (Roche Diagnostics, USA) for 35 cycles, and the
relative expression levels were analyzed with the accompanying software (version
1.0.0.1240; RRID: rid_000088). Relative expression levels were calculated using the
cumulative ratio of the cycle threshold of the target gene to the cycle threshold of two
reference genes (rpl13a and beta-actin). These two genes were chosen as they show the
most consistent expression pattern of commonly used reference genes (Tang et al., 2007).
These calculated values were then normalized against the relative expression value for
nox2/cybb at 12 hpf. nox2/cybb was chosen for normalization because of the stability of
expression throughout the testing period. One-way ANOVA and direct comparisons via
Dunnett’s post-hoc analyses were carried out using GraphPad Prism software version
6.05 (RRID: rid_000081).

Table 2.1: Quantitative PCR primers
Gene

Gene ID

Primer
Forward
nox1
NM_001102387.1
Reverse
Forward
nox2/cybb
NM_200414.1
Reverse
Forward
nox5
XM_009297785.1
Reverse
Forward
duox
XM_001919359.5
Reverse
Forward
Rpl13a
NM_212784.1
Reverse
Forward
β-actin
NM_007393.3
Reverse

5’ to 3’
GCTCCAAGACTCCAGTGAATTA
GACCCGCAATACTGGTGAATA
CTTTCGTTATGAAGCGGTGATG
GGTTCTCCTGGACGTGTTTAT
TCATGTGCCGCTATCGTATG
CCACCTTCCTCAGCTTCATT
CCTGGGAGGACTTTCACTTTC
CTTGTGCTGTCTGCCTAGTT
TCCTCCGCAAGAGAATGAAC
TGTGTGGAAGCATACCTCTTAC
CCTTCCAGCAGATGTGGATTAG
TGAAGTGGTAACAGTCCGTTTAG

Gene IDs are taken from GenBank.
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2.3.2 in situ hybridization

Probe sequences were amplified from 3 day-old zebrafish cDNA, prepared as
described above, and cloned into the pGEM-T Easy vector (Promega, Madison, WI).
Primers used for amplification are indicated in Table 2.2. Probe sequences were selected
by aligning the zebrafish nox genes, and identifying isoform-specific regions. Each
prospective sequence was then used as the query for a BLAST search against the
zebrafish RefSeq RNA database. The selected probes did not align to any other gene
besides the target. The sizes of the riboprobes are as follows: nox1- 207 nucleotides
(NM_001102387.1 position 645-851), nox2/cybb- 207 nucleotides (NM_200414.1
position 719-925), nox5- 202 nucleotides (XM_009297785.1 position 512-713) and
duox- 1000 nucleotides (XM_001919359.5 position 1013-2012). Probe-containing
vectors were then linearized, and riboprobes synthesized using the DIG RNA Labeling
Kit (Roche Diagnostics) and purified with 4M LiCl (Sigma) precipitation.
The in situ hybridization protocol was adapted from previous reports (Thisse and
Thisse, 2008; Hensley et al., 2011). Whole-embryos were anesthetized in 0.016%
Tricaine methanesulfonate (Sigma) at 24, 36 and 48 hpf before fixation in 4%
paraformaldehyde in PBS (Sigma). Samples from the same time-point were processed
together. The samples were then dehydrated stepwise in methanol (30%, 50% 70%,
100%), digested with 10 µg/mL Proteinase K (Worthington Biochemical Corp.,
Lakewood, NJ) for 5 min (24 hpf), 12 min (36 hpf) or 20 min (48 hpf), and prehybridized in hybridization buffer (50% formamide, 5x saline sodium citrate (SSC), 0.1%
Tween 20, 5 mg/mL torula RNA, 50 µg/mL heparin) overnight at 65°C. Embryos were
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then incubated overnight with 100 ng of riboprobe in 0.5 mL of hybridization buffer at
65°C. Excess and imperfectly bound probes were then removed by washing twice with
50% formamide/2x SSCT (SSC, 0.1% Tween 20) at 65°C, once in 2x SSCT and twice in
0.2x SSCT. Finally, embryos were washed twice with PBST (1x PBS, 0.1% Tween 20).
Anti-digoxigenin (DIG) antibodies (Roche Diagnostics) were pre-adsorbed by diluting
1:1000 in blocking solution (2 mg/mL bovine serum albumin, 2% normal sheep serum,
1x PBST) containing ≥ 50 embryos of various stages overnight at 4°C on a shaker. RNAhybridized embryos were incubated in blocking solution for 2 h at room temperature.
DIG-containing riboprobes were labeled overnight at 4°C on a rocker with pre-adsorbed
anti-DIG antibody diluted 1:3 in blocking solution. Excess antibody was removed with
five washes in PBST and three washes in staining buffer (100 mM Tris pH 9.5, 50 mM
MgCl2, 100 mM NaCl, 0.1% Tween 20, 1 mM levamisol). The colorimetric reaction was
carried out by incubation in nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate
(Sigma) diluted in water at room temperature until slight color was visible in the sense
control samples. The incubation times were kept consistent among time points for each
gene (nox1 for 3 h, cybb for 3 h, nox5 for 4 h and duox for 2.5 h). Non-specific signals
were washed out with a series of methanol washes (30%, 50% 70%, 100%) and a twomin incubation in benzyl alcohol/benzyl benzoate solution (2:1). Finally, the destained
embryos were rehydrated with a series of methanol washes (100%, 70% 50%, 30%) and
three washes in PBST.
Labeled embryos were stored in 4% paraformaldehyde in PBS at 4°C and imaged
as whole-mounts on a microscope slide in 3% methylcellulose using an Olympus SZX16
stereo microscope (Olympus Corp., Center Valley, PA) with an SDF PLAPO 1xPF

44
objective prior to being embedded in blocks of Tissue Freezing Media (Triangle
Biosciences, Cincinnati, OH). A series of 10 µm transverse sections was collected from
the most anterior region of the embryo through the spinal cord using a Leica CM 1510S
cryostat (Leica Biosystems, Buffalo Grove, IL). Sections were mounted on microscope
slides in VectaMount permanent mounting medium (Vector Laboratories, Burlingame,
CA). Cryosections were imaged on an Olympus BX51 upright microscope at with
UPlanFL 10x/0.3 and UPlanS Apo 20x/0.75 objectives, respectively (Olympus Corp.).
Images from both microscopes were captured using a SPOT RT3 2.0Mp Slider CCD
camera (SPOT Imaging Solutions, Sterling Heights, MI). At minimum, five individual
samples were processed for each gene and time-point combination.

Table 2.2: PCR primers used to amplify in situ probes
Gene

Gene ID

nox1

NM_001102387.1

nox2/cybb

NM_200414.1

nox5

XM_009297785.1

duox

XM_001919359.5

Primer
Forward

5’ to 3’
TGCTGGTTTAGTTTTCCACG

Reverse

AGCAGCCGTTCACAAATGTA

Forward

CATTGGATTGGTGCTTCATG

Reverse CTCTCACAGACATACAGGAACATG
Forward

ACAACAGTGGCTCCATCACA

Reverse

CCGTACAGGCAAAGGAAGAAG

Forward ATATAAAAGGAACAGGACGTGTCA
Reverse GAAGGTCTGGAAAACTTTCTTCTC

Gene IDs are taken from GenBank.
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2.4 Methods for Chapter 5

2.4.1 Inhibitor treatment of live embryos

Chorions were removed from embryos at approximately 24 hpf (prim-5 stage)
using sharp forceps. Embryos were then maintained at 28°C until they reached 32 hpf
(prim-16 stage). E3 media was then replaced with media containing 2.5µM celastrol
(Cayman Chemical, Ann Arbor, MI) dissolved in DMSO. Control embryos received
media containing 0.1% DMSO alone. Embryos were then returned to the incubator for 4
hours after which they were washed extensively with fresh E3 media. Following drug
treatment, embryos were returned to the incubator and maintained in E3 media containing
0.003% PTU.

2.4.2 Immunolabeling

At the indicated stages, samples were anesthetized in 0.016% tricaine and fixed
overnight in 4% PFA/1x PBS at 4°C. All steps were carried out in 1.5mL microcentrifuge
tubes unless specified otherwise. Embryos were then washed twice with 0.5mL PBT (1x
PBS, 0.5% TritonX-100) at RT for ten minutes per wash. Next, samples were incubated
in pre-chilled acetone for 30 (48 hpf), 40 (72 hpf), 50 (96 hpf) or 60 minutes (120 hpf) at
-20°C. Samples were then washed four times with 0.5mL PBT for five minutes per wash.
Samples were then incubated with 10µg/mL Proteinase K (dissolved in PBT) at RT
(Worthington Biochemical Corp.). Proteinase K digestion times were 10 (48 hpf), 15 (72
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hpf), 20 (96 hpf) or 30 minutes (120 hpf). Embryos were then post-fixed in 4% PFA/1x
PBS for 30 minutes, and washed four times with 0.5mL PBT for 30 minutes per wash.
Samples were then incubated with blocking solution (10% goat serum in PBT; Sigma) for
2 hours at RT. Mouse monoclonal antibody against zebrafish alcama, zn-8 (Zebrafish
International Resource Center [ZIRC], Eugene, OR), was diluted 1:500 in blocking
solution and spun at max speed for 30 minutes at RT. Samples were then incubated in
primary antibody solution overnight at 4°C. The following day, samples were washed
four times with 0.5mL PBT for one hour per wash. Secondary antibody, goat anti-mouse
Alexa Fluor 488 (Thermo Fisher, Rockford, IL), was diluted 1:500 in blocking solution.
The nuclear counterstain diamidino-2-phenylindole (DAPI) was added to the secondary
solution at a 1:500 ratio (Thermo Fisher). Samples were incubated overnight in secondary
antibody solution at 4°C. The following day, samples were washed four times with
0.5mL PBT for one hour per wash and stored at 4°C in the dark.
Immunolabeled samples were positioned on coverslips in 1% low melting point
agarose dissolved in 1x PBS as described in section 2.1.2. A microscope slide was
prepared by filling a grease ring with 70% glycerol/1x PBS. The coverslip containing
samples was then inverted onto the microscope slide, and pressed down to seal onto the
grease ring. Excess 70% glycerol/1x PBS was aspirated and the slide was cleaned with
glass cleaner. Z-stacks were collected at 1µm intervals using a Zeiss LSM 710 inverted
scanning confocal microscope equipped with a 40x LD C-Apochromat 1.1 NA W Korr
M27 objective (Zeiss USA, Thornwood, NY). Panels showing zn-8 labeling are
maximum intensity projections while DAPI panels show a single optical section.
Maximum intensity projections were created using ImageJ software (Schneider et al.,

47
2012) and additional image processing was performed with Photoshop CS3 extended
(Adobe, San Jose, CA).

2.4.3 Live-imaging of transgenic lines

We used Tg(ath5:GFP) embryos to visualize RGCs and RGC axons in live
embryos (Poggi et al., 2005). Samples were anesthetized in 0.016% tricaine
methanesulfonate (Sigma) and mounted in 1% low melting point agarose on 35mm glassbottom dishes. Dishes were then filled with E3 media containing 1x tricaine. Images were
acquired from the anterior perspective showing the eyes and optic chiasm on a Nikon
TE2000 Eclipse microscope equipped with a 10x Plan Fluor 0.3 NA oil objective, an Xcite 120 metal halide lamp (EXFO), appropriate fluorescence filter sets (Chroma),
Cascade II cooled EM-CCD camera (Photometrics) and MetaMorph 7.8 software
(Molecular Devices). Dorsal images showing the optic tecta were collected on a Zeiss
LSM 710 laser scanning confocal microscope using a 20x Plan-Apochromat 0.8 NA M2
objective (Zeiss USA). For multi-day imaging, embryos were removed from agarose with
a scalpel and forceps and maintained in 24-well plates at 28°C. The embryos were then
remounted as described each subsequent day.

2.4.4 Hydrogen peroxide rescue

In celastrol-treated embryos, 2mM H2O2 was applied immediately following drug
washout (section 2.4.1). Samples were maintained in H2O2-containing media until harvest.
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We chose not to co-incubate celastrol and H2O2 due to possible complications arising
from the direct oxidation of celastrol which may interfere with activity. gRNA-injected
embryos were maintained in media containing 2mM H2O2 from injection to harvest. We
tested the effects of prolonged exposure to H2O2 concentrations ranging from 1-5mM
H2O2. Using Tg(ath5:GFP) embryos, we found that concentrations less then 2.5mM did
not affect embryonic survival, morphology or optic nerve outgrowth (see Figure 5.2). We
did find that H2O2-treated embryos showed more melanization compared to non- H2O2
exposed groups even when treated with 0.003% PTU. At later stages, this increased
pigment caused dark spots in fluorescent images. This can be observed in Fig. 5.3H”.

2.4.5 gRNA design and synthesis

gRNAs were designed with software from Massachusetts Institute of Technology
(http://crispr.mit.edu/) that generates a list of scored candidate gRNAs as well as a list of
scored potential off-target regions. Scores range from 0-100 with 100 being the top score.
The algorithm used to calculate scores is not available, but it is clear that gRNAs with
few, poorly matched off-targets have the best scores. Off-target scoring is determined by
the number and position of mismatches. The higher the off-target score, the higher
probability that the gRNA will bind. Coding sequences from the each of the zebrafish nox
genes were input into the software to generate a list of candidate gRNAs. Each was then
evaluated for their location in the target gene and the probability of off-target binding.
We identified two gRNAs per isoform targeting early regions of the coding sequence and
with a score ≥ 95 (Table 2.3 and shown in Fig. 5.3A & 7.2). In order for a gRNA to be
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chosen, it’s predicted off-target sites met the following criteria: score ≤ 0.5, ≥ 2
mismatches in the 11 nucleotides adjacent to the protospacer adjacent motif (PAM), ≥ 4
mismatches overall and ≤ 2 predicted exonic off-targets. These strict parameters were
chosen to minimize the probability of off-target mutagenesis. A summary of the predicted
off-target sites for each gRNA is given in Table 2.4.

Table 2.3: gRNAs targeting zebrafish nox genes
gRNA
Sequence (5'-3')
PAM Score Gene ID Chr.
nox1 I
GGGAAAGGGATTAAGGTAAG TGG 96
555604
14
nox1 II
GGTTTAGTTTTCCACGGCGC AGG 98
nox2/cybb I GGAAACTTTGCTGCAAATGA AGG 97
393386
11
nox2/cybb II GGATTGGTGCTTCATGGAAT CGG 97
nox5 I
GGTGACCCATTCCAGCCAGC GGG 99
100149800 25
nox5 II
GGGAGATCGCACTCTCTCGC AGG 96
duox I
GGTGCTGATCCTCCGAGGGT TGG 95
565097
25
duox II
GGCAGACTGGGACACGAGCA CGG 99
gRNA sequences are listed along with the protospacer adjacent motif (PAM). Ideal PAM sites should are
‘NGG’. Scores were assigned by the design software. Gene IDs refer to GenBank accession numbers.

We then used a set of zebrafish codon optimized plasmid constructs to transcribe
the gRNAs and Cas9 mRNA (Jao et al., 2013). The full protocol for plasmid construction
is given at http://www.addgene.org/crispr/Chen. Forward and reverse oligos matching the
gRNA sequences shown in Table 2.3 were ordered from Integrated DNA Technologies
(Coralville, IA). TAGGN18 was added to the forward strand and AAACN18 was added to
the reverse strand to facilitate cloning. 2µL of 100mM stock from the forward and
reverse oligos was combined with 2µL NEBuffer 1 (New England Biolabs, Ipswitch, MA)
and 14µL ultrapure water. The tube was then heated in a thermal cycler to 95°C for 5
minutes, ramped down to 50°C for 10 minutes and held at 4°C.
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Annealed oligos were cloned into the pT7-gRNA vector (Cat. 46759; Addgene,
Cambridge, MA) by combining the following: 1 µl annealed oligos, 400ng pT7-gRNA
vector, 1µl 10x NEBuffer 3, 1µl 10x T4 ligase Buffer, 0.5µl BsmBI, 0.3µl BglII, 0.3µl
SalI, 0.5µl of T4 DNA ligase, and water to a total of 10µl. All buffers and enzymes were
from NEB. The single-step digestion and ligation was carried out in a thermal cycler with
three cycles of 20 minutes at 37°C and 15 minutes at 16°C. Samples were then incubated
for 10 minutes at 37°C, 15 minutes at 55°C, and 15 minutes at 80°C.
The product was transformed into lab-made, chemically competent E. coli (DH5alpha strain) according to the following protocol. 50µL of cells were thawed for < 5
minutes on ice. 2µL of the ligated gRNA vector was added to the cells and then incubated
for 30 minutes on ice. Cells were then heat shocked in a water bath at 42°C for 30
seconds and returned to ice for 5 minutes. Cells were diluted in 300µL of pre-warmed
SOC media and incubated at 37°C on a shaker for 1 hour. 50-100µL of the cell
suspension was plated onto LB plates containing 50µg/mL carbenicillin (Sigma) and
incubated at 37°C overnight. The following day, single colonies were picked and growth
in 3mL liquid cultures overnight. DNA was isolated using the Wizard SV plus miniprep
system (Promega), and analyzed via restriction digest and Sanger sequencing. pCS2-nlszCas9-nls plasmid (Addgene Cat. 47929) was also transformed into bacteria and isolated
via miniprep.
Plasmids were then linearized with BamHI (gRNA vector) or NotI (Cas9 vector)
and purified using the Wizard SV PCR cleanup system (Promega). Cas9 mRNA was
transcribed using the mMessage mMachine SP6 kit (Thermo Fisher), and gRNAs were
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synthesized using the MEGAshortscript T7 kit (Thermo Fisher). DNA was then
quantified using a NanoDrop Lite (Thermo Fisher).

Table 2.4: Potential off-target sites for gRNAs
gRNA
Sequence (5'-3')
nox1 I
A GGAAAGAT ATTAAGGTG AG
nox1 II
GGTTTT GTTTTCCCA GGCT C
nox2/cybb I GC AG ACTTTC CTC CAAATGA
nox2/cybb II GGATTGGG GCTTCG TGGAGG
nox5 I
GGTCT CCCAC TCCT GCCAGC
nox5 II
GT GAGATCGCAG TCC CTCGA
duox I
GA TGCTGT TCCTCCGAT GGA
duox II
GGGG GACTGC GAA ACGAGCA

PAM Score Gene ID
GAG 0.2 567212
CAG 0
567798
AGG 0.5 387260
AGG 0
393852
AAG 0.2 568565
AAG 0.1 368662
CAG 0.3 563429
GAG 0.5 368415

Chr.
15
2
8
7
20
2
5
12

Sequences for the predicted off-target sites along with the accompanying PAM. Bold characters represent
mismatches. Scores were assigned by the design software. Gene IDs refer to GenBank accession numbers,
and the chromosome on which each sequence appears is given.

2.4.6 gRNA injection

Microneedles were prepared by pulling 1mm borosilicate capillaries (World
Precision Instruments, Sarasota, FL, Cat. 1B100F-4) with a single pull at 68°C on a
vertical puller (Narishige Intl. Inc., East Meadow, NY, Model PP-830). The tips of the
needles were broken with fine forceps under a stereomicroscope (AmScope, Irvine, CA,
Cat. ST-6TP) to a width of 5-10µm. The injection mix was prepared by diluting the
gRNA to 90-120ng/µL and Cas9 mRNA to 150ng/µL in a solution containing phenol red
(1:10, Sigma) as a tracer. The injection needle was filled with 1-2µL of injection mix
using a narrow pipette tip and secured into the micromanipulator (World Precision
Instruments).
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Embryos were collected as described in section 2.1.1, and transferred to injection
molds consisting of 1.5% agarose in E3. One nanoliter of a mix containing 90-120ng/µL
gRNA and 150ng/µL Cas9 mRNA was injected into single-cell embryos. After injection,
the embryos were collected in petri dishes and maintained at 28°C. Dead embryos were
removed the following day and media was changed daily.

2.4.7 Genotyping

Genomic DNA was isolated from 72 hpf tail biopsies (Wilkinson et al., 2013) or
whole embryos (Meeker et al., 2007). Tail biopsies were performed by first anesthetizing
embryos in 0.016% Tricaine. Embryos were then placed onto the lid of a petri dish, and a
small region of the tail was cut with a clean scalpel. The embryo was then placed into one
well of a 24-well plate filled with fresh E3 for recovery. The tail biopsy was transferred
into a 0.5mL tube containing 13.5µL of 50mM NaOH with a clean 10µL pipette. Fish can
be maintained in the 24-well plate up to 5 days post-fertilization. Whole embryos were
anesthetized and directly dissolved in 50mM NaOH. In either case, samples in 50mM
NaOH were incubated for 10 minutes at 95°C. One-tenth volume of 1M Tris HCl pH 8.0
was added to neutralize, and the samples were stored at -20°C. DNA was then quantified
using a NanoDrop Lite (Thermo Scientific, Wilmington, DE). 5-10ng of DNA was used
for PCR amplification using GoTaq Flexi polymerase (Promega).
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Table 2.5: PCR primers for genotyping
gRNA

PCR primer sequence (5'-3')
Product length (bp)
ACA GTT TAG AGG GTG AAG AC
nox1 I
143
CTC TGA CAG GAC TGG TTT A
GTA CAC GCA TCA CCT CTT C
nox1 II
139
TTG GAC GAA AGC GTC TG
CCC GAT AGC TTA CGA TAA CAA A
nox2/cybb I
105
CTC TCG ATC TCA TCT CCT GAT
GAA TAG AAG CAA ACC CTC ACC
nox2/cybb II
109
GTC ATC CGA AGG TCC TAC TT
AATTTCACCCCTCACCATCC
nox5 I
903
GACATGTTTCTTCTGACACAAC
AAT GTG ATG GAG CCA CTG
nox5 II
142
CTA TAG ACC CAG ATG AGT TGC
TCT CTG GTC CGT CTG TAT C
duox I
143
ACG CTT CTG TTC TTG TGG
GTC TCC AAC TCT TCA CAG C
duox II
105
GTA TAC ACG CAC CTG TGT C

Genotyping was done using a gel based method that was previously published
(Zhu et al., 2014). Briefly, gRNA target regions were amplified via PCR using the
primers listed in Table 3. Following PCR amplification, samples were heated to 95°C and
allowed to cool for 10 minutes at RT. Samples were then loaded onto a 15% acrylamide
gel (29:1 acrylamide:bis ratio, Bio-Rad Laboratories, Hercules, CA) without SDS and run
for 2.5 hours at 150V. Gels were stained with 50µg/mL ethidium bromide (Sigma) for 10
minutes to visualize DNA bands. Heteroduplexes indicative of heterozygous mutants or
chimeras exhibited slower electrophoretic mobility as described previously (Zhu et al.,
2014). In addition, we were able to reliably distinguish wild type and homozygous
mutants due to the electrophoretic shift as a result of DNA deletions (data not shown; see
Fig. 4A for a mutant sequences). For each set of PCR primers, the gel-based method
described here was initially verified with Sanger sequencing to ensure reliability.
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2.4.8 Generation of stable mutant lines

NOX2/CYBB gRNAs and Cas9 mRNA was injected into embryos from a cross of
AB strain, wild type fish. The injected embryos were genotyped via tail biopsy, and
mutants were raised to adulthood. Adult injectants were outcrossed with an unrelated AB
line, and the resultant embryos were again genotyped via tail biopsy at 72 hpf. DNA from
heterozygotes showing the formation of heteroduplexes on acrylamide gels was reamplified and purified with the Wizard SV Gel and PCR Clean-Up System (Promega).
Purified DNA was then cloned into the pGEM-T Easy vector (Promega) for sequencing.
Mutant sequences were confirmed with at least three technical replicates showing the
same mutation from an individual larva. We then used Vector NTI (Thermo Fisher) to
determine the resulting amino acid sequences, and these were aligned to the wild type
protein sequences. Heterozygous larva carrying mutations leading to truncated
NOX2/CYBB proteins were used to found lines by outcrossing with AB strains to
achieve a stable population of nox2/cybb+/- adults. nox2/cybb-/- embryos were produced
by crossing these heterozygous lines. Homozygous, nox2/cybb-/-, embryos used for
analysis were identified via gel-based genotyping and/or Sanger sequencing.

2.4.9 Quantification of retinal and tectal anatomy

Length and area measurements were performed on raw images using MetaMorph
7 software (Molecular Devices). Optic nerve thickness was measured 5-10µm medial to
the ganglion cell layer (Figure 5.1A). Two measurements were taken per embryo and
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these were averaged to produce single value per sample. Area of the GCL was measured
from single images (Tg(ath5:GFP)) or max intensity projections from 10, 1µm optical
sections centered on the optic nerve (zn-8 labels). Retinal areas were measured from
phase images (Tg(ath5:GFP)) or a single 1µm optical section from the DAPI channel
centered in the optic nerve (zn-8 labels). GFP- or zn-8-positive area measurements were
divided by the corresponding total retinal area to obtain the values reported. Again, two
values were averaged per embryo. Tectal area was measured from maximum intensity
projections compiled from 25-30, 1µm optical sections. An example of the measured area
of one tectum is shown in Figure 5.1I. Areas from the left and right tecta were averaged
to produce a single value for each embryo. Line scans of zn-8 fluorescent intensity in the
optic tectum were performed with MetaMorph 7 software using raw, maximum intensity
projections from 30-35, 1µm optical sections through the midbrain. Lines were drawn
from ~10µm outside of the sample to a depth of ~250µm (72 hpf) or 300µm (120 hpf)
into the midbrain. Average intensity was collected from 25 pixels on either side of the
line. Examples of the position of the line scans is shown in Figure 5A & D. Graphs of
average intensity along the length of each line scan were produced using GraphPad Prism
software version 6.05. Integrated intensity values were calculated from the area under the
curve for each condition.

2.4.10 Statistical analysis

Data sets were analyzed using GraphPad Prism software version 6.05 (GraphPad
Software, Inc, La Jolla, CA). All raw data was assessed for normality using the
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D'Agostino-Pearson omnibus test included in GraphPad. All data displayed a normal
distribution (p ≥ 0.05), and no transformations were necessary. Outliers were
automatically identified and removed using the ROUT algorithm with a Q-value of 1%.
In all cases, ≤ 2 outliers were identified per group. Since all data sets contained three or
more groups, one-way ANOVA was used to identify differences among means, and pvalues less than 0.05 were considered significant. Corresponding F statistics and p-values
are reported in the Results section. If a significant difference was detected with the
ANOVA, the Tukey HSD method was used for multiple comparisons among groups or
the Dunnett’s test was used for specific comparisons to a control. The test used is
specified in the figure legend. Tukey or Dunnett’s adjusted p-values are displayed in the
figures and the Results section. Graphs in Chapter 5 show mean ± standard deviation for
each group.

2.5 Methods for Chapter 6

2.5.1 SiR-actin and SiR-tubulin labeling

NIH/3T3 fibroblasts were seeded at 3000 cells per cm2 on uncoated 35mm glass
bottom dishes. Media was DMEM (Thermo Fisher) supplemented with 10% calf serum,
Pen/strep, 20mM HEPES and 20mM L-glutamine (all from Sigma). The cells were
allowed to adhere for 6-10 hours at 37°C in a humidified incubator with 5% CO2. Once
the cells start to become adherent, media was replaced with 2-3mL of media containing
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SiR-actin or SiR-tubulin probes at 100-200nM. The dishes were then maintained in the
incubator for ~12 hours and imaged using a Nikon TE2000 Eclipse microscope equipped
with a 60X 1.4 NA oil (plus 1.5x magnification) objective, an X-cite 120 metal halide
lamp (EXFO), appropriate fluorescence filter sets (Chroma), Cascade II cooled CCD
camera (Photometrics) and MetaMorph 7 software (Molecular Devices).

2.5.2 Dissociated neuronal culture

Protocol was modified from Chen et al. 2013. At 33-34 hpf embryos from the
transgenic Tg(ath5:GFP) line were sterilized with 70% ethanol and then transferred to a
new dish containing sterile E2 media (15mM NaCl, 0.5mM KCl, 1mM MgSO4, 0.15mM
KH2PO4, 0.05mM Na2HPO4,1.0mM CaCl2, 0.7mM NaHCO3). Chorions were removed
with sharp forceps and embryos were sacrificed by decapitation. Whole eyes were
extracted, triturated 20-30 times in L15 media (Invitrogen, Carlsbad, CA) supplemented
with 2% FBS, 0.4% pen/strep, and 12.5% saline solution (10 mM D-glucose, 5 mM Napyruvate, 1.26 mM CaCl2, and 32 mM HEPES, all from Sigma) Individual cells were
then plated on coverslips pre-coated with 0.5 mg/ml poly-D-lysine (70-150 kDa) (Sigma)
and 20 µg/ml laminin (Sigma). Cells were maintained in supplemented L15 medium
overnight at room temperature.
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2.5.3 Measurements of neurite outgrowth in cultured neurons

For live-cell imaging, coverslips containing overnight retinal cultures were
transferred from culture dishes to a custom-made open imaging chamber described
previously (Suter, 2011). Prior to imaging, media was replaced with serum-free L15.
Imaging was performed with the Nikon TE2000 Eclipse microscope and Cascade II
cooled CCD camera described above. A 60x 1.4 NA oil objective (Nikon) and an OG590
long-pass red filter (Chroma Technology Corp.) were also used for this set of
experiments. Media was replaced with 1-2mL of serum-media containing nerve growth
factor (NGF, 20ng/mL), netrin-1 (Netrin, 250ng/mL) and semaphorin 3E (Sema3E,
5µg/mL). Controls received fresh serum-free media. After a 15 minute pre-incubation,
initial DIC images were acquired (time 0 minutes). Additional images were acquired at
20, 40 and 60 minutes. Using MetaMorph 7.8 software, neurite lengths were measured
from the base of the cell body to the tip of the growth cone lamellipodia on cells having
processes ≥ 15µm. Neurite growth rates of individual cells were determined by
subtracting the length at time 0 from the length at time 60 and dividing the difference by
the elapsed time.
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2.6 Methods for Chapter 7

2.6.1 Microangiography

Methods are adapted from published protocols (Hoffman et al., 2012). A detailed
protocol can be found at: http://zfish.nichd.nih.gov/Intro%20Page/angiography.html.
Embryos were collected as described in section 2.1.1. Microneedles were prepared by
pulling 1mm borosilicate capillaries (World Precision Instruments) with a single pull at
68°C on a Narishige puller (Model PP-830). The tips of the needles were then broken
with fine forceps under a stereomicroscope to a width of 5-10µm. Holding pipets were
prepared by flame polishing 1mm capillaries in a Bunsen burner to a width of 0.2-0.5mm
depending on the age of the embryos being injected. The injection mixture was prepared
by dissolving 3kDa dextran-Texas Red (10% w/w; Thermo Fisher) in nanopure water
containing 1% BSA. The solution was spun at maximum speed for 20 minutes, and the
supernatant was distributed into 5µL aliquots and frozen at -20°C.
On the day of the injection, embryos were removed from chorions using sharp
forceps and anesthetized in 0.016% Tricaine diluted in E3 media. The injection apparatus
was assembled as shown in Figure 2.1. The holding pipet was secured into a
micromanipulator (World Precision Instruments) on the left, and attached to a 1mL
syringe. The injection needle was filled with 1-2µL of injection mix and secured in the
micromanipulator on the right. The injection volume was calibrated to < 1nL in mineral
oil by delivering short pulses with a pneumatic PicoPump with a foot pedal attachment
(World Precision Instruments). An embryo was positioned with the lateral side of the
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yolk touching the opening of the holding pipette. A small amount of suction was applied
with the 1mL syringe to immobilize the embryo such that the ventral side is up. It is
critical not to apply too much suction as this will destroy the embryo. Once secured, the
needle was inserted into the sinus venosus and 1-2 small boluses are injected. The dye
should be observed entering the heart, not the pericardium, and the injections may cause
temporary cardiac arrest. If the heartbeat has not resumed within a few seconds, the
embryo was discarded. Once the cardiac rhythm was established, dye was quickly
injected 15-20 more times while ensuring that the heart continues to beat and the dye is
moving through the bloodstream. The embryo was then released from the holding pipette
by application of negative pressure and transferred to a dish containing fresh E3 for
recovery. The injection was then repeated for the remaining embryos.

Figure 2.1: Microangiography setup (A) Photo showing the entire injection setup for microangiography.
Injection needle is connected to a pneumatic PicoPump (not shown). Holding pipette connects to the 1mL
syringe to apply pressure to immobilize embryos. (B) Higher magnification view of the injection dish
showing the positions of the holding pipette and injection needle.

Once all the injection are complete (no more then 20-30 minutes), the embryos
are again anesthetized in 0.016% Tricaine methanesulfonate and mounted in 1% low
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melting point agarose on 35mm glass-bottom dishes. Dishes were then filled with E3
media containing 0.016% Tricaine methanesulfonate. Z-stacks were collected at 1µm
intervals using a Zeiss LSM 710 inverted scanning confocal microscope equipped with a
20x Plan-Apochromat 0.8 NA M2 objective or a 40x LD C-Apochromat 1.1 NA W Korr
M27 objective (Zeiss USA).Maximum intensity projections were created using ImageJ
software (Schneider et al., 2012) and additional image processing was performed with
Photoshop CS3 extended (Adobe).

2.6.2 Alcian blue staining

Methods were adapted from a protocol published in 2007 (Walker and Kimmel,
2007) An updated, detailed protocol is available here: https://wiki.zfin.org/pa
ges/viewpage.action?pageId=13107315. 2% Alcian blue stock was prepared by
dissolving 0.2g of Alican blue powder (Sigma) in 11.2mL of 50% ethanol. The solution
was warmed and stirred gently for 30-60 minutes to allow the powder to dissolve
completely. Once all of the powder dissolved, the solution was brought to 100mL with 95%
ethanol. 10mL aliquots of the 2% stock were stored in parafilm-sealed 15mL conical
tubes at room temperature. The parafilm is necessary to prevent evaporation.
5 day old embryos were anesthetized in 0.016% Tricaine methanesulfonate then
fixed in 2% paraformaldehyde/1x PBS for 1 hour at room temperature. All steps were
performed in 1.5mL centrifuge tubes. Embryos were washed twice for 10 minutes each in
a solution containing 100mM Tris pH 7.5 and 10mM MgCl2. The staining solution (0.04%
Alcian blue, 10mM MgCl2) was prepared by combining 10mL of 2% Alcian blue stock
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with 5mL 1M Tris pH 7.5, 0.5mL 1M MgCl2, 32.6mL 95% ethanol and 1.9mL water.
Wash solutions were replaced with 1mL staining solution, and the tubes were incubated
overnight with gentle agitation at room temperature. The next day, embryos were washed
for 5 minutes with 100mM Tris pH 7.5/10mM MgCl2/80% ethanol. This was followed by
one 5 minute wash in 50% ETOH/100mM Tris pH 7.5 and a final wash in 25%
ETOH/100mM Tris pH 7.5.
After washing, 1mL of bleaching solution (3% H202/0.5% KOH) was added to the
tubes and incubated for 10 minutes without agitation. Tube lids were left open during this
incubation. After bleaching, the samples were washed extensively with 25% glycerol/0.1%
KOH until bubbles are no longer visible. Samples were then washed twice with 50%
glycerol/0.1%KOH for 10 minutes each and stored at 4°C in the final wash solution.
Samples were imaged on a depression slide using an Olympus SZX16 stereo
microscope (Olympus Corp.) with an SDF PLAN APO 1x objective at 3.2x
magnification. Image processing was performed using Photoshop CS3 extended software.
Pharyngeal arch labels in Figure 7.4 are derived from published literature (Schilling et al.,
1996).
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CHAPTER 3. LOCALIZATION AND FUNCTION OF NOX IN NEURONAL
GROWTH CONES

This work described in this chapter was previously published. The text presented here is
adapted, with permission, from the original publication to highlight my individual
contributions (Munnamalai et al., 2014).

3.1 Introduction

As introduced in Chapter 1, this study is focused on the role of NOX enzymes in
the growth and development of axons. One critical component of axon outgrowth is
regulation of the cytoskeleton to drive leading edge protrusion. There is little known
about the ways in which NOX-derived ROS contribute to axon outgrowth and neurite
extension. A recent study found that NOX2 inhibition led to alteration in mouse
hippocampal neuronal maturation, and neurite extension (Wilson et al., 2015). This
certainly suggests that NOX2 plays a positive role in the regulation and promotion of
neurite outgrowth in these cells. What that study lacks is a detailed description of the
subcellular localization of NOX2 subunits. This is important since as I introduced in the
previous chapter, one way to regulate ROS-mediated signaling is to maintain ROS
production and downstream effectors in close approximation within the cell. Studies of
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NOX subcellular localization may yield insights into downstream ROS effectors and
signaling.
With the dearth of localization and functional studies focused on NOX enzymes
in neurons, it is necessary to turn instead to non-neuronal cells. NOX subunits have
previously been identified at sites relevant to adhesion and cell migration including focal
adhesions and leading edge protrusions in non-neuronal cells (Ushio-Fukai, 2006). NOXderived ROS have been implicated in fibroblast cell adhesion and (Chiarugi et al., 2003)
migration in endothelial cells (Moldovan et al., 2000; Ushio-Fukai et al., 2002; Ikeda et
al., 2005), HeLa cells (Nimnual et al., 2003; Kim et al., 2009), smooth muscle cells
(Schroder et al., 2007; Lee et al., 2009) and keratinocytes (Kim et al., 2011a). Despite the
many similarities between cell migration and neurite outgrowth, the role of NOX in the
latter process is largely unexplored.
As introduced in Chapter 1, NADPH oxidase family members NOX1, NOX2,
NOX3, and NOX4 are expressed in different portions of the nervous system, particularly
in neurons and microglia (Sorce and Krause, 2009; Hernandes and Britto, 2012). Also
reviewed in Chapter 1, NADPH oxidase-derived ROS have been implicated in
hippocampal synaptic plasticity and memory formation (Kishida et al., 2006), NMDA
receptor activation (Brennan et al., 2009), nerve growth factor induced neuronal
differentiation and neurite outgrowth of PC-12 cells (Suzukawa et al., 2000; Ibi et al.,
2006), and neuronal apoptosis (Tammariello et al., 2000; Guemez-Gamboa and Moran,
2009). On the other hand, microglial cells and proinflammatory cytokine-treated neurons
release NADPH oxidase-derived superoxide leading to neuronal toxicity (Barth et al.,
2012), as described in Alzheimer's and Parkinson's disease (Sorce and Krause, 2009; Gao
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et al., 2012). We have recently reported that ROS derived from NOX regulate F-actin
organization, dynamics, and neurite outgrowth (Munnamalai and Suter, 2009); however,
the exact subcellular localization and interactions of NOX with the actin cytoskeleton in
neuronal growth cones have not been investigated.
Here, we report on the first localization of a NOX2-type NADPH oxidase in
neuronal growth cones. NOX inhibition with VAS2870 or celastrol resulted in reduced
retrograde F-actin flow and neurite outgrowth, confirming our earlier results. NADPH
oxidase activation with a PKC activator resulted in increased ROS levels in the growth
cone periphery. We found that the regulatory cytosolic subunit p40phox exhibited F-actinassociation in unstimulated growth cones and little co-localization with plasma
membrane-bound NOX2. Additional works presented here shows that upon growth cone
stimulation with the cell adhesion protein apCAM, p40phox and NOX2 accumulated and
co-localized at adhesion sites. In summary, these findings point towards an interesting
bidirectional relationship between NADPH oxidase and the actin cytoskeleton in
neuronal growth cones.

3.2 Results

3.2.1 NADPH oxidase inhibition impacts the actin cytoskeleton and neurite outgrowth

We previously reported that lowering cytosolic ROS levels in Aplysia neuronal
growth cones by either a general radical scavenger, α-N-tert-butyl-phenylnitrone, or by
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NOX inhibition via phenylarsine oxide and apocynin resulted in reduced actin content,
impaired actin dynamics, and decreased neurite outgrowth (Munnamalai and Suter, 2009).
Phenylarsine oxide is a highly potent inhibitor, but being a vicinal dithiol-binding reagent
it is not exclusively specific to NOX (Le Cabec and Maridonneau-Parini, 1995; Jaquet et
al., 2009). Apocynin is still widely used as NADPH oxidase inhibitor; however, there is
now evidence that it may act as antioxidant and require the presence of myeloperoxidase
to function as a NADPH oxidase inhibitor (Heumuller et al., 2008; Jaquet et al., 2009;
Wind et al., 2010). To confirm that our previous results were indeed caused by reduced
NADPH oxidase activity, we repeated oxidase inhibition experiments with one of the
most specific chemical pan-NADPH oxidase inhibitors currently available, VAS2870
(ten Freyhaus et al., 2006; Wind et al., 2010; Altenhofer et al., 2012).
Treatment of Aplysia growth cones with 5 µM VAS2870 for 20 min reduced
transition (T) zone ruffling, flattened the peripheral (P) domain, caused extension of the
central (C) domain and filopodial lengthening when compared to DMSO control pretreatment (Fig. 3.1 A-C). These effects were partially reversible 60 min following drug
washout (Fig. 3.1D). NOX inhibition significantly decreased the F-actin content in T
zone ruffles, as well as in filopodial actin bundles and lamellipodial actin networks in the
P domain (Fig. 3.1 E-H). Treatment with 5µM VAS2870 reduced retrograde actin flow
rates by 35% compared to DMSO pre-treatment (Fig. 3.1I; mean flow rates ± SEM were
4.6±0.1 µm/min in DMSO vs. 3.0±0.1µm/min in VAS2870). Flow rates nearly recovered
to control values following drug washout. Total neurite length per neuron was strongly
reduced in neurons treated with 2.5µM VAS2870 for a 24 h when compared to medium
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Figure 3.1: NADPH oxidase inhibition reduces F-actin content in growth cones as well as neurite
outgrowth (A) DIC image of Aplysia bag cell neuronal growth cone cultured for 1d. C domain, T zone,
and P domain, as well as C domain boundary (dashed line) are indicated. (B) Treatment with 0.1% DMSO
for 20 min did not noticeably affect growth cone morphology or motility. Arrow points towards T zone
ruffle. (C) Treatment with 5µM VAS2870 for 20 min caused flattening of the T zone and P domain as well
as some extension of the C domain and filopodia (arrowhead). (D) Drug washout for 60 min partially
reversed these effects, resulting in further growth cone protrusion. (E-H) 5µM VAS2870 for 20 min
reduced F-actin content in the T zone and P domain, including in ruffles, filopodial bundles, and
intervening lamellipodial networks. (I) NADPH oxidase inhibition by 5µM VAS2870 resulted in reduced
retrograde flow rates (Mean flow rates ± SEM; n=11 growth cones; one-way ANOVA followed by
Dunnett’s T3 post-hoc test; ****P<0.0001). (J) NADPH oxidase inhibition by 2µM VAS2870 between day
0 and 1 reduced neurite outgrowth irreversibly when compared with medium or DMSO-containing medium.
The drug was washed out between day 1 and day 2. Mean values of total neurite length per cell ± SEM are
given for different times in culture: before drug application (day 0); 24h after drug treatment (day 1); and
24h after drug washout (day 2). n=number of neurons; one-way ANOVA followed by Dunnett’s T3 posthoc test; ****P<0.0001. Scale bars: 10 µm.

only or DMSO control conditions (Fig. 3.1J; 81% reduction compared to DMSO).
Extensive drug washout over the following 24 h period did not reverse total neurite
length values. This is likely due to the significantly longer drug incubation time when
compared to the results of the 20 min VAS2870 treatments. Using a different NOX
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inhibitor, celastrol (Jaquet et al., 2011), we observed similar effects on growth cone
morphology, actin flow, and neurite outgrowth (Fig. 3.2A-D). In summary, we found that
treatment of cultured Aplysia neurons with VAS2870 or celastrol resulted in similar
effects as our previous approaches of NOX inhibition (Munnamalai and Suter, 2009),
confirming our findings that NOX activity is critical for controlling actin organization
and dynamics in growth cones as well as neurite growth.

Figure 3.2: NADPH oxidase inhibition via celastrol reduces retrograde flow and neurite outgrowth
(A) DIC image of an Aplysia bag cell neuronal growth cone following a treatment with 0.1% DMSO for 20
min. C domain, T zone, and P domain are indicated. (B) Treatment with 5μM celastrol for 20 min caused
flattening of the T zone and P domain as well as some extension of filopodia (arrowheads). (C) NADPH
oxidase inhibition by 5μM celastrol resulted in retrograde flow rates that were reduced by 76% compared to
DMSO control condition (Mean flow rates ± SEM; n=11 growth cones; Student’s t-test; **** P<0.0001).
(D) NADPH oxidase inhibition by 1μM celastrol between day 0 and 1 reduced neurite outgrowth
irreversibly when compared with DMSO-containing medium. The drug was washed out between day 1 and
day 2. Mean values of total neurite length per cell ± SEM are given for different times in culture: before
drug application (day 0); 24h after drug treatment (day 1); and 24h after drug washout (day 2). n=number
of neurons; Student’s t-test; * = P<0.05, **** = P<0.0001. Scale bar: 10μm.
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3.2.2 Localization of NOX2-type NADPH oxidase in neuronal growth cones

Although NOX1, NOX2, and NOX4 have been previously detected in cultured
cerebellar granule neurons (Coyoy et al., 2008) and NOX2 additionally in hippocampal
neurons (Tejada-Simon et al., 2005; Park and Jin, 2008), sympathetic neurons
(Tammariello et al., 2000; Hilburger et al., 2005), and DRG neurons (Cao et al., 2009),
None of these studies investigated the localization of these enzyme complexes
specifically in neuronal growth cones. A previous lab member identified a NOX2-type
NADPH oxidase complex in growth cones using antibodies raised against human
homologs of the membrane-bound NOX2 (Quinn et al., 1989) and cytosolic p40phox
subunits (Gauss et al., 2002). Western blotting of Aplysia CNS protein extracts with these
antibodies detected a major band at the expected molecular weights of 75 kDa and 40
kDa, respectively (Fig. 3.3A). NOX2 proteins run between 73 and 91 kDa on SDS-PAGE
depending on the species (Krijnen et al., 2003). The variations in molecular weight are
believed to be caused by differences in glycosylation (Quinn et al., 1989; Gauss et al.,
2002).
To confirm the specificity of the NOX2 antibody, I preincubated the rabbit anti
NOX2 antibody with either the human peptide used for raising the antibody or the
corresponding Aplysia peptide. Preincubation with either of these peptides significantly
reduced the fluorescence intensity in the growth cone periphery (Fig. 3.3B).
Immunolabeling of growth cones with NOX2 and p40phox antibodies revealed a punctate
pattern of both proteins within growth cones (Fig. 3.3C-D). NOX2 labeling in the P
domain is more uniform and dense than p40phox labeling, which is expected for a plasma
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Figure 3.3: Localization of NOX2-type NADPH oxidase complex in Aplysia growth cones (A)
Western blot of Aplysia CNS proteins detected by NOX2 and p40 antibodies. Each antibody detects a
major band at the expected molecular weights of 75 kDa and 40 kDa, respectively. (B) Preincubation of the
polyclonal rabbit anti-NOX2 antibody with either the human (hgp91) or the corresponding Aplysia peptide
(agp91) reduced NOX2 labeling in the P domain of Aplysia bag cell growth cones by 40% and 28%,
respectively, when compared to PBS preincubation. (C) Immunolocalization in cultured Aplysia bag cell
growth cones revealed homogeneous NOX2 distribution in the P domain, suggesting plasma membraneassociation, while the strong C domain labeling is indicative of vesicular association. (D) p40phox
immunolocalization is somewhat less dense than NOX2 labeling. p40 phox is prominent in the growth cone
periphery including in filopodia (arrow). No labeling is found in very flat portions of the P domain
(arrowhead). (D-G) VAS2870 lowers Number of growth cones are indicated; Student’s t-test; * P<0.05,
*** P<0.001. Scale bars: 10 µm.

membrane-associated protein. NOX2 signals were markedly higher in the C domain of
the growth cone (Fig. 3.3C) compared to the P domain, which can be attributed to
NOX2’s association with vesicles. In the growth cone, localization of the cytosolic
p40phox subunit differed from NOX2 in a few ways. First, p40phox exhibited a striking
array-like localization (Fig. 3.3C), very similar to F-actin bundles in the P domain.
Second, the labeling in the C domain was not increased as in the case of NOX2. Third,
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hardly any p40phox was found in very thin growth cone regions that were clearly NOX2
positive (arrowhead in Fig. 3.3C and 3.6C).
NOX2 is expected to associate with the plasma membrane. Due to the thinness of
growth cones, it is difficult to differentiate membrane associated and cytosolic proteins
using immunolabeling. Instead, we found evidence for the expected plasma membrane
association of NOX2 in unstimulated Aplysia neurons by confocal imaging of the large
neuronal cell body (Fig. 3.4A). p40phox labeling was not enriched at the membrane in the
cell bodies of unstimulated cells (Fig. 3.4B). NOX2 and p40phox positive structures also
colocalized with actin in some cases (arrowheads in Fig3.4A’-F’). Collectively, these
results demonstrate the presence of a NOX2-like and a p40phox-like proteins in Aplysia
neurons that can be detected with specific antibodies either by Western blot or
immunolabeling.

3.2.3 NOX2 produces reactive oxygen in neuronal growth cones

NADPH oxidase produces superoxide, which can be converted quickly into H2O2,
a ROS that has a longer half-life than superoxide and is likely involved in many ROSmediated signaling processes (Bedard and Krause, 2007; Winterbourn, 2008). We used
Peroxyfluor-6 acetoxymethyl ester (PF-6) as a H2O2-specific fluorescent dye (Dickinson
et al., 2011) in combination with Calcein Red-Orange AM as a volume marker in order to
perform ratiometric quantification of H2O2-levels in the growth cone P domain following
activation and inhibition of NADPH oxidase (Fig. 3.5A-D). PF-6 signals were the highest
in the C domain, specifically in mitochondria, a well-known intracellular ROS source, as
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Figure 3.4: NOX2 and p40 exhibit distinct subcellular localizations in the cell body (A-C)
Immunolabeling of Nox2 (A) and p40 (B) with phalloidin labeling of f-actin (C) in the cell body 10µm
above the focal plane of the growth cone. (D and E) Dual-channel overlays of the images in A-C. (F)
Triple-channel overlay of the images in A-C. (A’, B’, C’ and F’) Magnified views of the red boxes in A-C
and F showing triple-labeled (arrowheads) and Nox2/p40-labled (arrows) puncta. Scale bar in A: 10μm, A’:
2µm.

well as in T zone ruffles. NADPH oxidase inhibition with 5µM VAS2870 reduced H2O2
levels more than the control treatment with DMSO alone after 15 min (Fig. 3.5E; 30%
reduction by VAS2870 vs. 16% reduction by DMSO), although these reductions were not
significantly different (Student’s t-test; P=0.12). Conversely, we used the phorbol ester
phorbol 12,13-dibutyrate (PDBu) to activate PKC, which is known to stimulate activity
of NADPH oxidase through phosphorylation of p47phox (Fontayne et al., 2002). Within 30
sec of PDBu application, H2O2-levels increased by 12±3%. This PDBu-induced rise in
H2O2-levels could be significantly decreased by co-incubation with 5µM VAS2870 to
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levels that were similar to basal H2O2-levels (Fig. 3.5F). In summary, these data confirm
that NOX is functional in neuronal growth cones.

3.3 Discussion

This is the first report on subcellular localization of NOX in neuronal growth
cones. Expression of NOX1-NOX4 family members at the RNA and protein levels has
been shown for various brain regions including cortex, cerebellum, hippocampus, as well
as for peripheral ganglia (Sorce and Krause, 2009; Hernandes and Britto, 2012). NOX2
subunits have been localized in cultured neurons, such as hippocampal (Tejada-Simon et
al., 2005; Park and Jin, 2008), cerebellar granule (Coyoy et al., 2008), sympathetic
(Tammariello et al., 2000; Hilburger et al., 2005), and DRG neurons (Cao et al., 2009).
However, most of these studies did not investigate the detailed subcellular distribution of
NOX complex proteins. Here, we have shown that a NOX2-type protein is localized to
the plasma membrane of Aplysia neuronal growth cones (Fig. 3.4A). Whether another
type of NOX is also present in Aplysia growth cones remains to be investigated. NOX
inhibition with VAS2870 or celastrol impaired actin organization and dynamics as well
as neurite outgrowth, confirming our previous findings (Fig. 3.1 & 3.2; (Munnamalai and
Suter, 2009). NOX activation increased H2O2 levels in the growth cone P domain, and
this was partially blocked by a NOX inhibitor (Fig. 3.5F).
Since p40phox exhibited an F-actin-like distribution, previous lab members
performed triple labeling with phalloidin, p40phox, and NOX2 antibodies to determine a
potential colocalization between p40phox and F-actin. Upon analyzing this raw data, I
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Figure 3.5: Aplysia growth cones produce reactive oxygen via NOX (A-D) VAS2870 lowers H2O2
levels in the P domain (indicated with dashed line). PF-6 signals were reduced in growth cones treated with
e used for volume
correction. (E) Volume-corrected PF-6 signals after 15 min are shown as % of the pretreatment levels.
DMSO: 84±4%; VAS2870: 70±8% (Mean values ± SEM; n=16 growth cones; Student t-test; †P=0.12). (F)
Activation of NADPH oxidase increases H2O2 levels. Growth cones were treated with the protein kinase C
activator PDBu (0.1 µM) to activate NADPH oxidase, or a combination of 0.1 µM PDBu and 5 µM
VAS2870. Volume-corrected PF-6 signals measured after 30 sec were normalized against DMSO control
values and presented as % changes of pretreatment values. PDBu increased H2O2 in the growth cone
periphery to levels that were significantly higher than in growth cones treated with a combination of PDBu
and VAS2870 (Average % changes in H 2O2-levels ± SEM are given; n=32 growth cones; one-way
ANOVA followed by Dunnett’s T3 post-hoc test; **P<0.01). Scale bars: 10 µm.

found that in the growth cone P domain, p40phox signal exhibited only a partial overlap
with NOX2. 38±2% of p40phox colocalized with NOX2, while 22±1% of NOX2
overlapped with p40phox. The highest colocalization between p40phox and NOX2 was
found in the neck of the growth cone, which consolidates into the axon, as well as in
contact areas between two adjacent growth cones. p40phox exhibited higher colocalization
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with filopodial F-actin bundles in the growth cone periphery, when compared to NOX2colocalization with F-actin.
Additional work performed by other lab members was included in the original
publication, but I will summarize it here. They observed variations in p40phox levels
between growth cones, which correlated with F-actin content. Cytochalasin B
significantly reduced the amount of p40phox, but not NOX2, in the growth cone periphery.
Cell fractionation and actin co-immunoprecipitation experiments confirmed a partial
association of p40phox with F-actin. The cell fractionation studies were performed on total
CNS lysates suggesting that the differential association of NOX2 and p40phox not only
occurs in the growth cone but also in other regions of the cell. This was supported by my
data showing the differential localization of NOX2 and p40phox in the cell body of
Aplysia neurons (Fig. 3.4). Finally, these additional experiments found increased
p40phox/NOX2 co-localization at adhesion sites during apCAM-evoked neuronal growth.
In summary, all of these findings provide evidence for a bidirectional functional
relationship between NADPH oxidase activity and the actin cytoskeleton in neuronal
growth cones, which may contribute to the control of neurite outgrowth.
Very little is known about NADPH oxidase signaling in neuronal development,
particularly in axonal growth and guidance. Previous work from our lab and others
suggested a role for NADPH oxidase-derived ROS in regulating neurite outgrowth
(Suzukawa et al., 2000; Ibi et al., 2006; Munnamalai and Suter, 2009). A recent study
showed that tail wound-derived H2O2 can promote regeneration of sensory axons in
Zebrafish embryos (Rieger and Sagasti, 2011). Furthermore, we have shown that
NADPH oxidase inhibition in Aplysia growth cones results in reduced F-actin content
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(this study; Munnamalai and Suter, 2009). ROS have also been implicated in Rac1dependent Ca2+ -release in Aplysia growth cones (Zhang and Forscher, 2009). Due to the
short half-life and high reactivity of ROS, target proteins need to be close to the ROS
source to establish signaling specificity (Ushio-Fukai, 2006). Consistent with this idea,
we found NADPH oxidase localized in the growth cone periphery at sites where actin
assembly occurs.
The present study is also interesting from an evolutionary point of view. While
ancestral NOX2-, p22phox -, p47phox -, and p67phox -homologs have been identified for
several invertebrate species including Monosiga brevicollis, Nematostella vectensis,
Strongylocentrotus purpuratus, as well as the snail Lottia gigantea, no p40phox homolog
has been identified in these species thus far, which has led to the conclusion that p40phox
may have evolved later with the chordata (Kawahara et al., 2007a; Sumimoto, 2008).
Very recently several predicted Aplysia NADPH oxidase-like sequences have been
released to the NCBI database, including NOX2-like (XP_005090645), NOX5-like
XP_005101964), DUOX1-like (XP_005108327), and DUOX2-like (XP_005106629).
Our antibody results suggest that a NOX2-type NADPH complex with all membrane and
cytosolic subunits including the regulatory subunit p40phox already evolved with the
appearance of the molluscan clade. Other available antibodies against NOX2-type
subunits did not detect proteins with high enough specificity (data not shown); thus,
because of this limitation we were unable to detect other subunits of the NOX2-type
complex in Aplysia growth cones thus far.
Our quantification of H2O2-levels following PKC activation revealed that the
NADPH oxidase is functionally active in growth cones. VAS2870 abolished the fast
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PDBu-stimulated increase in H2O2-levels in the growth cone periphery within 30 sec (Fig.
3.5I). Treatment of growth cones with VAS2870 alone for 15 min resulted only in a
modest decrease of H2O2-levels (Fig.3.5H). These findings are in line with another study
demonstrating that VAS2870 significantly blocked the increase of ROS levels in
endothelial cells activated by oxidized low-density lipoprotein, but had minimal effect on
the basal ROS levels without stimulation (Stielow et al., 2006). There are several possible
reasons why VAS2870 treatment alone did not lower basal H2O2-levels more
significantly. First, NADPH oxidases are not the only source for superoxide/hydrogen
peroxide. Second we are measuring hydrogen peroxide in this assay and not superoxide,
which is the primary product of NADPH oxidase. Third, ROS are highly reactive, act
locally, and are tightly regulated; thus, it might be difficult to optically detect local
changes in ROS levels induced by NADPH oxidase inhibition with sufficient temporal
resolution, despite the fact that such changes can affect cellular physiology and
morphology.
Cytoskeletal association of regulatory NOX subunits has been previously reported
for p40phox, p47phox, and p67phox in non-neuronal cells. All three cytosolic subunits
associate with the Triton X-100-insoluble cytoskeleton as well as the membrane
cytoskeleton in neutrophils and endothelial cells (Nauseef et al., 1991; el Benna et al.,
1994a; El Benna et al., 1999; Li and Shah, 2002). Furthermore, p40phox and p47phox
associate with the neutrophil cytoskeleton through a PX-domain-dependent interaction
with the actin-associated protein moesin (Wientjes et al., 2001; Zhan et al., 2004), while
p40phox also interacts with the actin-binding protein coronin (Grogan et al., 1997), as well
as directly with the actin cytoskeleton via its PX domain (Shao et al., 2010). These
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findings suggested that actin-association of cytosolic NADPH oxidase subunits may have
a regulatory function by keeping the complex in an inactive state until a stimulus releases
the subunits from the cytoskeleton during the activation process. In agreement with this
idea, COS-7 expression experiments revealed that p40phox is associated with actin and
moesin, and that a mutated form of p40phox shows higher actin association and inhibits
NOX2 activity (Chen et al., 2007). Furthermore, the actin-binding protein cortactin has
been suggested to regulate NOX2 activation in lung endothelial cells trough an
interaction with p47phox (Usatyuk et al., 2007). Thus, actin rearrangements could also
deliver cytosolic NADPH oxidase subunits to the plasma membrane. Does NOX2
localization show actin-dependence? In migrating endothelial cells, NOX2 colocalizes
with F-actin along the leading edge in an IQGAP1-dependent manner, while
manipulating the actin cytoskeleton with latrunculin and jasplakinolide alters NOX2
localization (Ikeda et al., 2005). Our growth cone studies presented here also suggest a
certain actin-dependence of NOX2 localization as indicated by the reduction of NOX2
following cytochalasin treatment and the co-localization of NOX2 with actin along the
leading edge and in transition zone ruffle/intrapodia (not shown). Thus, a fraction of
NOX2 along with p40phox appears to undergo retrograde flow together with the actin
cytoskeleton. In summary, our present work in neuronal growth cones is consistent with
previous findings made with leukocytes and endothelial cells indicating that the actin
cytoskeleton may play a role in NADPH oxidase activation through localization of its
subunits.
On the other hand, NADPH oxidase-derived ROS regulate actin organization and
dynamics, growth cone motility, and neurite growth (this study; Munnamalai and Suter,
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2009) and actin organization and migration of non-neuronal cells including leukocytes,
keratinocytes, endothelial, smooth muscle, and HeLa cells (Nimnual et al., 2003;
Wojciak-Stothard et al., 2005; Schroder et al., 2007; Kim et al., 2009; Kim et al., 2011a;
Kuiper et al., 2011). Thus, together with these findings, our current study suggests an
interesting bi-directional relationship between NADPH oxidase and F-actin. We propose
that the regulatory cytosolic NADPH oxidase subunits such as p40 are associated with
actin structures in unstimulated growth cones. Upon growth cone stimulation by guidance
cues, cytosolic subunits p47phox, p67phox, p40phox, and Rac1 translocate to the plasma
membrane (either with or without F-actin) and activate the membrane bound subunits
NOX2/p22phox. NADPH oxidase-produced superoxide (or most likely hydrogen peroxide)
diffuses back into the growth cone for local regulation of the cytoskeleton and related
directional growth. In agreement with this hypothesis, we found increased p40phox/NOX2
levels and co-localization at growth cone contact sites with apCAM beads (not shown)
and interacting growth cones, where apCAM exhibits increased density as well
(Thompson et al., 1996; Suter et al., 1998). These results indicate that apCAM-clustering
can trigger actin remodeling as well as NADPH oxidase activation related to neurite
outgrowth. The details of the functional relationship and order of events of apCAM
clustering, actin reorganization, and NADPH oxidase activation are unclear at this point.
apCAM clustering could first activate NADPH oxidase followed ROS-mediated actin
reorganization; or apCAM-mediated actin remodeling could activate NOX2 by
translocating cytosolic subunits close to plasma membrane. Thus, additional studies will
be necessary to address the important question whether NADPH oxidase activation plays
a functional role in directional axonal growth triggered by apCAM or other guidance cues
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CHAPTER 4. NOX EXPRESSION DYNAMICS IN ZEBRAFISH

This work described in this chapter was previously published. The text presented here is
adapted, with permission, from the original publication (Weaver et al., 2015).

4.1 Introduction

Reactive oxygen species (ROS) are a class of small molecules that can oxidize
many biomolecules including proteins and lipids. Overproduction of ROS has been
implicated in a number of diseases including hypertension, neurodegenerative conditions,
and cancer (Montezano and Touyz, 2014; Nakanishi et al., 2014; Nayernia et al., 2014).
However, when produced in a controlled fashion in response to a specific stimulus, ROS
also act as critical signaling intermediates in a growing number of cellular signaling
pathways regulating multiple biological processes including cell differentiation,
migration, and death (Finkel, 2011; Forman et al., 2014). Although there are several
sources of ROS within the cell, one class of enzymes called nicotinamide dinucleotide
phosphate (NADPH) oxidases (commonly abbreviated NOX) are especially interesting in
the context of cellular signaling, because these enzymes can be activated and inactivated
by a variety of mechanisms, including by cytosolic proteins and signaling molecules as
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well as by controlling expression (Bedard and Krause, 2007; Lambeth et al., 2007; Brown
and Griendling, 2009; Brandes et al., 2014). Thus, a comprehensive knowledge of NOX
soform expression could inform future studies on regulation and function of different
NOX isoforms.
NOX2 is the first isoform to be identified and characterized. It is expressed in
phagocytes, which use NOX2-derived ROS for bacterial killing (Nauseef, 2004).
Following the initial discovery of NOX2, several additional isoforms have been identified
in multicellular organisms, including NOX1, NOX3, NOX4, NOX5, DUOX1, and
DUOX2 in humans (Fig. 1.1) (Kawahara et al., 2007b). In the human cardiovascular
system, NOX1, NOX2, NOX4, and NOX5 are expressed in vascular smooth muscle cells
(Jay et al., 2008; Zimmerman et al., 2011; Xu et al., 2014) as well as in endothelial cells
(BelAiba et al., 2007; Drummond and Sobey, 2014). NOX activity is involved in blood
pressure regulation and can lead to hypertension if out of control (Bedard and Krause,
2007). In the reproductive systems, NOX1 and 5 have been detected in human uterine
tissue (Cheng et al., 2001; Brown and Griendling, 2009), while testis and ovary express
NOX2, NOX4, and NOX5 (Cheng et al., 2001; Banfi et al., 2004b). NOX isoforms are
also found in several other tissues including rabbit fibroblasts (NOX2), fish keratinocytes
(DUOX), human kidneys (NOX1/2/4/5), human epithelial tissues of the colon (NOX1)
and lung (DUOX), and in human thyroid tissue (DUOX) (Pagano et al., 1997; De Deken
et al., 2000; Harper et al., 2006; Bedard and Krause, 2007; Rokutan et al., 2008; Rieger
and Sagasti, 2011; Holterman et al., 2015; Zhu et al., 2015).
Of particular interest to the present study is the expression of NOX in the nervous
system. NOX1, NOX2, and NOX4 have been identified in cultured neurons derived from
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both peripheral and central nervous system (Hilburger et al., 2005; Tejada-Simon et al.,
2005; Coyoy et al., 2008; Cao et al., 2009; Sorce and Krause, 2009; Choi et al., 2012;
Kallenborn-Gerhardt et al., 2012; Munnamalai et al., 2014; Wilson et al., 2015). NOX3 is
expressed in inner ear neurons (Banfi et al., 2004a) and has been implicated in balance
based on swimming defects observed in NOX3 mutant mice (Paffenholz et al., 2004).
Not surprisingly, NOX1 and NOX2 are also expressed in microglia, the phagocyte-like
cells with immune function in the central nervous system (Wu et al., 2006; Cheret et al.,
2008; Fischer et al., 2012). With respect to neuronal functions, NOX proteins have been
implicated in neuronal stem cell maintenance in the brain (Dickinson et al., 2011),
cerebellar development (Coyoy et al., 2013), neuronal differentiation (Tsatmali et al.,
2006), neuronal polarity and neurite outgrowth (Munnamalai and Suter, 2009;
Munnamalai et al., 2014; Olguin-Albuerne and Moran, 2015; Wilson et al., 2015), and
synaptic plasticity (Kishida et al., 2006).
As detailed above, different NOX enzymes are found in many tissue types
including in the nervous system and perform critical functions in these cells. In several
cases, different NOX isoforms have been identified in the same tissue or even cell types;
however, the functional relationship of the individual isoforms is often unclear. NADPH
oxidase appears to have important roles in neuronal development; however, a systematic,
tissue-scale characterization of NOX isoform expression throughout development of the
nervous system has not been performed so far. In part, this is due to the limited
availability of antibodies against several NOX isoforms in a number of species including
zebrafish (Danio rerio) (Altenhofer et al., 2012). Furthermore, the current expression
data from antibodies lacks validated support from other methods such as in situ
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hybridization (ISH) (Nayernia et al., 2014). Tissue-specific NOX expression has often
been reported in the form of Western blot data involving mixed cell populations. Some
studies have shown cell-type specific expression of NOX in cultured cells, but these are
often limited to specific isoforms (Kishida et al., 2006; Munnamalai et al., 2014; Wilson
et al., 2015) and therefore fail to show the contributions, if any, of other NOX isoforms in
the same cell type. In addition, immunolocalization studies using cell cultures often focus
on a specific cell type. Thus, there are only a few studies that investigated NOX isoform
expression in a broad range of tissues during development and into adulthood (Cheng et
al., 2001). Here, researchers found that NOX5 is expressed in all human fetal tissues but
later becomes restricted to specific adult tissue such as uterus (Cheng et al., 2001). In
summary, a comprehensive NOX isoform expression analysis in the developing nervous
system is missing. Expression data would not only confirm/identify the neuronal source
of ROS for established functions but potentially unveil new functions of ROS signaling
in neurons.
Here, we analyzed expression of Nox isoforms during early zebrafish
development. Zebrafish have been used to study several NOX functions including
neutrophil migration, wound healing, and axon regeneration (Niethammer et al., 2009;
Rieger and Sagasti, 2011; Yoo et al., 2011; Yan et al., 2014; de Oliveira et al., 2015).
Sequences for nox1, nox2 (also called cytochrome B-245 or cybb), nox4, nox5, and duox
genes have been identified in the zebrafish genome. nox4, however, is not well annotated,
consists of multiple transcripts, and the suggested mRNA sequence does not align well
with other known nox4 gene sequences; therefore, we decided to focus our expression
analysis on the other four isoforms. Humans express two distinct isoforms of duox (1/2)
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while zebrafish express only a single isoform (Niethammer et al., 2009; Rigutto et al.,
2009). To expand the current knowledge of NOX function in zebrafish nervous system
development and regeneration, it is critical to know the spatiotemporal expression pattern
of NOX genes. We used quantitative PCR (qPCR) along with ISH to characterize
expression of nox1, nox2/cybb, nox5, and duox in the embryonic zebrafish during the first
forty-eight hours after fertilization, which coincides with the development of major
aspects of the zebrafish central nervous system (Schmidt et al., 2013). We identified
dynamic changes in expression levels among three of the four isoforms studied.
Furthermore, we found broad expression of all NOX isoforms during early development,
which becomes more enhanced in specific regions of the brain at later developmental
stages.

4.2 Results

4.2.1 nox1

In the present study, we investigated the expression of nox1, cybb, nox5, and duox
genes at the mRNA level during the first forty-eight hours after fertilization in developing
zebrafish embryos. The molecular compositions of the respective NADPH oxidase
complexes for each of these isoforms are shown in Fig. 1.1. Quantitative PCR performed
on mRNA extracted from whole zebrafish embryos showed that nox1 expression is the
highest at 12 hpf among all four isoforms investigated (Fig. 4.1B). After this time point,
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Figure 4.1: nox genes are expressed during early zebrafish development Relative expression levels
derived via quantitative PCR from each of the 4 zebrafish NOX genes normalized to cybb at 12 hpf. cybb
was chosen to normalize the data set as it was the most consistently expressed isoform. n = 6 for each data
point. Error bars = SEM from all 6 data points.

the nox1 expression decreases nearly ten-fold and remains consistent at this level
throughout the next 36 h (p < 0.0001 at 12 hpf versus 24, 36 and 48 hpf). We next used
ISH with single-stranded, antisense RNA probes to investigate nox1 gene
expression in the nervous system of developing zebrafish embryos at 24, 36, and 48 hpf
(Fig. 4.2). We did not use 12 hpf embryos for ISH because our main focus was on the
nervous system and no significant nervous system development has occurred at this stage.
Images of whole-mount embryos demonstrate that nox1 expression is broad in the head
and anterior spinal cord (Fig. 4.2A-C). Next, we made 10 µm-thick transverse tissue
sections from in situ hybridized embryos to provide a higher spatial resolution profile of
nox1 expression in the forebrain (Fig. 4.2E-H), eye (Fig. 4.2I-L), midbrain (Fig. 4.2M-P),
hindbrain (Fig. 4.2Q-T), and anterior spinal cord (Fig. 4.2U-X). At 24 and 36 hpf, nox1
expression is relatively uniform in all of these regions. By 48 hpf, nox1 expression is
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Figure 4.2: Broad nox1 expression through the first two days of development (A-D) Lateral views of
whole-mount ISH embryos probed with antisense (A-C) and sense control (D) riboprobe against zebrafish
nox1 mRNA. Lines represent the position of sections shown in E-X. E-H. 10 µm thick transverse sections
through the forebrain (line labeled ‘f’ in A) of 24, 36, 48 hpf embryos incubated with antisense probes (E-G,
respectively) and 24 hpf embryo incubated with a sense control probe (H). (I-L) Transverse sections
through the eye (line labeled ‘e’ in A). (M-P) Corresponding midbrain sections (line labeled ‘m’ in A). (QT) Corresponding hindbrain sections (line labeled ‘h’ in A). (U-X) Corresponding spinal sections (line
labeled ‘s’ in A). Scale bar: 0.5 mm (A-D), 100 µm (E-X). 3V = third ventricle, DC = diencephalon, E =
eye, MC = mesencephalon, MyC = myelencephalon, NC = notochord, ON = optic nerve, OV = Otic vesicle,
SC = spinal cord, SM = somites; TC = telencephalon, Tec = tectum, TecV = tectal ventricle.
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slightly elevated in the region corresponding to the optic tectum (Fig. 4.2O) and the
dorsal region of the spinal cord (Fig. 4.2W).

4.2.2 nox2/cybb

Nomenclature for NOX2 varies among species. In zebrafish, it is commonly
referred to as cytochrome b-245 beta polypeptide (cybb; GenBank ID 393386). As
assessed via qPCR, cybb expression levels display marked consistency during the first
two days of development in comparison to the other NOX isoforms (Fig. 4.1B). Images
of whole-mount ISH embryos show broad expression of cybb throughout the head and
spinal cord (Fig. 4.3A-D). Similarly to nox1, cybb is broadly expressed in all tissues
examined during the first 36 h (Fig. 4.3 E-F, I-J, M-N, Q-R, U-V). By 48 hpf, the region
of the midbrain corresponding to the optic tectum shows a slight increase in cybb
expression (Fig. 4.3O). cybb remains broadly expressed in the forebrain, eye, hindbrain
and spinal cord.

4.2.3 nox5

qPCR results indicate that nox5 has a similar expression profile as nox1 but at a
significantly lower level (Fig. 4.1B). nox5 reaches peak expression at 12 hpf, but exhibits
lower expression levels by 24 hpf, which remain constant until 48 hpf (p < 0.0001 at 12
hpf versus 24, 36 and 48 hpf). By 36 hpf, nox5 exhibits the lowest expression levels of
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Figure 4.3: Broad nox2/cybb expression through the first two days of development (A-D) Lateral
views of whole-mount ISH embryos probed with antisense (A-C) and sense control (D) riboprobe against
zebrafish nox2/cybb mRNA. Lines represent the position of sections shown in E-X. E-H. 10 µm thick
transverse sections through the forebrain (line labeled ‘f’ in A) of 24, 36, 48 hpf embryos incubated with
antisense probes (E-G, respectively) and 24 hpf embryo probed with a sense control (H). (I-L) Transverse
sections through the eye (line labeled ‘e’ in A). (M-P) Corresponding midbrain sections (line labeled ‘m’ in
A). (Q-T) Corresponding hindbrain sections (line labeled ‘h’ in A). (U-X) Corresponding spinal sections
(line labeled ‘s’ in A). Scale bar 0.5 mm (A-D), 100 µm (E-X). 3V = third ventricle, DC = diencephalon, E
= eye, MC = mesencephalon, MyC = myelencephalon, NC = notochord, ON = optic nerve, OV = Otic
vesicle, SC = spinal cord, SM = somites, TC = telencephalon, Tec = tectum, TecV = tectal ventricle.
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any NOX isoform during zebrafish development. Both whole-mounts and transverse
tissue sections of ISH embryos demonstrate that nox5 is broadly expressed throughout the
nervous system at 24 and 36 hpf similarly to nox1 and nox2 (Fig. 4.4 A-B, E-F, I-J, M-N,
Q-R, U-V). By 48 hpf, nox5 shows a small increase in expression levels dorsally along
the anterior-posterior axis from the forebrain (Fig. 4.4G) to the spinal cord (Fig. 4.4W).

4.2.4 duox

At 12 hpf, total duox expression is lower than any other NOX isoform. duox
remains at this low level until 36 hpf, when expression increases by more than 10-fold (p
= 0.0001 at 36 hpf versus 12 and 24 hpf). High expression levels similarly to cybb and
nox1 are maintained from 36 hpf to 48 hpf (Fig. 4.1B). duox is the only NOX isoform to
undergo such a significant increase in expression during the first 48 h of development.
Similarly to the other three NOX isoforms, whole-mount ISH embryos and tissue
sections through the head and spinal cord at 24 and 36 hpf demonstrated that duox
expression is relatively broad (Fig. 4.5 A-B, E-F, I-J, M-N, Q-R, U-V). By 48 hpf, duox
expression domains become more unique. In the midbrain of 48 hpf fish, duox
demonstrated a unique expression pattern that clearly deviates from any other NOX
isoforms. duox is highly expressed in small regions surrounding the tectal ventricle,
rather than broadly expressed in the dorsal region as found for nox5 (Fig. 4.5O).
Furthermore, duox expression is not increased in the tectum unlike the other three
isoforms. In the spinal cord, duox is expressed throughout the neural tissue of 48 hpf fish
with a slight increase on the dorsal side (asterisk in Fig. 4.5W). In summary, similarly to
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Figure 4.4: Broad nox5 expression through the first two days of development (A-D) Lateral views of
whole-mount ISH embryos probed with antisense (A-C) and sense control (D) riboprobe against zebrafish
nox5 mRNA. Lines represent the position of sections shown in E-X. (E-H) 10 µm thick transverse sections
through the forebrain (line labeled ‘f’ in A) of 24, 36, 48 hpf embryos incubated with antisense probes (E-G,
respectively) and 24 hpf embryo probed with a sense control (H). (I-L) Transverse sections through the eye
(line labeled ‘e’ in A). (M-P) Corresponding midbrain sections (line labeled ‘m’ in A). (Q-T)
Corresponding hindbrain sections (line labeled ‘h’ in A). U-X. Corresponding spinal sections (line labeled
‘s’ in A). Scale bar 0.5 mm (A-D), 100 µm (E-X). 3V = third ventricle, DC = diencephalon, E = eye, MC =
mesencephalon, MyC = myelencephalon, NC = notochord, ON = optic nerve, OV = Otic vesicle, SC =
spinal cord, SM = somites, TC = telencephalon, Tec = tectum, TecV = tectal ventricle.
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the other NOX isoforms duox exhibits a relatively broad expression pattern in the
developing zebrafish nervous system until 48 hpf, when more distinct expression
domains appear.

4.3 Discussion

NOX enzymes are a family of multi-subunit enzyme complexes, and each NOX
isoform is subject to a unique type of regulation. This makes NOX enzymes excellent
candidates to participate in cellular signaling in response to specific upstream stimuli.
Within the nervous system, NOX isoforms have been shown to function in astrocytes,
microglia, and neurons (Sorce and Krause, 2009; Fischer et al., 2012; Nayernia et al.,
2014). NOX hyperactivity plays a role in the development and progression of
neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (Bedard and Krause, 2007). Despite these well-publicized deleterious roles,
NOX enzymes also have important functions in normal central and peripheral nervous
system development and function (Sorce and Krause, 2009; Nayernia et al., 2014). These
include neuronal stem cell maintenance (Dickinson et al., 2011), cerebellar development
(Coyoy et al., 2013; Olguin-Albuerne and Moran, 2015), neuronal differentiation
(Tsatmali et al., 2006), neuronal polarity and neurite outgrowth (Munnamalai and Suter,
2009; Munnamalai et al., 2014; Wilson et al., 2015), and synaptic plasticity (Kishida et
al., 2006). However, comprehensive analyses of NOX expression in the nervous system,
such as the current study, are crucial to better understand the role these enzymes plays in
development, disease, and regeneration.
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Figure 4.5: duox is highly expressed around tectal ventricle at 48 hpf (A-D) Lateral views of wholemount ISH embryos probed with antisense (A-C) and sense control (D) riboprobe against zebrafish duox
mRNA. Lines represent the position of sections shown in E-X. (E-H) 10 µm thick transverse sections
through the forebrain (line labeled ‘f’ in A) of 24, 36, 48 hpf embryos incubated with antisense probes (EG, respectively) and 24 hpf embryo probed with a sense control (H). (I-L) Transverse sections through the
eye (line labeled ‘e’ in A). (M-P) Corresponding midbrain sections (line labeled ‘m’ in A). High duox
expression was detected around the tectal ventricle (arrows in O). (Q-T) Corresponding hindbrain sections
(line labeled ‘h’ in A). (U-X) Corresponding spinal sections (line labeled ‘s’ in A). Asterisk and arrows
represent regions and small areas of increased duox expression in the spinal cord and midbrain, respectively.
Scale bar 0.5 mm (A-D), 100 µm (E-X). 3V = third ventricle, DC = diencephalon, E = eye, MC =
mesencephalon, MyC = myelencephalon, NC = notochord, ON = optic nerve, OV = Otic vesicle, SC =
spinal cord, SM = somites, TC = telencephalon, Tec = tectum, TecV = tectal ventricle.
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In this study, we provide a detailed characterization of NOX expression within the
nervous system of the developing zebrafish embryo. Sequences for nox1, cybb, nox5, and
duox genes have been identified in the zebrafish genome; however, when and where
individual NOX genes are expressed in fish embryos is currently unknown. We used
qPCR (Fig. 4.1B) and ISH (Figs. 2-5) to characterize the expression of nox1, cybb, nox5,
and duox in the developing fish nervous system between 12 and 48 hpf. qPCR data shows
dynamic changes in nox1, nox5 and duox expression while cybb levels are remarkably
consistent from 12 to 48 hpf. Whole-mount ISH data is overall qualitatively in agreement
with the qPCR data; however, it is important to keep in mind that ISH is not a
quantitative method. Thus, proper quantification of ISH is difficult if not impossible
between different time points and within tissues. All four NOX isoforms are broadly
expressed in the early nervous system at 24 and 36 hpf. Whereas the broad expression
continues, subtle differences in midbrain expression are visible by 48 hpf. nox1, cybb,
and nox5 show slightly elevated expression in the dorsal regions of the midbrain
corresponding to the optic tectum. In contrast, duox expression was enriched in the
regions adjacent to the tectal ventricle by this time. Increased labeling in dorsal and
ventricle-adjacent regions was not observed in other samples using tissue of comparable
thickness. Therefore we believe that the small increases in nox1, cybb, and nox5
expression in the dorsal midbrain is real and not due to a technical artifact caused by
incomplete probe penetration or probe trapping. Nonetheless, in most cases these
increases are subtle and may not necessarily suggest functional significance.
One might wonder why the four zebrafish NOX isoforms show a very similar
expression pattern early in development. A few points should be considered here. First,
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we have not assessed protein levels, since isoform-specific antibodies are still sparse and
not well validated in the zebrafish model system. It is possible that different NOX
isoforms show more distinct expression patterns at the protein level during first 2 days of
zebrafish development depending on translational regulation. MicroRNAs have been
shown to effect the activity of NOX4, the constitutively active isoform of NOX (Gordillo
et al., 2014; Wang et al., 2014). Based on this, it is plausible that other NOX isoforms
could be post-transcriptionally regulated. Thus, it will be important to investigate the
levels of protein expression in the developing nervous system. Second, broad NOX
expression during early development is not without precedent as NOX5 expression is
present in all human fetal tissues but more restricted in adult tissue (Cheng et al., 2001).
Because of broad expression of all NOX isoforms early during development, knocking
out one isoform might result in functional compensation by another NOX isoform and
therefore not generate strong phenotypes. This idea is supported by the fact that ROS
levels in cultured cerebellar granule neurons derived from NOX2 knockout mice were not
different from wild type control neurons (Olguin-Albuerne and Moran, 2015). In addition,
there is not much information in the literature about strong nervous system phenotypes of
existing NOX knockout mouse models, besides the mild impairments in hippocampusdependent memory in NOX2 knockout mice (Kishida et al., 2006). Lastly, it is important
to keep in mind that the different NOX isoforms have unique activation mechanisms, and
the resulting ROS are expected to act locally close to the source. Thus, even if multiple
isoforms are expressed in the same cell type at any given time, different upstream signals
could activate distinct NOX isoforms, which act in specific functions such as cell
differentiation, adhesion, or migration.
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Our current data on broad expression of NOX genes suggest that NOX activity
may be a central contributor during nervous system development. We are aware that the
present expression data of the main enzymatic subunit of the NOX complex is not
sufficient to make any conclusions about ROS levels in different regions of the nervous
system. However, we believe that the results from this study will provide important
information when interpreting results of future studies addressing the function of NOX
enzymes in embryonic zebrafish nervous system development and neurogenesis using
pharmacological and molecular manipulations of activity and expression levels of NOX
isoforms
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CHAPTER 5. FUNCTION OF NOX IN ZEBRAFISH RETINAL DEVELOPMENT

5.1 Introduction

Reactive oxygen species (ROS) readily oxidize many biomolecules, including
proteins, DNA, and lipids. Like other post-translational modifications, oxidation can have
a significant impact on biological functions such as cell migration (Hung et al., 2011;
Yoo et al., 2011; Tauzin et al., 2014). Thus, there is a need to tightly control the
production of ROS in the cell. Unlike other cellular sources of ROS, some isoforms of an
enzyme family called nicotinamide dinucleotide phosphate (NADPH) oxidases (Nox)
produce a burst of ROS only upon activation. This makes Nox enzymes ideal candidates
to be involved in ROS-mediated signaling. Nox activity has now been linked to various
cellular signaling pathways involving Src tyrosine kinase, Wnt, and tumor necrosis factor
alpha. Specifically, Nox-derived ROS are shown to be key signaling molecules in
multiple biological processes (Brown and Griendling, 2009; Yoo et al., 2011; Choi et al.,
2012; Kajla et al., 2012; Spencer et al., 2013; Weaver and Taylor-Fishwick, 2013;
Nayernia et al., 2014; Tauzin et al., 2014).
Nox-derived ROS have also been shown to mediate signaling in the nervous
system (Nayernia et al., 2014). Nox activity in adult mouse brains is essential for
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neuronal plasticity in the hippocampus and long-term potentiation (Tejada-Simon et al.,
2005; Kishida et al., 2006). Studies using cultured rat hippocampal neurons have shown
that Nox2 is critical for the establishment of neuronal polarity (Wilson et al., 2015).
Nox2 activity also regulates neurite outgrowth and actin dynamics in cultured neurons
from Aplysia californica (Munnamalai and Suter, 2009; Munnamalai et al., 2014).
Additionally, Nox inhibition causes defects in rat cerebellar development (Coyoy et al.,
2013) and reduced neurite outgrowth of cerebellar neurons (Olguin-Albuerne and Moran,
2015). Furthermore, neural stem cells retain a high level of ROS that is critical for their
self-renewal, and ROS production in these cells has been linked to Nox2 (Dickinson et al.,
2011; Le Belle et al., 2011; Ren et al., 2015). Taken collectively, these studies show that
Nox-derived ROS are critical components of normal signaling in the nervous system.
However, the detailed functions of Nox during normal nervous system development in
vivo are not well understood.
The goal of the present study was to determine the role of Nox in the development
of axonal tracts in the nervous system. We used zebrafish embryos as a model system
since they are a well-validated model of vertebrate neurodevelopment and compatible
with in vivo imaging, immunolabeling, and molecular genetics. Gene sequences for five
nox isoforms have been identified in the zebrafish genome (nox1, nox2 also called cybb
in zebrafish, nox4, nox5, and duox). Since the nox4 gene is not well annotated in
zebrafish, it was excluded from the current study. A series of studies showed that Noxderived ROS mediate leukocyte and macrophage recruitment and promote wound healing
in zebrafish (Yoo et al., 2011; Yoo et al., 2012; Tauzin et al., 2014). With respect to the
nervous system, one study found that DUOX is important for peripheral axon
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regeneration (Rieger and Sagasti, 2011). We have recently shown that zebrafish express
nox1, cybb, nox5 and duox broadly throughout the central nervous system during early
development (Weaver et al., 2015). However, whether or not specific Nox isoforms play
a functional role in zebrafish neurodevelopment remains unclear.
Here, we report that Nox2 is critical for the development of retinotectal
connections. We show that transient pharmacological Nox inhibition during early
development leads to an expansion of the ganglion cell layer (GCL), thinning of the optic
nerve (ON), and decreased innervation of the optic tectum (OT). To determine which
Nox isoforms are involved in retinal development, we generated isoform-specific nox
mutant fish using CRISPR/Cas9. We found that homozygous nox2/cybb mutations
caused an expansion of the GCL and mistargeted retinal axons in the OT. Taken together,
these results demonstrate a novel role for nox2/cybb in the developing zebrafish visual
system.

5.2 Results

5.2.1 Nox inhibition leads to defects in retinal development

In order to study the role of Nox function in nervous system development, we
applied a pan-Nox inhibitor, celastrol (Jaquet et al., 2011), to zebrafish embryos and
screened for neuroanatomical defects. This compound was chosen because it shows no
antioxidant effects common in other Nox inhibitors like apocynin (Heumuller et al.,
2008). We observed defects specifically in the formation of the ganglion cell layer (GCL)
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and the optic nerve (ON) when celastrol was applied between 32 and 36 hpf (Figure 5.1)
as well as the formation of anterior forebrain commissures when the inhibitor was applied
between 20 and 24 hpf (data not shown). Since the zebrafish visual system is well
characterized anatomically, functionally, and developmentally, we chose to focus this
study on the development of the retinal ganglion cells (RGCs) and ON. In zebrafish, the
retina begins to differentiate at 28 hours post-fertilization (hpf). At this time, RGCs
differentiate in the GCL medial to the lens of the eye (Hu and Easter, 1999). At a point in
the middle of the eye called the optic disk, axons throughout the GCL fasciculate into a
single bundle called the ON. The left and right ONs then grow toward the midline of the
embryo where they cross at a point called the optic chiasm at ~36 hpf (Burrill and Easter,
1995; Stenkamp, 2015). From the chiasm, ON axons grow dorso-caudally toward a
midbrain region called the optic tectum (OT) where they form synapses with tectal
neurons by 48 hpf (Kita et al., 2015).
To assess the effects of Nox inhibition on retinal and ON development, celastrol
was applied at 2.5 µM during the period of ON fasciculation and growth toward the
chiasm (32–36 hpf). The inhibitor was then washed out and the embryos were allowed to
develop until ON axons reached the OT (48 hpf). Embryos were then fixed and
immunostained with zn-8, an antibody that labels the GCL and ON (Avanesov and
Malicki, 2010). We observed an expansion of the zn-8-positive GCL and a thinning of
the ON in celastrol-treated fish embryos (Figure 5.1A, B). We quantified GCL width and
ON thickness as measures of retinal development (Figure 5.1D, E). Differences in GCL
width were found to be statistically significant (F(2, 35) = 66.6, p < 0.0001). Control
GCLs had an average width of 100 ± 10.6 µm (mean ± SD, Figure 5.1A, D). Inhibitor-
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Figure 5.1: Nox inhibition causes defects in retinal development and tectal innervation (A-C) Retinal
micrographs of 48 hpf embryos labeled with the RGC marker zn-8 following a 4 hour treatment with 0.1%
DMSO (A) or 2.5 µM celastrol (B–C). Embryo in C was incubated with 2 mM H 2O2 following drug
washout. White arrowhead in B indicates ON thinning. (D) Graph of GCL width in zn-8 labeled embryos
treated with celastrol. (E) Graph of ON thickness in zn-8 labeled embryos treated with celastrol. (F–H)
Anterior views of 48 hpf Tg(ath5:GFP) embryos after treatment with DMSO (F) or celastrol with (H) or
without (G) subsequent H2O2 incubation. Inset in G shows the optic chiasm. (I–K) Dorsal views of control
(I), inhibitor-treated (J) and H2O2 rescue (K) embryos at 72 hpf of embryos showing optic tectum
innervation. White arrows indicate the optic chiasm (F-H) or optic tecta (I-K). (L) Graph of GFP-positive
area corresponding to the GCL divided by total retinal area in Tg(ath5:GFP) embryos treated with celastrol.
(M) Graph of ON thickness in Tg(ath5:GFP) embryos treated with celastrol. (N) Graph of OT area in
Tg(ath5:GFP) embryos treated with celastrol. Scale bars = 50µm (A–C) and 100µm (F–K). All graphs
show mean ± standard deviation. Number in parenthesis indicates the number of embryos analyzed. pvalues from Tukey HSD tests are reported above comparison bars.
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treated embryos displayed a significant increase in GCL thickness compared with control
(128 ± 5.0 µm, p < 0.0001, Figure 5.1B, D). Previous studies have shown that Nox lossof-function can be rescued via the addition of hydrogen peroxide (H2O2) (Le Belle et al.,
2011; Rieger and Sagasti, 2011). Therefore, we optimized a rescue approach using
several concentrations of H2O2 applied continuously throughout the first 48 hpf (Figure
5.2). We found that 2 mM H2O2 did not have any impact on embryonic survival or any
visible effect on visual system development (Figure 5.2). Therefore, we applied 2 mM
H2O2 immediately following celastrol treatment; however, this did not affect the width of
the GCL compared to celastrol only-treated embryos (127 ± 3.6 µm, p = 0.7886, Figure
5.1C, D). Differences among mean ON thickness were also found to be significant ((F2,
35) = 133.5, p < 0.0001). Control embryos treated with 0.01% DMSO displayed a mean
ON thickness of 25 ± 3.4 µm (Figures 1A, E). ONs of celastrol-treated embryos were
significantly thinner (9 ± 2.2 µm, p < 0.0001 versus control, Figure 5.1B, E). Here, H2O2
application caused a marked recovery of ON thinning (17.9 ± 1.5 µm, p < 0.0001
compared to celastrol alone, Figure 5.1C, E).
We then used the Tg(ath5:GFP) transgenic line to label RGCs and the ON in live
embryos. Using this strategy, we were able to image retinal development and OT
innervation at different time points in the same embryo. In response to the Nox inhibitor
treatment, the GCL again appeared wider (Figure 5.1G). To determine if this wider GCL
represented an expansion of RGCs within the retina, we calculated the ratio of the GFPpositive area divided by the total area of the retina, and found significant differences

102

Figure 5.2: Optimization of H2O2 rescue (A) Percent survival versus hydrogen peroxide concentration
measure at 24 and 48HPF. Embryos were maintained in the solution from 0-48HPF. n = 80 individuals per
condition. Error bars represent SEM. (B-F) DIC images of 48HPF Tg(ath5:GFP) embryos following
hydrogen peroxide treatment. (B’-F’) Corresponding images of the GFP signals. Scale bar = 100µm.

among groups (F(2, 47) = 159, p < 0.0001). The GCL in inhibitor-treated embryos
occupied a greater proportion of the retina versus controls (Figure 5.1L; 0.45 ± 0.05, 0.24
± 0.03, respectively, p < 0.0001). Similarly to our findings with zn-8 labeling (Figure
5.1D), treatment with H2O2 did not significantly diminish the ratio of the retina occupied
by GFP-positive RGCs versus celastrol treatment (0.47 ± 0.04, p = 0.43). We again found
a significant difference among mean ON thickness the three treatment groups (F(2, 47) =
85.6, p < 0.0001). Control embryos had ONs with a mean thickness of 25.5 ± 3.4 µm
(Figure 5.1F, M) whereas ONs of inhibitor-treated embryos were significantly thinner
compared to controls (9.9 ± 2.0 µm, p < 0.0001, Figures 1G, M). The addition of H2O2
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partially rescued ON thickness compared to celastrol treatment (22.0 ± 4.6 µm, p <
0.0001, Figures 1H, M).
We next investigated the innervation of the OT in response to Nox inhibition. No
differences in axon targeting were observed as all GFP signals localized to the
presumptive OT as determined by visual comparison to control embryos. However, we
measured the area of the OT innervated by GFP-positive axons and found significant
differences among groups (F(2, 53) = 105.3, p < 0.0001). Controls displayed a mean area
of 7998 ± 1154 µm2 at 72 hpf (Figure 5.1I, N). Celastrol-treated embryos showed a
significant decrease in OT innervation (3164 ± 721 µm2, p < 0.0001 versus control,
Figures 1J, N). Like ON thickness, OT innervation was partially rescued by the 2 mM
H2O2 applied immediately following inhibitor treatment (6538 ± 1384 µm2, p < 0.0001
versus celastrol, Figures 1K–N). Collectively, these results demonstrate that
pharmacological Nox inhibition results in GCL expansion, ON thinning, and reduced OT
innervation, indicating a role for Nox in normal retinal development.

5.2.2 nox2/cybb chimeric mutants display retinal defects

To determine the specific Nox isoform involved, we used the clustered regularlyinterspaced short palindromic repeats (CRISPR)/Cas9 genome editing technique to
generate isoform-specific mutations in zebrafish embryos. We designed two guide RNAs
(gRNAs) per Nox isoform, and injected these gRNAs into 1-cell stage embryos to
generate site-specific mutations in the nox genes. The locations of the gRNA target sites
with respect to full-length Nox proteins are shown in Figure 5.3A. We first calculated the
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efficiency of the gRNAs by quantifying the percentage of mutant embryos generated by
each gRNA (Table 4). All of the gRNAs produced mutations in at least 65 percent of the
injected embryos. Some (e.g. nox1 gRNAI and nox5 gRNAII) generated mutations in
greater than 90 percent of the injected embryos. We also genotyped the predicted offtarget sites, shown in Table 2, for each gRNA and found no mutations at these locations
in the genome (data not shown).

Table 5.1. gRNA efficiency
mutant
nox1
50
nox2/cybb
40
nox5
35
duox
49

gRNA I
total
55
60
52
55

%
91
67
67
89

gRNA II
mutant
total
46
61
49
58
50
55
42
50

%
75
84
91
84

Embryos were genotyped as described in Methods. Total refers to the total number of embryos that were
injected and genotyped. Mutant refers to the number of embryos found to carry mutations.

Using this validated set of Nox isoform-specific gRNAs, we investigated which
Nox isoforms contribute to retinal development. Therefore, we co-injected both gRNAs
against a given nox gene into Tg(ath5:GFP) embryos which generated a set of novel
mutations in each embryo. Due to the random incorporation of insertions and deletions in
the early cells, these embryos are chimeric. Therefore, these chimeric embryos retain an
unknown percentage of wild-type nox genes in certain tissues. The implications of this
will be addressed in the Discussion. The injected embryos were genotyped at both gRNA
loci, and resulting phenotypes were assessed only in individuals carrying mutations at
both gRNA sites. Restricting the analysis to double-site mutants maximizes the
probability of producing a loss-of-function mutation. At least 20 chimeric mutants were
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Figure 5.3: nox mutants show optic nerve and tectal defects (A) Schematic of zebrafish NOX protein
domains as determined by alignment to the human protein sequences. Red arrows indicate the relative
location of gRNA target sites. (B–F) Anterior views Tg(ath5:GFP)-positive, nox chimeras at 48 hpf. White
arrows indicate the optic chiasm. Inset in D shows in enlarged and enhanced view of the optic chiasm. (G–
K) Dorsal views of chimeric embryos showing the innervation of the optic tecta (white arrows). GFPpositive cells not indicated with arrows represent non-tectal early neurons from the hindbrain and eye.
Scale bars = 100 µm (B–F) and 50 µm (G–K). (L) Graph of ON thickness in Tg(ath5:GFP) positive,
chimeric mutants. (M) Graph of OT area in Tg(ath5:GFP) positive, chimeric mutants. Number in
parenthesis indicates the number of embryos analyzed. Graphs show mean ± standard deviation. p-values
from Dunnett’s tests are reported above comparison bars.

analyzed for each gene, and representative ON and OT images are shown in Figure 5.3
along with measurements of ON thickness at 48 hpf and OT area at 72 hpf. Injected
embryos that did not carry mutations at either gRNA site served as wild-type controls for
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these experiments (Figure 5.3B, G). None of the nox chimeric mutants showed expansion
of the GCL as in the case of inhibitor-treated embryos (Figure 5.3B-F) or significant
mistargeting of GFP-positive axons within the midbrain (Figure 5.3G–K). Importantly,
ON thickness and OT innervation in controls were similar to what was found previously
in DMSO-treated embryos (26.8 ± 5.0 µm and 7998 ± 1154 µm2, respectively, Figure
5.3B, G, L, M). ONs of nox1 mutants are not significantly different from wild-type
controls (28.7 ± 5.2 µm, p = 0.24, Figure 5.3C, L). OT innervation was similarly
unaffected in these mutants (8063 ± 1946 µm, p = 1.00, Figure 5.3H, M). Similar to what
was observed in response to pharmacological Nox inhibition, nox2/cybb mutants
displayed thin ONs (17.4± 5.1 µm, p < 0.0001 versus control, Figure 5.3D, L). The OT of
nox2/cybb mutant larvae showed sparse GFP signals indicating a reduced number of ON
axons innervating the tissue (4840 ± 1835 µm2, p < 0.0001 versus control, Figure 5.3I,
M). nox5 mutants also displayed ON thinning (18.2 ± 5.5 µm, p < 0.0001 versus control,
Figure 5.3E, L) and decreased tectal innervation (4995 ± 2243 µm2, p < 0.0001 versus
control, Figure 5.3J, M). However, nox5 mutants have severe general morphological
defects early in development that might interfere with the formation of the brain and
retina (data not shown). Since nox2/cybb mutants better phenocopied our inhibitor-treated
embryos, we chose to focus on nox2/cybb in subsequent experiments. Finally, duox
mutants displayed insignificant ON thinning (25.3± 5.5 µm, p = 0.44 versus control,
Figure 5.3F, L) and decreased tectal innervation (7556 ± 1417 µm2, p = 0.74 versus
control, Figure 5.3K, M). In summary, these results showed that among the different nox
isoforms, nox2/cybb plays a critical the development of the zebrafish visual system.
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5.2.3 Optic nerve projection is delayed in nox2/cybb mutants

The effect of nox2/cybb mutation is a thin, underdeveloped ON at 48 hpf, whose
axons fail to properly innervate the OT by 72 hpf (Figure 5.3D, I). To address whether
these defects in retinotectal connectivity persist at later time points, we leveraged the
live-imaging capability of the Tg(ath5:GFP) line to capture ON and OT images from
nox2/cybb chimeric embryos at multiple time points. We also included a set of nox2/cybb
chimeric mutants that were incubated with 2 mM H2O2 as a rescue control condition. As
shown in Figure 5.4B and C, we observed characteristic ON thinning in nox2/cybb
mutants at 48 hpf (14.7 ± 3.7 µm, p < 0.0001 versus control, Figure 5.4I). ONs from
nox2/cybb mutants incubated with H2O2 were significantly thicker than untreated mutants
(19.8 ± 3.4 µm, p = 0.0035 versus mutant, Figure 5.4D, I), indicating that the phenotype
observed in nox2/cybb mutants is likely due to reduced H2O2 levels. We then imaged the
same embryos at 72 hpf to assess the persistence of ON thinning. By this time point,
nox2/cybb mutants recovered (35.7 ± 7.8 µm, Figure 5.3B’-C’) such that they were nearly
identical to controls (39.9 ± 6.9 µm, Figure 5.4A’). H2O2-treated larvae were similar to
controls with a thickness of 37.3 ± 5.2 µm (Figure 5.4D’). No significant differences
were detected among groups suggesting that the ON phenotypes observed in response to
nox2/cybb mutation could be transient, and likely due to developmental delays (F(2, 57)
= 2.086, p = 0.7842).

We then turned our attention to the effects of nox2/cybb mutations on OT
innervation. Imaging the same samples over three days, we saw a progressive increase in
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Figure 5.4: ON extension and OT innervation are delayed in chimeric nox2/cybb mutants (A–D)
Anterior views of nox2/cybb chimeras at 48 hpf showing the formation of the optic chiasm. Insets in B & C
show enlarged and enhanced views of the chiasm. (A’–D’) The same samples as A–D imaged at 72 hpf
showing recovery of ON outgrowth in chimeras. (E–F) Dorsal views of nox2/cybb chimeras at 72 hpf
showing the innervation of the optic tecta. The same samples were imaged at 96 (E’–H’) and 120 hpf (E”–
H”) to assess the extent of recovery. White arrows indicate the optic chiasm (A–D’) or optic tecta (E–H”).
Scale bars = 100 µm (A–D’) and 50 µm (E–H”) (I) Graph of ON thickness in Tg(ath5:GFP) positive,
nox2/cybb chimeric mutants. (J) Graph of OT area in Tg(ath5:GFP) positive, nox2/cybb chimeric mutants.
Number in parenthesis indicates the number of embryos analyzed. Graphs show mean ± standard deviation.
p-values from Tukey HSD tests are reported above comparison bars. n.s. indicates no significant difference.
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tectal innervation between 72 and 96 hpf in wild type controls (Figure 5.4E-H, E’-H’, J).
Significant differences among groups were identified at both time points (F(2, 48) =
38.37, p < 0.0001 for 72 hpf; F(2, 48) = 9.106, p = 0.0004 for 96 hpf). Innervated areas in
the OT from nox2/cybb mutants were significantly smaller than control (p < 0.0001) and
H2O2 rescue condition (p < 0.0001) at 72 hpf (Figure 5.4E-H, J). By 96 hpf, innervated
tectal areas of mutants and H2O2-treated mutants were still smaller than controls (p =
0.0006 and 0.005, respectively), but were not different from one another (p = 0.72, Figure
5.4E’-H’, J). A more severe loss of OT innervation was detected in nox2/cybb mutants by
120 hpf (F(2, 48) = 291.9, p <0.0001). OT innervation in mutants drops to 3590 ± 1357
µm2 (p < 0.0001 versus control, Figure 5.4F”, G”, J) compared to wild-type controls
(13,505 ± 844 µm2, Figure 5.4E”, J), and is significantly different from H2O2 treated
mutants (11,462 ± 1444 µm2, p < 0.0001, Figure 5.4H”& J). These results suggest that
OT innervation is initially delayed in nox2/cybb chimeras, whereas more severe defects
arise later.

5.2.4 nox2/cybb-/- embryos show expansion of the GCL

To minimize the potential phenotypic variability of nox2/cybb mutant chimeras, we
generated stable fish lines harboring homozygous nox2/cybb mutations at either site
targeted by the nox2/cybb gRNAs (referred to as nox2/cybb-/-). Two lines carrying
mutations at different loci within the nox2/cybb gene were generated to confirm the
convergence of phenotypes and ensure the specificity of mutagenesis. The mutant line
generated from gRNA I had a 5 base-pair deletion while the line from gRNA II carried a
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23 base-pair deletion (Figure 5.5A). Each line carries a premature stop codon early in the
coding sequence for nox2/cybb, which results in a significant truncation of the
Nox2/Cybb protein (Figure 5.5B). Both Nox2/Cybb mutant enzyme types have lost the
C-terminal substrate binding domain. Four histidine residues within alpha helices III and
V are essential for electron shuttling to the O2 acceptor, and at least one of these critical
histidines are missing in both mutant types (Kawahara and Lambeth, 2007; Brandes et al.,
2014). Without these critical functional domains, the mutant Nox2/Cybb proteins are
likely not functional.
Since nox2/cybb-/- mutant lines do not carry the Tg(ath5:GFP) transgene, we used
zn-8 antibodies to visualize axons. Samples were also counterstained with the nuclear
label DAPI to assess overall retinal development and lamination. In these experiments, wt
clutch mates served as controls. In contrast to chimeras, nox2/cybb-/- embryos exhibited
significant expansion of the zn-8-positive GCL at 48 hpf (F(2, 41) = 63, p < 0.0001). The
GCL in gRNAI (0.49 ± 0.06, Figure 5.5D–D”, I) and gRNAII mutants (0.48 ± 0.04,
Figure 5.5E–E”, I) occupies a greater proportion of the retina compared to controls (0.34
± 0.03, Figure 5.5C–C”, I, p < 0.0001 versus mutants). Unlike the ON phenotypes
observed in chimeric mutants, GCL expansion did not recover by 72 hpf in nox2/cybb-/mutants, and many cells were pyknotic at this later stage (Figure 5.5G’–H’). In controls,
the wt GCL occupied a similar percentage of the retina at 72 hpf compared to that at 48
hpf (0.31 ± 0.02, Figure 5.5F–F”, I) Mutant GCLs represented a significantly higher
proportion of the retina compared with wild type controls (gRNA I 0.48 ± 0.05, gRNA II
0.45 ± 0.06, p < 0.0001, Figure 5.5G–H”, I). These results further confirm a role for
Nox2/Cybb in GCL development. Interestingly, the ON was not significantly thinner in
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the homozygous mutants compared to wt controls (data not shown). The phenotypic
differences observed among inhibitor-treated, chimeric, and homozygous mutant
embryos will be addressed in the discussion.

Figure 5.5: Homozygous nox2/cybb mutants exhibit GCL expansion (A) Genomic sequences of
nox2/cybb mutants showing the 5 and 23 base pair deletions generated from gRNA I and II, respectively.
(B) Schematic of the mutant Nox2/Cybb proteins based on translated mRNA sequences and alignment to
the human protein sequence. (C–E”) Micrographs of 48 hpf nox2/cybb-/- eyes labeled with the RGC marker,
zn-8 (C–E), and DAPI (C’–E’). Mutants show defects in RGC outgrowth and retinal lamination. White
brackets mark the ganglion cell layer. (F–H”) nox2/cybb-/- eyes at 72 hpf labeled with zn-8 (F–H) and DAPI
(F’–H’) showing that the phenotype does not recover at later stages. Scale bars = 100 µm. (I) Graph of zn8-positive area corresponding to the GCL divided by total retinal area in nox2/cybb-/- mutants. Number in
parenthesis indicates the number of embryos analyzed. Graph shows mean ± standard deviation. p-values
from Dunnett’s tests are reported above comparison bars.
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5.2.5 nox2/cybb-/- mutants exhibit mistargeted axons in the OT

We next investigated the effect of nox2/cybb-/- mutation on OT innervation. The
area of the midbrain occupied by innervating ON axons in wt embryos is largely devoid
of DAPI-positive cell bodies (Figure 5.6A–A”). This represents a prototypical
morphology of the zebrafish OT (Kita et al., 2015). In nox2/cybb-/- mutants, zn-8-positive
axons are mistargeted to adjacent midbrain regions outside of the presumptive OT
(Figure 5.6B–C). Additionally, there is no area devoid of DAPI-positive cell bodies in the
presumptive location of the OT suggesting the absence of a single nerve bundle entering
the midbrain (Figure 5.6B’–C’). To better evaluate the changes in tectal innervation, we
used line scans visualizing the changes in labeling intensity across the tectum. In wt
embryos at 72 hpf, fluorescent intensity is highest in the area corresponding to the OT,
and falls precipitously in adjacent regions (Figure 5.6B–C”). In contrast, line scans
through tectal areas of nox2/cybb-/- mutants reveal lower signals in presumptive tectal
areas, whereas zn-8-positive axons can be found in extra-tectal areas (Figure 5.6B, C, G).
By 120 hpf, a significant number of zn-8 positive axons in the midbrain of nox2/cybb-/mutants were not targeted uniformly to the presumptive OT (Figure 5.6E, F). Again,
DAPI staining in mutant embryos failed to show an area free of cell bodies indicative of
an axon tract (Figure 5.6 E’, F’). Line scans continued to show a reduced and more
diffuse zn-8 signals in tecta of mutants when compared with wild type embryos (Figure
5.6H). Collectively, these results show that nox2/cybb-/- embryos exhibit defective ON
development that results in improper axonal targeting within the OT.
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Figure 5.6: Axons are mistargeted in the OT of homozygous nox2/cybb mutants (A–C”) Micrographs
of 72 hpf nox2/cybb-/- midbrains labeled with zn-8 (A–C), and DAPI (A’–C’). Mutants show defects in
tectal innervation. (D–F”) Wild-type (D) and nox2/cybb-/- midbrains at 120 hpf labeled with zn-8 (E–F) and
DAPI (E’–F’) showing that the phenotype does not recover at later stages. White arrows indicate the optic
tecta. Scale bars = 100 µm. (G–H) Line scans plotting fluorescent intensity of zn-8 signals versus position
in the midbrain. Placements of the line scans are shown with red dashed lines in zn-8 panels.

5.3 Discussion

There is emerging evidence that NADPH oxidases play a role during nervous
system development (Munnamalai and Suter, 2009; Dickinson et al., 2011; Le Belle et al.,
2011; Coyoy et al., 2013; Munnamalai et al., 2014; Olguin-Albuerne and Moran, 2015;
Ren et al., 2015; Wilson et al., 2015); however, the detailed functions of individual Nox
isoforms in neuronal development are not well understood, especially in vivo. We have
previously shown in cultured Aplysia californica neurons that cell autonomous Nox
activity is critical for proper actin organization, actin retrograde flow, and neurite
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outgrowth (Munnamalai and Suter, 2009; Munnamalai et al., 2014). The latter study,
showed that Nox2 regulatory subunits co-localize at adhesion sites suggesting that Nox2
may be involved in adhesion-mediated axonal growth. A separate study identified Nox as
a critical regulator of neuronal polarity and axonal growth of rat hippocampal neurons
and mouse cerebellar granule neurons (Coyoy et al., 2013; Wilson et al., 2015).
Here, we investigated the role of Nox in zebrafish retinal development. We found
that Nox inhibitors caused an expansion of the GCL, thinning of the ON, decreased OT
innervation and mistargeting of axons within the OT. To investigate the role of specific
Nox isoforms in this process, we used CRISPR/Cas9 mutagenesis to create chimeric
mutants targeted to each of four zebrafish nox isoforms. Among all four nox isoform
mutants, we observed that nox2/cybb chimeric mutant fish displayed a phenotype that
was most similar to the one caused by pharmacological Nox inhibition. nox2/cybb
chimeric mutants exhibited ON thinning and decreased tectal innervation caused by
developmental delays, which were rescued by treatment with H2O2. In contrast to fish
embryos treated with Nox inhibitor, the GCLs in these nox2/cybb chimeric mutants were
not expanded when compared with wt embryos. To better characterize the impact of
nox2/cybb mutation, we then bred chimeric mutants into stable lines carrying a truncated
version of Nox2/Cybb for each of the two nox2/cybb-specific gRNAs (nox2/cybb-/-).
Homozygous mutants displayed GCL expansion, alterations in retinal morphology and
mistargeting of axons in the OT. None of these phenotypes improve at later stages
suggesting that they are not the result of developmental delays.
We can divide the phenotypes observed in this study into two broad classes. First,
we found developmental delays that recovered at later developmental stages and could be
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rescued by H2O2. These included ON thinning and a decrease in the area of OT
innervation. Since both of these phenotypes respond to H2O2, it seems that they are
generally sensitive to ROS and not absolutely dependent on Nox2/Cybb. Phenotypes of
the second class did not improve with time or respond to the addition of H2O2. These
include GCL expansion and the mistargeting of axons in the OT. This OT phenotype is
distinct from the decrease in OT innervation described above. Here, axons reach the
midbrain without delay, but extend outside of the presumptive OT. The absence of H2O2mediated rescue for this second class of phenotypes suggests that they specifically require
Nox2/Cybb, and alternative sources of ROS will not suffice. The presence or absence of
some of these phenotypes with the different experimental approaches can be explained by
inherit differences among the experimental techniques as further explained below.
Whereas the individual phenotypes (GCL expansion, ON formation, area of OT
innervation and targeting of axon in the OT) are likely functionally linked to one another,
the current strategy of global Nox inhibition and knockout approach does not allow us to
conclude that the observed effects are solely due to Nox2/Cybb activity in RGCs.
Nonetheless, our current study clearly demonstrates a functional role for Nox2/Cybb in
zebrafish retinal development and outgrowth of RGC axons towards the OT.
Embryos injected with CRISPR/Cas9 components display chimerism. This is due
to the time required for CRISPR/Cas9 complex formation after injection. During this
time, cells of the embryo continue to divide, leading to the generation of unique
mutations in each cell. This results in chimeric animals carrying multiple mutations along
with wild-type alleles. Since the type of mutation generated at the target site is variable, it
is impossible to determine the net result on protein function. This means that chimeras
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typically have less severe phenotypes, owing to the presence of an unknown percentage
of functional enzyme. nox2/cybb chimeric mutants express both functional and nonfunctional Nox2/Cybb, leading to a global decrease in Nox2/Cybb activity. This decrease
would be expected to diminish, but not completely inhibit propagation of Nox2/Cybbmediated signals. This means that Nox2/Cybb-dependent events such as GCL
development and targeting of axons in the OT still occur, but may happen more slowly.
This explains the presence of developmental delays in chimeras characterized by ON
thinning and decreased OT innervation that recover at later time points.
nox2/cybb-/- embryos on the other hand are not expected to express any functional
protein, and thus, experience a strong, persistent loss of Nox2/Cybb activity. Given that
Nox isoforms are known to compensate for one another, it is reasonable to speculate that
nox2/cybb-/- mutants might activate compensatory mechanisms to survive. These
mechanisms may include increased expression of other Nox isoforms, a decrease in
cellular antioxidants or activated regulatory subunits binding to a different Nox isoform
(Yang et al., 2001; Banfi et al., 2003; Frantz et al., 2006; Pendyala and Natarajan, 2010).
Any of these alternative sources of ROS would be expected to mask developmental
delays in much the same way that H2O2 can rescue these phenotypes. This fits our
observations since nox2/cybb-/- mutants do not exhibit delays characterized by ON
thinning or a decrease in OT innervation. However, compensatory sources of ROS might
not be able to rescue phenotypes specifically requiring Nox2/Cybb, just as H2O2 cannot
rescue these phenotypes. Again, this fits with our observation of GCL expansion and
mistargeting of axons in the OT in nox2/cybb-/- samples. Compensation to mask
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developmental delays is not expected in chimeras since functional Nox2/Cybb is still
present in these embryos.
Differences in the timing and extent of interfering with Nox activity among the
approaches used in our study might also explain the observed response to
pharmacological Nox inhibition. Celastrol treatment is expected to completely inhibit all
Nox isoforms temporally restricted to a few hours during ON development. These
embryos display phenotypes of both classes such as GCL expansion, ON thinning and a
decrease in the area of OT innervation likely stemming from the temporary but complete
loss of Nox activity.
We would predict that nox2/cybb-/- mutants have localized decreases in ROS that
impact signaling. ROS biosensors such as HyPer3 (Bilan et al., 2013) and ro-GFP (Meyer
and Dick, 2010) allow in vivo, ratiometric imaging of ROS. However, it is unlikely that
macro-scale changes in ROS production might be observed due to possible compensation
by non-mutant Nox isoforms and mitochondria that contribute to global redox
homeostasis. Our current approach of CRISPR/Cas9 mutagenesis does not allow for
spatial or temporal control. However, newly developed techniques allow for restricted
expression of Cas9 using cell-type specific (Ablain et al., 2015) or heat-shock promoters
(Yin et al., 2015). Cell-type specific mutagenesis will provide insight into cellautonomous functions of Nox, whereas temporally controlled mutagenesis will reveal the
role of Nox at specific developmental stages. Additionally, these new technologies will
allow for the dissection of molecular signaling pathways in specific cell types that
underlie the phenotypes we report here.
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In conclusion, we report that Nox2/Cybb is involved in the development and
differentiation of RGCs in the zebrafish retina, the timing of ON outgrowth and the
targeting of RGC axons within the OT. This finding advances the role of Nox-mediated
signaling to include neurodevelopmental events in the retina. Lastly, we believe that the
nox2/cybb-/- fish line generated in the present study will be a valuable resource for future
investigations of Nox2/Cybb function not only in the nervous system, but also in other
organ systems and cell types.
.
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CHAPTER 6. CONCLUSIONS FROM NEURONAL CULTURE STUDIES

6.1 NOX2 and p40phox in Aplysia neurons

In Chapter 3, I presented a series of experiments demonstrating the presence and
function of a NOX2-like protein in Aplysia neuronal growth cones. I demonstrated that
NOX activity is necessary for neurite extension, actomyosin-driven retrograde flow and
actin organization. Treatment with NOX inhibitors, VAS2870 or celastrol, decreased
retrograde flow rates and stalled neurite outgrowth (Figures 3.1 & 3.2). The effect was
reversed when inhibitors were washed out after 20 minutes, but the effects of overnight
application were irreversible. In cell bodies, NOX2 and p40phox were rarely colocalized.
NOX2 localized to the plasma membrane, and p40phox displayed a cytosolic, punctuate
distribution (Figure 3.4).. Some puncta were stained positive for NOX2, p40phox and actin
(Figure 3.4F’). VAS2870 caused a subtle decrease in ROS levels under basal growth
conditions, but was able to block spikes in ROS production caused by the NOX activator
phorbol 12, 13-dibutyrate (PDBu, Figure 3.5). In growth cones, antibody labeling for
NOX2 and p40phox revealed a punctuate distribution for both proteins (Figure 3.3). I then
showed that NOX2 and p40phox puncta colocalize with f-actin in the growth cone
periphery (Figure 3.6). Additional experiments included in the published version of this
work showed the dependence of peripheral NOX2 and p40phox localization on actin and
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the enrichment of NOX2/p40phox colocalization at artificially-induced adhesion sites
(Munnamalai et al., 2014). Collectively, this work identified NOX2 and p40phox in
Aplysia, and showed a direct interaction between the NOX subunits and actin. These
results showed that NOX activity is necessary for proper actin dynamics and neurite
outgrowth.
It is still unclear how exactly NOX-derived ROS are involved in growth cone
signaling. In this chapter, I will introduce additional evidence from our lab suggesting
that NOX may be involved in cell adhesions in neuronal growth cones and in zebrafish
RGC neurite outgrowth. Additionally, I will briefly review upstream signals and
downstream effectors that have been associated with NOX and are relevant to growth
cone guidance. Finally, I will propose approaches to extend our current work addressing
the function of NOX in axonal growth and guidance.

6.2 Evidence for NOX in neuronal cell adhesions

Compared to other species, neurites from Aplysia bag cell neurons grow slowly.
The large size of the growth cone, which is excellent for imaging, makes turning assays
difficult. Therefore, it is challenging to observe guidance in these cells. However, we can
induce artificial adhesion sites that mimic turning responses by applying 5µm beads
coated with a cell adhesion molecule (apCAM) directly to P domain of the growth cone
(Suter et al., 1998; Suter and Forscher, 2001; Suter, 2011). The beads are carried
retrogradely via actomyosin-driven flow. If the bead is restrained with a microneedle, the
growth cone will respond by extending the microtubule-rich central domain and apply
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additional force to pull the bead (Suter et al., 1998). This process is largely analogous to
the turning and steering responses in smaller growth cones that direct axon growth and
guidance
Additional work from our lab showed that NOX2/ p40phox colocalization is
enriched at sites of bead interactions (Munnamalai et al., 2014). Whether NOX is
activated in response to apCAM binding is still unknown, however the assembly of
subunits would suggest this is the case. Future experiments will determine whether NOX
activity is necessary for apCAM-meditated responses, but the finding of NOX2/ p40phox
colocalization suggests that NOX2 may be activated by apCAM binding, and may play a
role in downstream signaling that leads to growth cone turning.

6.3 Nox function in zebrafish retinal neurons

Cultured neurons with smaller, faster growing neurites would allow us to perform
growth cone turning assays that are not possible with Aplysia neurons. Since my in vivo
studies focus on retinal nerves from zebrafish, I decided to culture these cells for in vitro
assays. I performed preliminary experiments on neurons derived from 36 hpf zebrafish
retinas (AB strain) on coverslips coated with 20µg/mL laminin. Retinal neurons exhibited
processes extending >50µm after 12 hours in culture growing at 10 ± 1.3µm/hr (Figure
6.1A-E). This growth rate is similar to what has been observed for retinal neurons in vitro
(Chen et al., 2013) and in vivo (Kita et al., 2015). I then tested the response of retinal
neurons to the application of growth factors and cues including nerve growth factor (NGF,
20ng/mL), netrin-1 (Netrin, 250ng/mL) and semaphorin 3E (Sema3E, 5µg/mL,
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Figure 6.1E). Neurite growth rates were no different in response to NGF, but netrin-1
caused a slight, but not statistically significant decrease in growth rate (Figure 6.1E). This
could be due to the relatively low number of cells analyzed (n = 12) in this preliminary
study. The response to sema3E was a robust retraction of neurites. This pilot study
showed that we could culture zebrafish retinal neurons in our lab and that neurite growth
rates respond to growth factors and guidance cues.

Figure 6.1: Cultured zebrafish retinal neurons respond to soluble cues (A-D) Time-lapse image series
showing neurite outgrowth from a retinal neuron harvested from a wild type zebrafish at 36 hpf. Cells were
cultured on laminin for 12 hours prior to imaging. Images were captured at 20 minute intervals for 1 hour.
(E) Graph showing mean neurite growth rates ± SEM under control conditions (serum-free media) and in
response to global application of the indicated guidance cue. Numbers in parenthesis represent the numbers
of cells analyzed. Significant differences were identified with one-way ANOVA (F(3, 60) = 13.72, p <
0.0001). p-values for Dunnett’s multiple comparison tests versus controls are shown above comparison bars.
p < 0.05 was considered significant.

Since my preliminary trials, use of the zebrafish neuronal culture system has been
extended by others in the lab. We now culture neurons derived from the Tg(ath5:GFP)
transgenic line to restrict our analysis to RGCs. We have also moved from global
application of growth factors and guidance cues to directional applications that allow for
quantification of neurite turning in addition to measurements of growth rate.
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We also turned to the in vitro culture system to test the effect of Nox inhibitors on
RGC neurite outgrowth. The in vivo studies described in Chapter 5 present a complex set
of phenotypes that likely stem from the global manipulations of Nox activity with
inhibitor applications and CRISPR mutants. To focus specifically on Nox in RGCs, we
applied the inhibitors VAS2870 or celastrol to retinal neurons in culture. We saw a dosedependent reduction in RGC neurite outgrowth following a 15 minute pre-incubation
with the inhibitors. The sensitivity of these cells to the drugs suggests that RGCs express
one or more NOX isoforms, and that Nox activity is necessary for neurite outgrowth.
Additional experiments are needed to uncover the isoforms expressed and the
mechanistic details of Nox-mediated signaling in RGCs. The experiments proposed in
section 6.6 may be performed using Aplysia bag cell neurons or zebrafish RGCs.

6.4 Upstream activators of NOX

From our studies, NOX appears to be important for neurite outgrowth in multiple
species. Additionally, preliminary work suggests that NOX may be activated at adhesion
sites in Aplysia neurons. If NOX is to act as a signal in axon growth and guidance, it is
practical to consider what upstream signals might be using NOX-derived ROS as an
intermediate. At present, there is little evidence for the involvement of NOX in traditional
guidance cue signaling pathways like semaphorins, netrins, and slits. However, the
finding that Mical-derived ROS is necessary for semaphorin-mediated axon guidance in
Drosophila (see Chapter 1) leaves open the possibility that NOX may be involved in
some of these pathways as well. Axons are also guided by morphogens, mitogens,
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extracellular matrix proteins, proteoglycans and cell adhesion molecules (Fadool and
Dowling, 2008; Stenkamp, 2015). While the involvement of NOX in these cellular
signals has not been well studied in neurons, there is overwhelming evidence that NOX
mediates these signals in other cell types. To provide a basis for further experiments, the
following sections introduce NOX-mediated signaling pathways that are known to induce
cell motility. Additional NOX and ROS-related cellular signals involved specifically in
the development of the optic nerve are presented in Chapter 7

6.4.1 Platelet-derived growth factor

Shortly after their discovery, NOX enzymes were found in the cells of the
vasculature, and much of what is known about NOX-mediated cell signaling comes from
this field (Drummond and Sobey, 2014). The cells lining the walls of the vasculature
control blood circulation and blood pressure. In particular, the misregulation of two cell
types, vascular smooth muscle cells (VSMCs) and endothelial cells, contribute to the
onset and progression of atherosclerosis and hypertension (Hadrava et al., 1991;
Castellon and Bogdanova, 2016). Both cell types respond to platelet-derived growth
factor (PDGF). VSMCs treated with PDGF become proliferative and motile, and it is
well-established that PDGF stimulation of VSMCs is accompanied by H2O2 production
(Sundaresan et al., 1995). In the same study, authors found that application of ROS
scavengers blocks PDGF-stimulated kinase activity and chemotaxis, demonstrating that
ROS production was necessary for signal propagation. Subsequent studies found that the
NOX inhibitor VAS2870 also blocked PDGF-induced ROS production and VSMC

125
migration (ten Freyhaus et al., 2006). Interestingly, the authors found that VAS2870 did
not affect PDGF-stimulated DNA synthesis or cell cycle progression, suggesting that
these processes are not dependent on NOX. Finally, NOX1 was identified as the source
of ROS downstream of PDGF in VSMCs (Maheswaranathan et al., 2011).
Aortic smooth muscle cells (ASMCs) also produce ROS and become proliferative
in response to PDGF. Unlike VSMCs, ROS produced by human ASMCs in response to
PDGF is dependent on NOX5 (Jay et al., 2008). It is unclear exactly how PDGF signaling
pathways are divergent in VSMCs versus ASMCs in other aspects, but these studies
reveal that the source of ROS varies with cell type. Since NOX1 and NOX5 are activated
by very different types of upstream signals, these results suggest that PDGF signals are
propagated very differently in these two cell types
Endothelial cells also become proliferative in response to PDGF, and this is
dependent on the production of ROS via NOX. PDGF-induced cell migration in
endothelial cells is specifically dependent on NOX1 (Garrido-Urbani et al., 2011).
Authors found that endothelial cells express NOX1, 2 and 4, but PDGF signal
propagation is dependent on NOX1. This is one example of a cell type coexpressing
multiple NOX isoforms but maintaining functional specificity for each. This is relevant to
the results I presented in Chapter 4 of overlapping expression domains for multiple nox
genes in the zebrafish central nervous system.
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6.4.2 Additional NOX-mediated growth factors

Vascular endothelial growth factor (VEGF) is a potent mitogen that promotes
angiogenesis. VEGF stimulation of endothelial cells causes proliferation and migration.
Like PDGF, VEGF stimulation is accompanied by an increase in ROS. Preincubation
with NOX inhibitors blocks the VEGF-mediated spike in ROS along with cell migration
and proliferation demonstrating that all of these responses are NOX dependent (Abid et
al., 2000). A subsequent study showed that VEGF stimulation induced that translocation
of p47phox to sites of membrane ruffling (Wu et al., 2003). Translocation was
accompanied by p47phox phosphorylation, Rac1 activity and ROS production, and this
suggests that NOX2 is responsible for VEGF-induced ROS production.
Angiotensin II (AngII) is a growth promoting mitogen for smooth muscle cells
(Fyhrquist et al., 1995). One study identified expression of NOX1, 2 and 4 in VSMCs,
but found that NOX1 specifically contributed to AngII signaling and proliferative
responses (Lassegue et al., 2001). A separate study found that NOX4 was responsible for
basal ROS production in rat ASMCs, but NOX1 was specifically activated in response to
AngII (Dikalov et al., 2008). Authors of a different study found NOX1 and NOX4
activity downstream from insulin-like growth factor 1 in VSMCs (Meng et al., 2008).
However, the primary isoform responsible for ROS production in this pathway is still
unknown.
NGF-mediated signaling has also been linked to NOX. Treatment of PC12 cells
with NGF causes neurite extension that is accompanied by a rise in ROS levels. NGF
exposure leads to an increase in nox1 and decrease in nox2 mRNA transcripts.
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Accordingly, NOX inhibitors and nox1-targeted ribosymes block NGF-induced ROS
production (Ibi et al., 2006). However, the researchers found that blocking ROS enhanced
NGF-induced neurite outgrowth. They went on to speculate that NOX1 may prevent
excessive growth of neurites when cells are exposed to NGF.
Collectively, these results show that several growth factors induce the production
of ROS via NOX and rely on ROS-mediated signal transduction for some functions. It
should be noted that VSMCs, ASMC and endothelial cells all express multiple NOX
isoforms. However, specific isoforms seem to be involved in the transduction of signals.
Upstream signals are even able to differentiate between the NOX1 and NOX2, which are
regulated in very similar ways. How growth factor signaling cascades target individual
NOX isoforms is an open question that deserves further study.

6.4.3 Cell adhesions

Focal adhesions (FAs) are multi-protein complexes linking the cytoskeleton to the
extracellular matrix. Formation and turnover of FAs is critical for cell motility, and has
been implicated in cellular behaviors ranging from cancer metastasis to axon guidance
(Wozniak et al., 2004; Myers et al., 2011). Treatment of endothelial cells with H2O2
causes the formation of stress fibers and phosphorylation of the FA-associated proteins
focal adhesion kinase (FAK) and paxillin (Vepa et al., 1999). Subsequent studies showed
a direct interaction between the NOX2 subunit p47phox and another FA protein, TRAF4
(Wu et al., 2005). TRAF4 binding helped localize p47phox to the FA site. In this case,
ROS generated at FAs oxidized a protein tyrosine phosphatase, PTP-PEST, and likely
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inhibited function. This is similar to what was discussed in Chapter 1 wherein oxidation
inhibits the function of PTP-1B (Salmeen et al., 2003). A separate study suggested the
involvement of NOX4 in FAs due to the colocalization of NOX4 with vinculin, an FA
complex protein (Hilenski et al., 2004). While this work was solely based on
immunolabeling, additional evidence has shown that NOX4 mediates FA turnover and
migration in VSMCs (Datla et al., 2014). More recent studies continue to support for the
role of NOX-derived ROS in establishment and turnover of FAs during cell migration
(Basuroy et al., 2010; Abdelsaid and El-Remessy, 2012). However, much of the current
work is focused on NOX1/4 in spite early reports showing NOX2 in FA complexes.
Vascular CAM (VCAM) regulates the maintenance of stem cell populations in the
subventricular zone of adult mice. VCAM signaling is accompanied by ROS production
via NOX2 (Kokovay et al., 2012). The results of this study are particularly relevant to my
work since they demonstrate a role for NOX2-mediated CAM signaling in the central
nervous system.
NOX is known to mediate growth factor signals, focal adhesions dynamics and
CAM-based adhesions (summarized in Table 6.1). The role of these signals in axon
guidance is well established, and NOX enzymes are known to be expressed in neurons.
Further, our work demonstrates the importance of NOX activity to neurite outgrowth.
Therefore, it is reasonable to hypothesize that NOX-derived ROS may be involved in
axon growth and guidance downstream of one or more of these signals. I propose
experiments designed to test this hypothesis and extend our current results in section 6.6.
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Table 6.1: Growth factors and adhesion molecules involving NOX
Protein
PDGF
VEGF
AngII
NGF
TRAF4
Vinculin
Integrin
VCAM

Function(s)
growth factor:
proliferation, chemotaxis

focal adhesions: migration

Section Source of ROS
6.4.1
NOX1/5
NOX2
6.4.2
NOX1
NOX1
NOX2
NOX4
6.4.3
NOX2/4
NOX2

6.5 Downstream targets of NOX-derived reactive oxygen

Axon and neurite outgrowth is driven by cytoskeletal dynamics. In Chapter 1, I
introduced what is known about redox regulation of actin and microtubules. It is tempting
to speculate that NOX-derived ROS in Aplysia growth cones and zebrafish acts directly
on the cytoskeleton to effect dynamics, organization and neurite outgrowth. However,
there are several other redox-sensitive effectors that are involved in cytoskeletal
remodeling and cell motility. Many of these have been previously studied in our lab, and
thus, are even more relevant to consider for future experiments.

6.5.1 Src

Src is a non-receptor tyrosine kinase activated downstream of growth factors,
adhesion molecules and other cellular signals. Src signaling is commonly implicated in
cancer and has also been shown to be involved in growth cone guidance (Suter and
Forscher, 2001; Suter et al., 2004; Buday and Downward, 2007; He et al., 2015). Our lab
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has previously shown that Src activation promotes lamellipodial protrusion and filopodial
stability in Aplysia growth cones (He et al., 2015). With regard to NOX, early studies
showed that p47phox was a Src substrate, making Src an upstream activator of NOX2 in
VSMCs (Touyz et al., 2003). However, subsequent studies showed that Src is activated
by H2O2 oxidation via the formation of a C-terminal disulfide bond (Giannoni et al., 2005;
Mills et al., 2007; Basuroy et al., 2010). Eventually, it was discovered that Src and NOX1
form a positive feedback loop in response to inflammatory cytokines in beta cells
(Weaver et al., 2012; Weaver and Taylor-Fishwick, 2013).
Like developing axons, neutrophils and leukocytes are highly motile. These cells
infiltrate wound margins to facilitate healing. In zebrafish, H2O2 is produced at wound
margins by DUOX, and this ROS acts as a signal to recruit leukocytes to the damage
tissue (Niethammer et al., 2009). A zebrafish Src family kinase member, Lyn, was found
to be responsible for redox sensitivity in neutrophils. Oxidation of cysteine 466 mediates
Lyn activation and neutrophil migration into the ROS gradient (Yoo et al., 2011). This
work was extended to show that NOX-derived ROS and Src are necessary for tail
regeneration and, surprisingly, the reduction of post-injury inflammation (Yoo et al.,
2012; Tauzin et al., 2014). Our lab has significant experience studying Src in Aplysia
growth cones. Therefore, we are uniquely equipped to investigate a possible NOX/Src
signaling axis in this model system.
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6.5.2 Cortactin

Cortactin is an f-actin binding protein and a Src substrate (Decourt et al., 2009;
He et al., 2015). Our lab has also found that cortactin is involved in lamellipodial and
filopodial dynamics in Aplysia growth cones (He et al., 2015). It has been shown that
H2O2 treatment of endothelial cells caused an increase in Src-dependent cortactin
phosphorylation (Li et al., 2000). This is expected since Src activity is increased in
response to ROS application. However, later studies revealed that p47phox is localized to
f-actin filaments, and this interaction is mediated by direct interaction with cortactin
(Touyz et al., 2005). p47phox has also been linked to the regulation of cytoskeletal
dynamics via cortactin (Patel et al., 2013). However, this study posited a NOXindependent function for p47phox so the exact connection between cortactin and NOXderived ROS remains unclear.

6.5.3 Slingshot/cofilin

Actin depolymerizing factor (ADF)/cofilin is an actin filament severing protein
that regulates actin dynamics. ADF/cofilin activity is involved in several axon guidance
pathways including netrins, ephrins and slits (Marsick et al., 2010; Marsick et al., 2012).
ADF/cofilin binds and severs existing f-actin filaments. This causes f-actin to
depolymerize and creates new actin nucleators to facilitate polymerization (Bamburg and
Bernstein, 2010). The phosphorylated form of ADF/cofilin is inactive, therefore
activation is mediated by a phosphatase called Slingshot (Niwa et al., 2002; Kaji et al.,
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2003). Slingshot is regulated by binding to a 14-3-3 protein, which maintains Slingshot in
the inactive state. NOX-derived ROS oxidize the 14-3-3 protein inducing the release of
Slingshot and subsequent activation of cofilin (Kim et al., 2009). Redox regulation of
Slingshot/14-3-3 binding has been observed in VSMCs (Lee et al., 2009;
Maheswaranathan et al., 2011) and keratinocytes (Kim et al., 2011b). The study in
keratinocytes found NOX-mediated Slingshot regulation in response to neuregulin, a
growth factor known to be involved in neurodevelopment.

6.5.4 WAVE and moesin

The WASP-family verprolin homologous protein-1 (WAVE1) is an actin binding
protein involved in the regulation of actin lamellipodial networks via the nucleator
Arp2/3 (Pollitt and Insall, 2009). In response to VEGF, WAVE1 is localized to
membrane ruffles and mediates actin reorganization. One study found that WAVE1
directly interacts with p47phox, and this interaction is necessary for cytoskeletal
modification (Wu et al., 2003).
Early but promising research implicates another actin binding protein, moesin, in
NOX-mediated signaling. Moesin is one of a family of proteins shown to link f-actin to
the plasma membrane (Tsukita and Yonemura, 1997). Cell-free studies have shown that
moesin binds to the PX domain of both p47phox and p40phox (Wientjes et al., 2001). There
is no functional data to link moesin to NOX activity, but it is noteworthy given that other
actin binding proteins, like cortactin and WAVE, have been found to be regulated by
NOX-derived ROS.
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6.6 Future directions for the growth cone project

The studies discussed in sections 6.4 and 6.5 show that NOX is involved in
growth factor and adhesion-based signaling, and downstream signals in these pathways
are redox sensitive. While the bulk of this evidence is derived from non-neuronal cells,
the basic mechanisms of signal propagation and regulation of dynamics may translate to
many motile cells. My work, discussed in Chapters 3, shows the requirement for NOX
activity in Aplysia bag cell neurons, and the preliminary studies in section 6.3 extend this
into cultured zebrafish RGCs. In addition, we have evidence that suggests NOX2 may be
active at adhesion sites in Aplysia growth cones (Munnamalai et al., 2014). Moving
forward, I propose to investigate the specific function of NOX-derived ROS during axon
growth and guidance. I would then screen for soluble guidance cues and substrate
molecules that modulate the production of ROS in the neuronal growth cone. Next, I
would dissect the molecular signaling pathways downstream of the cues that lead to NOX
activation. Finally, I would investigate the direct effectors of NOX-derived ROS that
contribute to growth cone turning.
An essential part of all of these studies would be to monitor cellular ROS levels in
real time. In the past, we have used cell-permeable dyes like 2’,7’-dichlorofluorescin
(DCF) and Peroxyfluor-6 (PF6) to monitor ROS levels (Dickinson et al., 2011). These
dyes require the addition of a volume indicator dye, and are subject to ROS-mediated
autofluorescence. Therefore, they are not optimal for long-term, dynamic ROS imaging
of single cells. Better suited for these experiments are the latest generation ROS
biosensors: roGFP2-Orp1 and HyPer3 (Meyer and Dick, 2010; Bilan et al., 2013).
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Table 6.2: Downstream effectors targeted by NOX-derived reactive oxygen
Protein
Function(s)
Section Source of ROS
Actin
cytoskeletal remodeling
1.2.1
Unknown
Src
NOX1/3
tyrosine kinase
6.5.1
Lyn
NOX
Cortactin
actin adaptor protein
6.5.2
NOX2
Slingshot
6.5.3
NOX2
regulation of actin dynamics
WAVE
NOX2
6.5.4
Moesin
actin-membrane anchor
NOX2
‘ROS’ refers to redox sensitive targets where no source has been identified. ‘NOX’ indicates that no
specific isoform has been identified.

roGFP2-Orp1 relies on the peroxidase activity of yeast Orp1 to oxidize the redox
sensitive roGFP2 (Gutscher et al., 2009). The H2O2-specific HyPer3 is based on a
circularly permutated yellow fluorescent protein inserted into the regulatory domain of a
naturally occurring, redox sensitive protein called OxyR (Bilan et al., 2013). Both probes
provide a quantitative method of detecting ROS in live cells, and are preferable to cellpermeable dyes. One potential drawback is the pH sensitivity of HyPer, but this is not a
concern for roGFP (Roma et al., 2012). However, newly developed pH biosensors like
pHusion make it possible to measure pH changes and control for their effects on HyPer3
signals (Gjetting et al., 2012).

6.6.1 Correlating reactive oxygen with neurite outgrowth

Having shown that NOX inhibitors decrease basal ROS levels and cause neurites
to stall, it is now imperative to correlate ROS production and neurite outgrowth. We have
HyPer3 and roGFP2-Orp1 in our lab, and I propose using both biosensors, independently,
to quantify changes in growth cone ROS during neurite outgrowth. In the past, we have
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used dye-based measurements to correlate ROS levels with neurite growth rates. In these
experiments, we measured ROS at the end of 12 or 24 hours and compared this to overall
outgrowth. The major drawback of this approach is that ROS is a very short-lived signal,
and a single measurement is unlikely to correlate with long-term outgrowth. Instead, I
would predict that transient spikes and troughs in ROS production would precede
changes in growth rate. To capture these effects, we can use time-lapse imaging of
Aplysia or zebrafish neurons expressing ROS biosensors to determine whether or not
ROS levels correlate with or even predict changes in growth rate.
A newly developed set of cell-permeable actin and microtubules probes based on
silicon rhodamine dyes allow live-imaging of the cytoskeleton. Called SiR-actin and SiRtubulin, these probes use far-red fluorescent wavelengths that would be compatible with
either roGFP2 or HyPer3 (Lukinavicius et al., 2014). We have used these probes to label
NIH/3T3 fibroblasts for a separate project (Figure 6.1). Both SiR-actin and SiR-tubulin
provide stable, uniform signals in live cells, but additional validation experiments are
necessary to confirm the extent of labeling. However, preliminary results are promising
given that the tubulin probe even appears to label the primary cilia (Figure 6.1B).
Combining the cytoskeletal probes with ROS biosensors we could simultaneously
measure ROS levels, cytoskeletal restructuring and neurite outgrowth.
To directly determine the impact of changing ROS levels on neurite outgrowth,
we can manipulate ROS concentrations by adding H2O2 or ROS scavengers to the media.
More specifically, we can determine the role of NOX by treating cells with specific NOX
inhibitors (VAS2870, celastrol or apocynin) or activators (phorbol 12-myristate 13acetate or phorbol 12 13-dibutyrate). With the ROS biosensors, we can directly
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investigate the spatiotemporal relationships between intracellular ROS, cytoskeletal
organization and neurite outgrowth.

Figure 6.2: SiR-actin and SiR-tubulin label cytoskeletal structures in fibroblasts NIH/3T3 fibroblasts
were incubated with 100nM probes in normal media overnight. A primary cilia-like structure is visible with
SiR-tubulin (arrowhead). Scale bar = 10µm.

We could then investigate the ability of asymmetric gradients of ROS across the
growth cone to generate turning responses. Directional application of exogenous H2O2,
ROS scavengers, NOX activators or inhibitors would be expected to generate gradients of
ROS across the growth cone. We can verify this using the ROS biosensors.
Simultaneously, we can quantify changes in the cytoskeleton, growth cone morphology
and neurite outgrowth in response to the ROS gradients. This would be the first
demonstration of ROS levels predicting growth cone steering. Combined with
quantitative measurements of intracellular ROS and cytoskeletal dynamics, this type of
experiment would provide excellent evidence for the importance of NOX-mediated redox
signaling in axon guidance.
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6.6.2 Identification of upstream guidance cues

The experiments proposed above focus on the direct effect of ROS, but do not
provide any physiological relevance. Even if NOX-mediated ROS can be shown to alter
neurite outgrowth and guidance in vitro that it does not prove their function in vivo. If
redox signaling plays a role in axon patterning, ROS production must be controlled by an
upstream guidance cue. Earlier in this chapter, I detailed what is known regarding NOXmediated growth factor and adhesion signaling. Given this, I predict that some growth
factors, guidance cues or substrate proteins will modulate NOX activity in growth cones.
Applied asymmetrically, cues should induce a gradient of ROS that can be measured with
the ROS biosensors. Cues can be presented to the cell in various ways. The protein
coated, 5µm silica beads, discussed earlier, work well in Aplysia. Traditional pipet assays
or the development of patterned substrates would be more suitable for zebrafish neurons.
Initial experiments would be aimed at identifying cues that asymmetrically alter
intracellular ROS concentrations. This would be accomplished by combining directional
application of cues with ROS biosensor imaging. Once a suitable set of cues is identified,
necessity of ROS generation in cue-mediated turning can be tested by applying low
concentrations of ROS scavengers to block spikes in ROS. Further, the involvement of
NOX can be verified using the small-molecule inhibitors and activators presented in
earlier sections. For example, if cue-mediated turning requires the production of NOXderived ROS, pretreatment with a low concentration of scavenger or NOX inhibitor
should block turning responses. The relationship between ROS generation and growth
cone turning may be complex, and the response may vary among cues. Combining ROS
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measurements, cytoskeletal imaging and neurite guidance in response to specific cues
would provide physiologically relevant evidence for the necessity of NOX-derived ROS
in axon guidance.

6.6.3 Characterization of downstream targets

A more difficult problem is identifying downstream targets of NOX-derived ROS.
The simplest possible situation would be if NOX-derived ROS acted directly on the
cytoskeleton, likely actin, to mediate changes in stability and dynamics. However, given
the number of redox sensitive targets involved in growth cone steering, discussed in
section 6.5, it is unlikely that actin is the only effector of ROS. Time-lapse imaging with
SiR-actin and ROS biosensors would provide adequate temporal resolution to make this
determination. Direct effects of ROS on the cytoskeleton would happen rapidly while
effects controlled by intermediate signals would take longer to propagate. Careful
dissection of the timecourse of cytoskeletal rearrangements in response to ROSgenerating cues would delineate direct versus indirect effects, and inform subsequent
studies.
The next step would be to directly assess protein oxidation in response to cues.
There is a comprehensive review of methods to detect all forms of oxidation, and I will
not discuss them extensively here (Shacter, 2000). Instead, I will briefly mention methods
that would be most relevant to NOX-mediated protein oxidation in growth cones. Sglutathionylation, cysteine/methionine oxidation and disulfide crosslinking are the most
common protein modifications caused by H2O2, the primary signal produced by NOX
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(Brandes et al., 2014). These can be detected by high performance liquid chromatography,
SDS-PAGE and mass spectroscopy (Shacter, 2000; Verrastro et al., 2015). However, this
is not a straightforward procedure since cultured neurons are typically plated at low
densities and are non-proliferative. This makes it challenging to obtain enough protein for
analysis. Alternative methods such as harvesting from cue-treated explant cultures would
provide higher amounts of protein, but reduce the cell type specificity since non-neuronal
cells may be included. This compromise may be necessary, however, to perform direct
analysis of protein oxidation.
Another strategy would be to look for proteins that are activated in response to
ROS. Biosensors for Src and FAK, both known to be redox sensitive, are available
(Gulyani et al., 2011; Seong et al., 2011), and our lab has done significant work with a
novel Src biosensor in Aplysia. Using these tools, we could look for changes in activation
of either protein in response to ROS-generating cues. More importantly, we could dissect
the time course of activation to determine if either protein is the direct effector of NOXderived ROS. Unfortunately, the Src/FAK and ROS biosensors have similar excitation
and emission spectra, and are therefore not compatible. However, we can establish a time
course of ROS production and Src/FAK activation in separate experiments
In some of the studies listed in the previous sections, authors developed
oxidation-insensitive mutants such as SrcC245A and SrcC487A (Giannoni et al., 2009).
We could develop redox-insensitive mutants for targets we suspect are oxidized in
response to cues, and the mass spectroscopy experiments described above would identity
putative oxidation sites in the target proteins. Done correctly, this approach would
produce effectors that cannot be oxidized, but otherwise maintain their normal function.
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Cells expressing these redox-insensitive mutants would not be expected to exhibit turning
in response to cues that require oxidative signaling.
Using the described combination of approaches we can extend the current work to
directly identify cues that use NOX-derived ROS as intermediate signals and characterize
the spatiotemporal parameters of ROS generation. We can measure the time course of
cytoskeletal rearrangements, growth cone turning and neurite outgrowth in response to
cue-induced ROS production. We can also specify the downstream effectors of ROS that
lead to growth cone turning and drive neurite outgrowth. Collectively, the proposed
experiments would allow us to characterize an entire ROS-mediated signaling pathway in
neurons induced by specific cues.
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CHAPTER 7. CONCLUSIONS FROM ZEBRAFISH STUDIES

7.1 Summary of current work on zebrafish neurodevelopment

In Chapter 5, I described a series of experiments designed to investigate the
functions of NOX enzymes in zebrafish neurodevelopment. I began applying NOX
inhibitors to developing embryos. From these early screens, I identified defects in the
optic nerve and anterior forebrain commissures (Figure 5.1 & 7.1). I chose to focus
subsequent studies on the optic nerve because of the potential functional implications of
this system. Treatment with the NOX inhibitor celastrol caused an expansion of the glial
cell layer (GCL), thinning of the optic nerve (ON) and a decrease in ON axons reaching
their targets in the optic tectum (OT, Figure 5.1). ON thickness and OT innervation was
rescued by the addition of 2mM H2O2, but GCL expansion was not (Figure 5.1)
Generation of chimeric, isoform-specific nox mutants showed that mutations of
nox2/cybb resulted in ON thinning and a decrease in OT innervation comparable to
inhibitor treatments (Figure 5.2). No GCL expansion was observed in chimeric nox2/cybb
mutants (Figure 5.2). Time-lapse imaging of nox2/cybb chimeras revealed that ON
thinning was transient and recovered by 72 hours post-fertilization (hpf, Figure 5.3).
Similarly, the area of OT innervation increased between 72 and 96 hpf in nox2/cybb
chimeras (Figure 5.3) indicating that both phenotypes were the result of developmental
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delays. In addition, both phenotypes were partially rescued by the addition of 2mM H2O2.
Surprisingly, homozygous nox2/cybb mutants (nox2/cybb-/-) did not show
significant ON thinning like nox2/cybb chimeras. Instead, these homozygous mutants
displayed GCL expansion (Figure 5.4) and defects in axon targeting within the OT
(Figure 5.5). In addition, nox2/cybb-/- embryos had defective retinal lamination visualized
with DAPI nuclear staining. None of the observed phenotypes improved at later stages.

Figure 7.1: Forebrain development in zebrafish treated with a Nox inhibitor (A-B) Dorsal views of a
24 hpf embryo immunolabeled with an anti-acetylated tubulin antibody. Embryos were treated with 0.1%
DMSO (A) or 2µM VAS2870 (B) from 18-22 hpf to coincide with forebrain commissure development. The
anterior commissure is indicated with a white arrow in A. Commissures of inhibitor-treated embryos fail to
close at the midline.

In all cases, ON thinning and decreased OT innervation recovered at subsequent
developmental stages and was rescued by H2O2. Therefore, both of these phenotypes can
be regarded as symptoms of developmental delays. Further, that they can be rescued by
global application of exogenous ROS may indicate that they are generally mediated by
ROS, and do not specifically require NOX2/CYBB. That is to say that NOX2/CYBB
may normally produce the ROS that signals in these pathways, but it can be substituted
for with other sources of ROS. In contrast, GCL expansion and axon targeting in the OT
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do not recover at later stages, and in the case of inhibitor treatments GCL expansion
cannot be rescued by H2O2. This may indicate that these phenotypes are mediated
specifically by NOX2/CYBB, and cannot be substituted for other sources of ROS.
Chimeras may not be expected to show GCL expansion or mistargeted OT axons
because they carry some percentage of functional NOX2/CYBB. Therefore,
NOX2/CYBB-mediated signaling would still occur, but may take more time due to the
partial loss of protein function in chimeras. This simultaneously explains the presence of
developmental delays and lack of permanent phenotypes. Conversely, nox2/cybb-/embryos that have a complete loss of NOX2/CYBB may be forced to upregulate
compensatory mechanisms in order to survive. Compensation among NOX enzymes has
been evidenced in several studies (Yang et al., 2001; Banfi et al., 2003; Frantz et al., 2006;
Pendyala and Natarajan, 2010), and this is not surprising given the similarities among
isoforms. Upregulation of other NOX isoforms may not even be necessary. Recall that
many cells in the central nervous system express multiple isoforms. Some of the studies
cited above have shown that activated NOX2 regulatory subunits can bind and activate
NOX1 (Bedard and Krause, 2007; Bedard et al., 2007; Sorce and Krause, 2009).
Therefore the mere presence of other NOX isoforms in the cell could be enough to
mediate compensation. Phenotypes caused by a general decrease in ROS, like
developmental delays rescued by H2O2, would be masked by compensation in nox2/cybb/-

mutants. However, persistent phenotypes stemming specifically from the loss of

NOX2/CYBB, which are not recued by H2O2, would persist even with compensation.
This explains why nox2/cybb-/- mutants do not show developmental delays, but do have
GCL expansion and defects on axon targeting in the OT.
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Inhibitor treatments are a special case that induces both transient and permanent
effects. Developmental delays are explained by the potent inhibition of all NOX isoforms
over short time. Compensation could not have masked this because 1) all isoforms were
inhibited and 2) the time was too short to upregulated alternative compensation. GCL
expansion is likely due to the timing of application which coincided with RGC
differentiation. Delayed application of the drugs would likely leave the GCL unaffected,
but may cause defects in axon targeting in the OT.
The effects of NOX2/CYBB mutation extend beyond the eye. I also reported
microphthalmia, pericardial edema and ventral body curling in both chimeric and
homozygous NOX2/CYBB mutants. This suggests that NOX2/CYBB is involved
generally in development, and implies that future work should be directed at discerning
the role of NOX2/CYBB in specific cell and tissue types. These phenotypes may
contribute to the defects in OT innervation observed at 120 hpf. By this stage, the
worsening morphological defects may impact the health of the larva.
Given observations of GCL expansion, mistargeting of axons in the OT, and
developmental delays, I predict that NOX2/CYBB has a specific role in retinal and/or ON
development. This is supported by the work described below in section 6.3 which shows
that cultured zebrafish RGCs are sensitive to NOX inhibitors. To design future
experiments, it is important to identify signaling pathways involved in retinal and ON
development that may be redox sensitive. Therefore, in this chapter I will provide a brief
overview of eye and retinal development and highlight particular signals that have been
shown to involve redox signaling. I will also point out developmental events that may
explain the phenotypes observed in my experiments. In the final section of this chapter, I
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will suggest future directions for the zebrafish work with an aim to the delineate tissueand stage-specific functions of NOX isoforms.

7.2 Summary of eye and optic nerve development

NOX2/CYBB mutants display defects in the eye including GCL expansion and a
lack of retinal lamination. Additionally, axons are mistargeted to the OT in mutant larva.
Given this, it is reasonable to consider which developmental events that underlie these
processes might involve NOX-mediated signaling. To this end, the subsections below
describe the induction and development of the early eye, the specification of RGCs and
the mechanisms of RGC axon guidance at several stages. Comprehensive reviews of
these topics have previously been published (Fadool and Dowling, 2008; Erskine and
Herrera, 2014; Stenkamp, 2015), and it is not pertinent to repeat all of those details here.
Instead, I will provide a general description of development and focus specifically on
events and signaling pathways that might involve NOX.

7.2.1 Early eye development

In vertebrates, the eye field is specified from the early neuroepithelium by
expression of a suite of homoeodomain-containing transcription factors including pax6,
rx, six3, six6, lhx2 and otx2 (Nornes et al., 1998; Loosli et al., 1999; Stenkamp, 2015;
Samuel et al., 2016). Expression of these factors is restricted laterally by the presence of
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sonic hedgehog (Shh) at the midline (Macdonald et al., 1995; Masai et al., 2000). The
cells expressing these transcription factors evaginate from the neuroepithelium into
presumptive eye masses. In zebrafish, the centers of these eye masses invaginate at ~20
hpf to form bilateral optic cups, double-layers of neuroepithelium (Fadool and Dowling,
2008). The distal layer is highly proliferative and produces all of the cells of the neural
retina while the proximal layer differentiates into the retinal pigment epithelium
(Stenkamp, 2015).
One redox-sensitive target involved in eye specification could be pax6. pax6 is a
transcription factor involved in eye field specification that is highly conserved among
vertebrates (Fadool and Dowling, 2008). Misregulation of pax6 leads to the formation of
ectopic eyes in both zebrafish and Drosophila (Nornes et al., 1998). Two separate studies
have shown that the DNA binding affinity of a related protein, Pax8, is dependent on the
redox state of the protein (Kambe et al., 1996; Codutti et al., 2008). The latter study
showed that the redox sensitive cysteine residues of Pax8 were conserved among several
Pax family members. The authors went on to suggest that redox regulation could be
conserved feature of all Pax family members (Codutti et al., 2008) making Pax6 a
potential target for ROS-mediated signaling during eye development.

7.2.2 Ganglion cell fate determination

Following the formation of the optic cup, retinal progenitors begin to divide and
terminally differentiate into RGCs. In all vertebrates, RGC differentiation occurs as a
wave that passes through the early retina (Fadool and Dowling, 2008). The shape and
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starting point of this wave varies among species, but in zebrafish the wave begins
ventrally and extends nasally, dorsally and temporally until completed (Stenkamp, 2015).
Fibroblast growth factor (FGF) secreted from the optic stalk, a layer of neuroepithelium
connecting the eye to the forebrain, initiates RGC specification (Martinez-Morales et al.,
2005). atoh7, also called ath5, a basic helix-loop-helix transcription factor is wellestablished as an early RGC-specifying gene (Kay et al., 2001; Kay et al., 2005).
Expression of atoh7 determines RGC cell fate and leads to the expression of additional
RGC-specific genes including isl1 and brn3b (Prasov and Glaser, 2012; Pacal and
Bremner, 2014). The spatiotemporal characteristics of the RGC differentiation wave are
coordinated by several signaling pathways including Shh, Wnt, retinoic acid and
Notch/Delta (Bernardos et al., 2005; Masai et al., 2005; Meyers et al., 2012; Erskine and
Herrera, 2014; Imai et al., 2014). Differentiated RGCs also secrete cell-autonomous
signals to promote their survival. These include a neural epidermal growth factor-like
protein and VEGF (Hashimoto et al., 2006; Nakamoto et al., 2014).
Several factors involved in RGC specification are potentially redox sensitive. The
expansion of the GCL observed in nox2/cybb-/- mutants suggests misregulation of fate
specification, so this is a particularly promising area for future studies. I detailed several
examples of growth factor signaling that are mediated specifically by NOX in Chapter 6.
It is no surprise that FGF signaling, responsible for the initiation of RGC specification, is
also dependent on ROS production in other cell types. Treatment of smooth muscle cells
with FGF induces migration, and this is dependent on NOX1-derived ROS (Schroder et
al., 2007) The authors went on to shown that NOX1-mediated signaling was dependent
on JNK oxidation.
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VEGF, the cell-autonomous survival signal for newly differentiated RGCs, has
also been shown to be NOX-dependent in other cell types. One study found that NOX2
activity was necessary for cell survival and proliferation in response to VEGF in
leukemic cells (Maraldi et al., 2010). Another showed that FAK upregulation and cell
migration in response to VEGF was mediated by oxidative inactivation of a protein
tyrosine phosphatase (Abdelsaid and El-Remessy, 2012).
Notch/Delta signaling is also involved in the control of RGC fate determination.
While not linked to NOX, studies have shown that Notch signaling in neuronal precursors
is dependent on the activity of peroxyredoxin 4 (Prdx4) (Yan et al., 2015). Disruption of
Prdx4, resulting in a lack of downstream protein oxidation, causes premature
differentiation of neurons and a depletion of progenitors. It is known that neuronal
precursors require elevated ROS levels to maintain potency. Depleting ROS in these cells
causes premature differentiation (Le Belle et al., 2011). A second study has shown that
disrupting Notch/Delta signaling during zebrafish retinal development leads to a
phenotype similar to what was observed in the nox2/cybb-/- mutants (Bernardos et al.,
2005). The morphology of the eye, disruption of retinal lamination and pattern of GCL
expansion are strikingly similar between embryos with Notch/Delta impairment and
Nox2/Cybb mutants. Therefore, it is reasonable to hypothesize a connection between
Nox2/Cybb-derived ROS and Notch/Delta signaling in zebrafish retinal development.
This potential connection between ROS and Notch/Delta signaling is particularly
important given the results presented in Chapter 5. Nox2/Cybb loss-of-function lead to
disruption of inner retinal development that included an expansion of the GCL
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A final candidate for NOX-mediated signaling is Wnt which is involved in the
spatiotemporal control of the RGC differentiation wave. In developing vasculature, the
propagation of Wnt5a signals have been show to rely on redox signaling (Murdoch et al.,
2014). Additional studies revealed that redox controls the activation of canonical Wnt
signaling during endodermal fate specification (Sandieson et al., 2014), and that Wnt
signals in mouse colon epithelial cells and human colon cancers depend on NOX1. These
reports show that Wnt is well-established as a redox controlled pathway. Therefore, it is
possible that disruptions of Wnt signaling are responsible for some of the phenotypes
observed in NOX2/CYBB mutants.

7.2.3 Early retinal axon guidance

RGCs undergo a terminal differentiation in the apical retina, adjacent to the
retinal pigment epithelium. These non-polar cells then extend a process to the basal retina,
and the nucleus migrates along this process until it reaches its terminal position at the
vitreal surface (Fadool and Dowling, 2008). As the nucleus nears this final position, the
trailing, apical process is retracted and the axon begins to emerge. Apical retraction is
mediated by a coordination of slit and N-cadherin signaling (Erskine and Herrera, 2014).
Axon emergence is dependent on Rac1 (Ruchhoeft et al., 1999), and early polarized axon
growth is guided by cadherins (Riehl et al., 1996), integrins (Lilienbaum et al., 1995) and
a peripheral gradient of chondroitin sulfate proteoglycans (CSPGs) (Erskine and Herrera,
2014). The expansion of the GCL observed in nox2/cybb-/- mutants could also be due to
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disruptions in RGC migration or early axonogeneis. Therefore, it is important to discuss
potential nodes for redox signaling during these events.
In Chapter 1, I introduced Rac1 as a critical component of NOX1, 2 and 3 enzyme
complexes (Brown and Griendling, 2009). That initial RGC axon emergence is dependent
on cytoskeletal rearrangements involving Rac1, makes this event a prime candidate for
NOX-mediated signaling. In Chapter 6, I detailed the importance of NOX and ROS to the
formation and turnover of integrin-based focal adhesions (section 6.4.3). Disruption of
ROS production altered integrin-mediated motility in several cell types (Basuroy et al.,
2010; Abdelsaid and El-Remessy, 2012; de Rezende et al., 2012; Datla et al., 2014). Not
only does integrin guide early axons, but it also patterns the growth of axons at later
stages. Since both Rac and integrin have strong connections to redox signaling, terminal
RGC migration and early axonogeneis could be disrupted in nox2/cybb-/- mutants.

7.2.4 Intraretinal axon guidance

RGC axons extend along the vitreal surface directly toward the optic disc, the
point at which axons turn and exit the eye. The layer containing RGC axons is known as
the inner fiber layer. There are several cues and substrate molecules that help to guide
axons toward the optic disc and simultaneously prevent axons from growing into adjacent
retinal layers. Repulsive, peripheral gradients of slit2 and CSPGs coordinate to drive
growth inward toward the optic disc (Brittis et al., 1992; Zolessi et al., 2006). A gradient
of Shh along with the growth permissive substrate of neuronal cell adhesion molecule
(NCAM) attracts growing axons to the disc (Brittis and Silver, 1995). Additionally, cells
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at the optic disc express netrin-1 and the chemokine SDF-1 that act as attractive cues (Li
et al., 2005; Stacher Horndli and Chien, 2012; Erskine and Herrera, 2014). Slit1/2 are
strongly expressed by the lens and apical retinal layers to prevent axons from straying
outside the IFL (Zolessi et al., 2006). All of these molecules act in concert to guide RGC
axons to the optic disc. At this stage of our research, it is important to consider the redox
regulation of all steps during eye and ON development to decide which events by be
sensitive to NOX mutations. However, intraretinal axon guidance does not seem to be
affected in nox2/cybb-/- mutants. This may be because disruptions in early developmental
events mask a guidance phenotype, but the presence of normal appearing ONs in the
mutants suggests otherwise. Nonetheless, I will briefly describe possible targets for redox
regulation during intraretinal axon guidance.
Of the aforementioned guidance molecules, NCAM is a promising candidate for
NOX-mediated signaling. As detailed in Chapter 6 and repeated above, some components
of adhesion complexes are known to be redox sensitive. NOX2 subunits have been found
to colocalize with focal adhesion proteins (Wu et al., 2005). While much of this work is
focused specifically on integrin-based adhesions, our lab has found colocalization of
NOX2 and p40phox at apCAM-based adhesion sites in Aplysia (Munnamalai et al., 2014),
and others have identified a connection between NOX2 and VCAM (Kokovay et al.,
2012).
Another possible redox-mediated signal is cytokine SDF-1. Cytokines are a class
of secreted, small molecules that are classically associated with inflammatory signaling
(Zhang and An, 2007). NOX-derived ROS are a well-established component of the
inflammatory response. While there is nothing to directly link SDF-1 with NOX-
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mediated signaling, it is worth noting that cytokines and NOX are often identified in the
same inflammatory signaling pathways (Brandes et al., 2014).

7.2.5 Axons exiting the eye

As RGC axons reach the optic disc they make a 45° turn and exit the back of the
retina. As more axons reach this point, they fasciculate to form a single bundle, the ON
(Stenkamp, 2015). As described above, netrin-1 acts locally to attract RGC axons to the
optic disc (Deiner et al., 1997). Once axons reach the disc, netrin-1 converts from an
attractive to a repulsive cue (Hopker et al., 1999). This conversion is mediated by the
presence of laminin-1 at the optic disc which lowers the amount of cAMP in growth
cones. This change in cAMP levels transforms the growth promoting netrin-1 signal into
an inhibitory signal, and drives the axons toward the midline (Hopker et al., 1999). In
addition to the netrin-1/laminin-1 signaling axis, the expression of pax6 and surface
presentation of NCAMs facilitate the bundling of axons into a single ON (Manuel et al.,
2008; Tai et al., 2010). The phenotypes observed in nox2/cybb-/- mutants are not
indicative of defects in optic disc turning or axon fasciculation. However, there are
several signaling molecules with potential redox implication involved in this process.
I have detailed the involvement of ROS and/or NOX in the regulation of Pax6 and
CAMs in previous sections. However, laminin is uniquely involved in optic disc turning,
and therefore has not been mentioned. Laminins are large, extracellular matrix proteins
that provide structural support for tissues as well as participate in cellular signaling (Beck
et al., 1990). One group reported that treatment of tumor cells with H2O2 improved
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adhesion efficiency to laminin (Vilas-Boas et al., 2016). While this study was not linked
to NOX, it adds to the list of adhesion/matrix proteins whose signaling pathways involve
ROS.

7.2.6 Guidance at the optic chiasm

After exiting the eye, RGC axons extend to the midline where, in zebrafish, the
ONs completely cross and extend toward the contralateral tectum (Fadool and Dowling,
2008). This crossing event is mainly mediated by the restricted expression of repulsive
slit and semaphorin to prevent axons from straying into adjacent tissues (Hutson and
Chien, 2002; Fadool and Dowling, 2008; Erskine and Herrera, 2014). The establishment
of repulsive slit-expressing regions within the tissue is mediated by the presence of
heparin sulfate proteoglycans (HSPGs) and SDF-1 (Chalasani et al., 2007; Wright et al.,
2012). In addition to the repulsive cues, VEGF acts as an attractive cue for RGC axons at
the midline (Erskine et al., 2011). While we did not focus specifically on axons crossing
at the chiasm, nox2/cybb-/- mutants do not appear to harbor any defects in this area.
Nonetheless, there is at least one unique redox sensitive target involved in this event.
The protein core of some HSPGs can be directly modified by oxidation. The
authors of one study reported that perlecan, an endothelial matrix component, can be
modified by ROS derived from myeloperoxidase (Rees et al., 2010). Redox modification
of this HSPG altered its ability to promote cell adhesion in epithelial cell culture models.
This suggests yet another matrix adhesion protein whose signaling is redox sensitive.
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Potential redox regulation of VEGF and SDF-1, also involved in chiasm crossing, was
discussed in preceding sections, so that information will not be repeated here.

7.2.7 Guidance from the chiasm to the tectum

In teleost fish, axons that have completed midline crossing at the chiasm extend
dorsorostrally toward their final targets in optic tectum. This distance between the chiasm
and the tectum is known as the optic tract. Similar to other parts of ON development,
growth through the optic tract is controlled by repulsive cues flanking the tract and
attractive cues emanating from the target region. In this case, the repulsive cues include
integrins (Stone and Sakaguchi, 1996), Tenascin-R (Becker et al., 2003), Shh , CSPGs
and slits (Erskine and Herrera, 2014). FGF acts as a positive cue to attract RGC axons
toward the tectum (Stenkamp, 2015). Once RGC axons reach the tectum, they form
synapses in a retinotopic fashion (Fadool and Dowling, 2008). This means that axons
from specific regions of the retina innervate specific regions of the tectum. Within the
optic tract, dorsal and rostral RGCs axons are sorted, and this process is dependent on
HSPGs (Poulain and Chien, 2013). Once in the tectum, opposing gradients of ephrins and
Eph receptors refine target selection in a fashion that mimics retinal topography (Frisen et
al., 1998). RGC axons are mistargeted in nox2/cybb-/- mutants. Axons are not confined to
the OT and extend to adjacent midbrain regions. This could be due to defects in midbrain
formation, but could also result from disruption of RGC axon guidance. Therefore, it is
valuable to consider which signals that pattern tectal innervation may also be redox
sensitive.
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The involvement of ROS in integrin, FGF and HSPGs signaling has been detailed
one or more of the previous sections. However, ephrin signaling is unique to the tectum,
and has not been discussed previously. One study found that inhibition of integrin-based
cell adhesion by ephrinA1 was dependent on the downregulation of Rac1. The authors
went on to show that this was mediated by the redox-dependent inactivation of a protein
tyrosine phosphatase (Buricchi et al., 2007). While this study does not directly implicate
NOX, the involvement of Rac1 and the redox inactivation of a protein tyrosine
phosphatase strongly suggest a role for NOX-derived ROS in ephrin-mediated signaling.
This means that it is reasonable to speculate that Eph/ephrin-based target selection in the
tectum could be disrupted in nox2/cybb-/- mutants.

7.2.8 Summary of potential redox signaling in optic nerve development

The preceding sections describe vertebrate, specifically zebrafish, ON
development in some detail, and highlight signaling pathways that potentially involve
NOX-derived ROS or redox signaling in general. Table 7.1 summarizes the cues and
other proteins with potential connections to redox signaling for each section above. As
stated previously, nox2/cybb-/- mutant phenotypes likely rule out the involvement of
NOX2/CYBB in certain events (i.e. crossing at the chiasm). However, RGC fate
determination, early axonogenesis and axon guidance in the tectum are good candidates
based on the phenotypes observed and the presence of redox sensitive signaling pathways.
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7.3 Future directions for the zebrafish project

Chapter 1 introduced a number of studies that show the involvement of NOX in
neurodevelopment. Some focused on declines in cognitive ability (Pao et al., 2004;
Kishida et al., 2006) while others detail the well-established role of ROS in stem cell
maintenance or neuronal maturation (Dickinson et al., 2011; Forsberg et al., 2013;
Forsberg and Di Giovanni, 2014; Olguin-Albuerne and Moran, 2015). One report

Table 7.1: Redox sensitive events during eye and optic nerve development
Develomental event
Eye field specification

Cue/signal Source of ROS Section
Pax6
Unknown
7.2.1
FGF
Unknown
VEGF
NOX
RGC differentiation
7.2.2
Notch
Unknown
Wnt
NOX1
Rac1
NOX1/2/3
Early RGC axon guidance
7.2.3
Integrin
NOX2/4
NCAM
NOX2
Intraretinal axon guidance
7.2.4
SDF-1
Unknown
Pax6
Unknown
CAM
NOX
Turning at the optic disc
7.2.5
Laminin
H2 O2
VEGF
NOX
Crossing at the optic
7.2.6
SDF-1
Unknown
chiasm
HSPGs
Unknown
Integrin
NOX2/4
Optic tract and tectal
FGF
Unknown
7.2.7
innervation
HSPGs
Unknown
Ephrin
Rac1*
‘Unknown’ refers to redox-mediated pathways in which no source of ROS has been identified. ‘NOX’
indicates that no specific isoform has been implicated. *Ephrin signaling is mediated by Rac1-dependent
generation of ROS. Rac1 is not a direct source of ROS.
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addressed NOX-mediated axon guidance, but this was done in peripheral nerves (Rieger
and Sagasti, 2011). Yet another investigated ROS in brain development, but did not
establish a direct link to any NOX isoform (Coyoy et al., 2013). My study is the first to
directly assess the impact of a specific NOX on neurodevelopment and axon outgrowth.
The results suggest a functional role for NOX in this process. However, many questions
remain regarding when, where and how NOX-derived ROS are involved the
differentiation and/or growth of axons. The next section suggests strategies to address
these questions. In addition, I propose approaches to study the impact of NOX on overall
development and morphogenesis.

7.3.1 Further characterization of Nox mutant lines

In Chapter 5, I described the use of gRNAs against all four zebrafish Nox
isoforms. However, I only detail the development and testing of nox2/cybb mutant lines.
In fact, we have developed mutant lines for all of the Nox isoforms, and can predict the
domains that remain in the mutant proteins (Figure 7.2). As these lines are already
developed, future experiments should be designed to assess the impact of Nox1, 5 and
DUOX mutants on development. The first steps would be to cross the heterozygous
mutants, genotype the resulting embryos and look for morphological changes that appear
only in heterozygous or homozygous mutants. From there, studies similar to those
described in Figures 5.4 and 5.5 could be done to address the effect of Nox mutants on
ON and OT development.
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Further genetic and molecular characterization should be done on all of the lines.
If the mutant lines are to be distributed to the community or placed in a repository, it will
be necessary to sequence the genomes of each line. This can be done at the Purdue
Genomics Core facility. A complete genome would also confirm the absence of any
unpredicted off-target mutagenesis. There are still no suitable antibodies against zebrafish
Nox proteins, but we have tested some potential antibodies with varying degrees of
success. The identification of specific antibodies would allow for proper characterization
of the mutant proteins via Western blot and/or immunoprecipitation. The presence or
absence of co-precipitating regulatory subunits would address the binding capacity of
mutant Nox proteins. This is an important question given that inactive mutant proteins
that retain the ability to bind regulatory subunits could act as dominant negatives, and this
could change the way we approach future experiments. The introduction of dominant
negatives into cultured cells or whole embryos would also be a useful knockdown
strategy in the future.

Figure 7.2: Protein domains from all Nox mutant lines Wild type and mutant domain structures for all
of the Nox isoforms are shown. Elements are color-coded and the legend is shown at the bottom-right.
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Functional characterization can be done by cloning and expressing wild type and
mutant zebrafish Nox proteins in cultured eukaryotic cells. Standard ROS activation
assays using luciferase reporters could be used to measure ROS production. One example
is the ROS-Glo™ H2O2 Assay from Promega (Cat. G8820). The type of cells used in the
assay would need to be chosen carefully. Eukaryotic cells would be necessary due to the
glycosylation of NOX proteins (Brandes et al., 2014). Cell types that do not express
endogenous NOX would require the co-transfection of additional subunits while cells
expressing endogenous NOX might not be sensitive to the introduction of mutant NOX
proteins. This is another reason to investigate the ability of mutant proteins to act as
dominant negatives. While this series of experiments would be labor intensive, the wild
type and mutant constructs would have may uses for other projects.

7.3.2 Specifying the role of Nox in retinal and optic nerve development

As described in the preceding sections, NOX-derived ROS may play a role in
several events during RGC development and ON growth. The challenge is to determine
which of these events is disrupted in nox2/cybb mutants and how Nox-derived ROS
mediates this specific process. One approach to accomplish this would be to deactivate
Nox during specific developmental stages and assess the impact on RGC differentiation
and ON development. Application of Nox inhibitors allows for this type of precise
temporal control, but lacks isoform specificity. A better method was recently introduced
that allows for temporally controlled CRISPR-mediated mutagenesis (Yin et al., 2015).
The authors describe the use of heat shock promoters to drive expression of Cas9 while
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gRNAs are expressed ubiquitously. The result is the generation of mutations at discrete
timepoints. The advantages are obvious, but this approach requires the construction of
new fish lines that express specific gRNAs for each target gene. This can be laborious
and time-consuming. However, I would recommend two approaches to improve
efficiency. First, we can use our gRNAs that have already been proven to be specific and
efficient. This saves time in validating a new set of tools. Second, I recommend initial
screening experiments by injecting gRNAs into lines expressing heat shock-inducible
Cas9. This would result in the ubiquitous expression of gRNA with temporally controlled
expression of Cas9. However, this approach would not require extensive time and labor
investment, and would allow the user to screen several gRNAs prior to constructing lines.
In addition to temporal control, it is also desirable to have spatial control of Nox
function. One method to obtain spatial and temporal restriction would be intravitreal
injection of Nox inhibitors. Since the RGCs lie at the vitreal surface of the retina, they are
more sensitive to substances injected in the vitreous space. Intravitreal administration of
ouabain has been shown to selectively impair the innermost retinal neurons (Fimbel et al.,
2007). I suggest a similar approach to selectively inhibit Nox in RGCs. However, this
would be limited to early developmental events since RGC axon pathfinding outside of
the intraretinal space is unlikely to be affected by inhibitor treatment in the vitreal space.
Spatial or cell-type specificity is commonly achieved using transplantation assays
(Detrich et al., 2010). I propose to transplant mutant RGCs or whole eye primordia into
wild type hosts and track RGC specification and ON outgrowth throughout development.
Depending on the methods used, we can eliminate potential interference from non-cell
autonomous sources of Nox. This approach would require that donor cells be labeled, so I
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suggest the use of mutant lines that have been crossed into Tg(ath5:GFP) backgrounds.
The transplant could also be reversed, wild type RGCs into a mutant host, to assess the
RGC-independent functions of Nox. A similar approach was used to study the function of
zebrafish DUOX in regenerating peripheral nerves (Rieger and Sagasti, 2011).
A final method for achieving cell-type specificity is the generation of CRISPR
mutants using a gene-specific promoter to drive Cas9 expression (Ablain et al., 2015). I
propose to use this method to generate mutations in RGCs. However, it may also be
useful to develop lines that express Cas9 in other retinal cell types. Again, I would
recommend the use of our validated gRNAs for building the new lines, and screening the
different gRNAs by injecting them into embryos that express Cas9 in a specific subset of
cells. The drawback of this approach is the complete lack of temporal control. Mutations
are generated early in development and carried throughout development. It is advisable to
pair this approach with temporally controlled mutagenesis to achieve a more
comprehensive set of results.

7.3.3 Nox in axon guidance

In Chapter 6, I introduced a number of ways to investigate the role of Nox in
axonal growth and guidance. A simple way to enhance those studies would be to perform
the experiments with neurons derived from Nox mutant embryos. This would eliminate
the need for inhibitor applications, and would be especially useful for determining
upstream guidance cues that use ROS as an intermediate signal. I would expect specific
isoform mutants to be insensitive to redox-controlled cues.
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While I propose that the initial experiments into axon guidance should be done
using in vitro culture systems, there are some methods to address axon guidance in vivo.
One way is to track single axons from transplanted RGCs (see above). Time-lapse
imaging of transplanted mutant axons yields insights into the cell-autonomous role of
Nox in axon guidance. However, this is very low throughput, and transplantations can be
technically challenging. So this approach should be used in combination with more
robust methods.
Previous studies have introduced approaches for labeling single axons in vivo
without the need for difficult transplantations. The authors injected a small amount of
plasmid encoding a neuron-specific EGFP into single-cell zebrafish embryos. This
produced mosaic labeling and allowed for single axon tracking (St John and Key, 2012).
A subsequent study then used the mosaic labeling strategy to study guidance during
forebrain development with single axon resolution (St John et al., 2013). I propose to use
a similar strategy to label single RGCs in the retina of Nox mutants. Using an RGCspecific promoter we could drive the expression of a fluorescent reporter to track axon
outgrowth. Alternatively, we could drive expression of the ROS biosensors discussed in
Chapter 6 in RGCs to simultaneously quantify ROS levels and track single axons.
The cell type-specific CRISPR mutagenesis described above requires the
synthesis of plasmid constructs encoding the gRNA and Cas9 gene along with requisite
promoters. Most of these constructs also include a fluorescent tag to track mutagenesis in
vivo. In addition to using these constructs for the generation of lines, we could use them
to mosaically label embryos. This would result in mutagenesis and labeling of single
RGCs within an otherwise wild type embryo. Using this approach, we could investigate
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the cell-autonomous role of Nox in RGCs without constructing novel lines or performing
laborious transplantations.

7.3.4 Nox in general development

All of the approaches outlined in the preceding sections may be combined with
immunolabeling and in situ hybridization (ISH) to characterize the impact of Nox
mutations on tissues within and outside of the eye. We have already begun a project using
ISH to mark the development of several early tissues in wild type and nox2/cybb mutants.
We aim to use a set of seven, validated ISH probes to mark neural crest cells, blood cell
progenitors, mesodermal progenitors, heart, several brain regions, retina, RGCs, somites
and macrophages (see Table 7.2). We will label wild type and mutant embryos with these
probes at 16, 24 and 36 hpf to compare the extent and pattern of development in all these
tissues. To achieve the desired throughput for this project, we will use an ISH method
published previously (Thisse and Thisse, 2008). I anticipate that the results of this project
will inform future studies into novel roles for Nox in early development.
For some of the anatomical targets listed above, we could supplement or
substitute ISH with antibody labeling. Again, we have developed a list of suitable
antibodies that label early tissues (Table 7.2). In the eye, we can determine the impact of
Nox mutations on retinal lamination using antibodies that mark specific retinal layers.
Alternatively, we can make use of a new line of transgenic fish called Zebrabow
(Brainbow) that uses multicolor labeling strategies to trace single cell lineages as well as
single axon outgrowth (Pan et al., 2013). This would be useful to address the impact of
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Nox mutations on overall brain development, retinal architecture and axon outgrowth
simultaneously.

Table 7.2: Gene targets for developmental analysis
ISH probe
Gene
Tissues
(+/-)
cdh5
Vasculature, pericardium
+
crestin
Neural crest, brain regions, pharyngeal arches
+
ets1
Hematopoetic mesoderm, neural crest, vascualture
+
gata1a
Mesoderm, primative blood, vasculature
+
gltscr1
Brain regions, eye, hematopoetic mesoderm
+
jph2
Heart, somites, myotomes
+
kdrl
Vasculature
+
mab21l2
Retina, tectum, hindbrain
+
mpx
Macrophages
+
myl7
Heart, pericardium
+
myod
Somites,muscle
+
pak1
Brain regions, retina, RGCs
+
pax2a
Hindbrain, mesoderm, spinal neurons
+
pax6a
Early brain, eye primordium, hindbrain, retina
+
pax7
Neural crest, muscle progenitors
ppp1r13ba
Brain regions, myotomes, blood
+
sall2
Diencephalon, MHB, limited spinal cord (19-30 hpf)
+
spi1b
Hematopoetic mesoderm, macrophages, eye, blood
+

Antibody
(+/-)
+
+
+
+
+
+
+
+
+

Tissues listed are not comprehensive and may vary with developmental stage. ‘+’ and ‘-’ refer to the
availability of validated in situ hybridization probes or antibodies.

The role of Nox in angiogenesis, vascular function and disease is well
documented (Bedard and Krause, 2007; Drummond and Sobey, 2014). Therefore, it is not
surprising to observe cardiovascular defects in Nox mutant zebrafish. Pericardial edema
first appears between 50 and 72 hpf in mutant embryos and appears to precede any
defects in heart development. However, additional experiments focused specifically on
cardiac development are needed to support this assertion. Nonetheless, edema seems to
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be the first cardiovascular insult, but this presents a problem since edema is a symptom of
several distinct cardiovascular defects (Miura and Yelon, 2011). The challenge is to
delineate what first induces pericardial edema, and what developmental defects occur as a
result. Pericardial edema is commonly caused by heart valve leakage, vascular
malformations, leaks in the vascular walls and over secretion of fluid by cells of the
pericardium. I propose using several labeling strategies to screen for these defects in Nox
mutants. First, we can use ISH and immunolabeling to visualize early heart and vascular
development (see Table 7.2 for markers). Second, we can cross the Nox mutant lines with
transgenic lines carrying fluorescent reporters in vascular tissues. One example is the
fli1:GFP transgenic line that labels blood vessels throughout development (Lawson and
Weinstein, 2002).
Finally, we can label vasculature and test for leakage by directly injecting
fluorescent dye into the bloodstream. This technique is called microangiography (MAG),
and is routinely used to label blood vessels and the heart in zebrafish embryos (Hoffman
et al., 2012). I have conducted preliminary MAG experiments by injecting fluorescently
labeled dextran into the sinus venosus at 48 hpf. I have imaged vasculature throughout
the body in wild type embryos (Figure 7.3A-B), but only eye vasculature in nox2/cybb-/embryos (Figure 7.3C-E). These experiments appear to show additional fluorescent
signals that could indicate increased angiogenesis or vascular leakage within the eye of
mutant embryos (Figure 7.3D-E, red arrowheads). In addition, the blood vessels of the
eye in mutant embryos appear to be swollen (Figure 7.3D-E, red arrows). However, the
injection protocol needs to be standardized, and the results quantified before making any
meaningful comparisons.
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Figure 7.3: Homozygous nox2/cybb mutants have defects in eye vasculature (A-B) 48 hpf embryos
injected with fluorescent dextran showing the anterior (A) and medial (B) regions. (C-E) Highmagnification views of eye vasculature in wild type (C) and nox2/cybb mutant embryos (D-E). Dorsal (dv),
nasal (nv) and ventral (vv) veins are indicated. Mutants exhibited vascular swelling (red arrows) and
additional labeling that may indicate increased angiogenesis or vascular leakage (red arrowheads). MCeV =
medial cerebral vein, AA = aortic arch, ISeV = intersegmental vessels, DA = dorsal aorta, CV = cardinal
vein, YSE = yolk sac extension. Scales are indicated in A and C.

In vertebrates, the pharyngeal arches (PA) are derived from neural crest cells, and
often in zebrafish PA malformations can result from defects in neural crest migration or
differentiation (Schilling et al., 1996). Nox is known to mediate the survival and
differentiation of neural crest cells (Lee et al., 2014), so defects in PA arch formation
may be expected in Nox mutants. Alcian blue is staining the most common method of
labeling the PA in zebrafish, and I have conducted preliminary labeling studies on
nox2/cybb mutant embryos (Figure 7.4). Mutants appear to have all PA components, but
they are underdeveloped and shifted toward the posterior. I propose advancing these
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studies by optimizing the labeling protocol and quantifying the extent and type of PA
malformations. We can then compare these results to previously characterized PA defects
to predict the signaling pathways that are disrupted in our mutants. An excellent catalog
of PA defects and their causative mutations has previously been published (Schilling et
al., 1996).

Figure 7.4: Homozygous nox2/cybb mutants have defects in craniofacial development 5 day old wild
type (A-A’) and nox2/cybb gRNA I (B-B’) and gRNA II (C-C’) mutants labeled with Alcian blue to mark
cartilage. Elements of the seven pharyngeal arches are labeled. First arch derivatives are Meckle’s cartilage
(Mk) and the palatoquadrate (pq). Second arch derivatives are the basihyal (bh), ceratohyal (ch) and
hyosymplectic (hys). The gill arch derivates are the basibranchials (bb) and ceratobranchials I-V (cb i-v).
The dorsal-most structure is the ethmoid plate (eth) and the cartilage of the pectoral fins is also shown (pec).
Lateral views also show the pterygoid process of the quadrate (pty) and the auditory capsule (aud).
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7.4 Concluding remarks

The current study presents evidence that NOX activity is important for the
outgrowth of cultured neurites derived from Aplysia and zebrafish neurons. NOX
inhibition slows outgrowth, and NOX2 was directly identified in Aplysia growth cones.
There is even suggestion that NOX may be involved in cell adhesions within these
growth cones. The in vivo studies showed that nox genes are expressed broadly
throughout the zebrafish central nervous system, and that perturbations or mutations in
nox genes cause defects in retinal development and axon targeting in the optic tectum.
Future studies should be aimed at discerning the role of NOX in specific tissues and
developmental events. The strategies outlined above would allow for a more complete
characterization of the role NOX enzymes play in retinal development. In addition, these
experiments may provide new insights into roles for NOX enzymes beyond the eye and
brain. The combination of in vitro approaches in cultured neurons with in vivo strategies
in zebrafish affords unique opportunities to completely characterize cellular signaling
pathways that use NOX-derived ROS as intermediate signals. Carefully devised,
thoughtful experiments meshing these experimental strategies will be extremely
informative, and may reveal novel insights into NOX biology that would not otherwise be
attainable.

BIBLIOGRAPHY

169

BIBLIOGRAPHY

Abdelsaid MA, El-Remessy AB (2012) S-glutathionylation of LMW-PTP regulates
VEGF-mediated FAK activation and endothelial cell migration. Journal of cell
science 125:4751-4760.
Abid MR, Kachra Z, Spokes KC, Aird WC (2000) NADPH oxidase activity is required
for endothelial cell proliferation and migration. FEBS letters 486:252-256.
Ablain J, Durand EM, Yang S, Zhou Y, Zon LI (2015) A CRISPR/Cas9 vector system
for tissue-specific gene disruption in zebrafish. Developmental cell 32:756-764.
Abo A, Webb MR, Grogan A, Segal AW (1994) Activation of NADPH oxidase involves
the dissociation of p21rac from its inhibitory GDP/GTP exchange protein
(rhoGDI) followed by its translocation to the plasma membrane. The Biochemical
journal 298 Pt 3:585-591.
Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW (1991) Activation of the
NADPH oxidase involves the small GTP-binding protein p21rac1. Nature
353:668-670.
Ago T, Kuribayashi F, Hiroaki H, Takeya R, Ito T, Kohda D, Sumimoto H (2003)
Phosphorylation of p47phox directs phox homology domain from SH3 domain
toward phosphoinositides, leading to phagocyte NADPH oxidase activation.
Proceedings of the National Academy of Sciences of the United States of America
100:4474-4479.
Ago T, Liu T, Zhai P, Chen W, Li H, Molkentin JD, Vatner SF, Sadoshima J (2008) A
redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy.
Cell 133:978-993.
Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P,
Ho H, Wingler K, Schmidt HH (2012) The NOX toolbox: validating the role of
NADPH oxidases in physiology and disease. Cellular and molecular life sciences
: CMLS 69:2327-2343.

170
Amatore D, Sgarbanti R, Aquilano K, Baldelli S, Limongi D, Civitelli L, Nencioni L,
Garaci E, Ciriolo MR, Palamara AT (2015) Influenza virus replication in lung
epithelial cells depends on redox-sensitive pathways activated by NOX4-derived
ROS. Cellular microbiology 17:131-145.
Ansari MA, Scheff SW (2011) NADPH-oxidase activation and cognition in Alzheimer
disease progression. Free radical biology & medicine 51:171-178.
Association As (2014) 2014 Alzheimer's disease facts and figures. Alzheimer's &
dementia : the journal of the Alzheimer's Association 10:e47-92.
Avanesov A, Malicki J (2010) Analysis of the retina in the zebrafish model. Methods in
cell biology 100:153-204.
Ayoob JC, Terman JR, Kolodkin AL (2006) Drosophila Plexin B is a Sema-2a receptor
required for axon guidance. Development 133:2125-2135.
Baehner RL, Nathan DG (1967) Leukocyte oxidase: defective activity in chronic
granulomatous disease. Science 155:835-836.
Baldridge CW, Gerard RW (1933) The extra respiration of phagocytosis. Am J Physiol
103:235-236.
Bamburg JR, Bernstein BW (2010) Roles of ADF/cofilin in actin polymerization and
beyond. F1000 biology reports 2:62.
Banfi B, Clark RA, Steger K, Krause KH (2003) Two novel proteins activate superoxide
generation by the NADPH oxidase NOX1. The Journal of biological chemistry
278:3510-3513.
Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH (2004a)
NOX3, a superoxide-generating NADPH oxidase of the inner ear. The Journal of
biological chemistry 279:46065-46072.
Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N, Krause KH (2001)
A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. The
Journal of biological chemistry 276:37594-37601.
Banfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Molnar GZ, Krause KH, Cox JA
(2004b) Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). The
Journal of biological chemistry 279:18583-18591.
Barth BM, Gustafson SJ, Kuhn TB (2012) Neutral sphingomyelinase activation precedes
NADPH oxidase-dependent damage in neurons exposed to the proinflammatory
cytokine tumor necrosis factor-alpha. J Neurosci Res 90:229-242.

171
Basuroy S, Dunagan M, Sheth P, Seth A, Rao RK (2010) Hydrogen peroxide activates
focal adhesion kinase and c-Src by a phosphatidylinositol 3 kinase-dependent
mechanism and promotes cell migration in Caco-2 cell monolayers. American
journal of physiology Gastrointestinal and liver physiology 299:G186-195.
Beck K, Hunter I, Engel J (1990) Structure and function of laminin: anatomy of a
multidomain glycoprotein. FASEB journal : official publication of the Federation
of American Societies for Experimental Biology 4:148-160.
Becker CG, Schweitzer J, Feldner J, Becker T, Schachner M (2003) Tenascin-R as a
repellent guidance molecule for developing optic axons in zebrafish. The Journal
of neuroscience : the official journal of the Society for Neuroscience 23:62326237.
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases:
physiology and pathophysiology. Physiological reviews 87:245-313.
Bedard K, Lardy B, Krause KH (2007) NOX family NADPH oxidases: not just in
mammals. Biochimie 89:1107-1112.
Bedard K, Jaquet V, Krause KH (2012) NOX5: from basic biology to signaling and
disease. Free radical biology & medicine 52:725-734.
BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, Hess J, Pogrebniak A,
Bickel C, Gorlach A (2007) NOX5 variants are functionally active in endothelial
cells. Free radical biology & medicine 42:446-459.
Berendes H, Bridges RA, Good RA (1957) A fatal granulomatosus of childhood: the
clinical study of a new syndrome. Minnesota medicine 40:309-312.
Bernardos RL, Lentz SI, Wolfe MS, Raymond PA (2005) Notch-Delta signaling is
required for spatial patterning and Muller glia differentiation in the zebrafish
retina. Dev Biol 278:381-395.
Bilan DS, Pase L, Joosen L, Gorokhovatsky AY, Ermakova YG, Gadella TW, Grabher C,
Schultz C, Lukyanov S, Belousov VV (2013) HyPer-3: a genetically encoded
H(2)O(2) probe with improved performance for ratiometric and fluorescence
lifetime imaging. ACS chemical biology 8:535-542.
Boillee S, Cleveland DW (2008) Revisiting oxidative damage in ALS: microglia, Nox,
and mutant SOD1. The Journal of clinical investigation 118:474-478.
Brandes RP, Weissmann N, Schroder K (2014) Nox family NADPH oxidases: Molecular
mechanisms of activation. Free radical biology & medicine 76:208-226.

172
Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, Edling Y, Chan
PH, Swanson RA (2009) NADPH oxidase is the primary source of superoxide
induced by NMDA receptor activation. Nature neuroscience 12:857-863.
Brittis PA, Silver J (1995) Multiple factors govern intraretinal axon guidance: a timelapse study. Molecular and cellular neurosciences 6:413-432.
Brittis PA, Canning DR, Silver J (1992) Chondroitin sulfate as a regulator of neuronal
patterning in the retina. Science 255:733-736.
Bromberg Y, Pick E (1985) Activation of NADPH-dependent superoxide production in a
cell-free system by sodium dodecyl sulfate. The Journal of biological chemistry
260:13539-13545.
Brown DI, Griendling KK (2009) Nox proteins in signal transduction. Free radical
biology & medicine 47:1239-1253.
Buday L, Downward J (2007) Roles of cortactin in tumor pathogenesis. Biochimica et
biophysica acta 1775:263-273.
Buricchi F, Giannoni E, Grimaldi G, Parri M, Raugei G, Ramponi G, Chiarugi P (2007)
Redox regulation of ephrin/integrin cross-talk. Cell adhesion & migration 1:3342.
Burrill JD, Easter SS, Jr. (1995) The first retinal axons and their microenvironment in
zebrafish: cryptic pioneers and the pretract. The Journal of neuroscience : the
official journal of the Society for Neuroscience 15:2935-2947.
Cao X, Demel SL, Quinn MT, Galligan JJ, Kreulen D (2009) Localization of NADPH
oxidase in sympathetic and sensory ganglion neurons and perivascular nerve
fibers. Auton Neurosci 151:90-97.
Carbone F, Camillo Teixeira P, Braunersreuther V, Mach F, Vuilleumier N, Montecucco
F (2014) Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke:
Focus on the Phagocytic NADPH Oxidase 2. Antioxidants & redox signaling.
Castellon X, Bogdanova V (2016) Chronic Inflammatory Diseases and Endothelial
Dysfunction. Aging and disease 7:81-89.
Cerutti P, Ghosh R, Oya Y, Amstad P (1994) The role of the cellular antioxidant defense
in oxidant carcinogenesis. Environmental health perspectives 102 Suppl 10:123129.

173
Chalasani SH, Sabol A, Xu H, Gyda MA, Rasband K, Granato M, Chien CB, Raper JA
(2007) Stromal cell-derived factor-1 antagonizes slit/robo signaling in vivo. The
Journal of neuroscience : the official journal of the Society for Neuroscience
27:973-980.
Chen J, He R, Minshall RD, Dinauer MC, Ye RD (2007) Characterization of a mutation
in the Phox homology domain of the NADPH oxidase component p40phox
identifies a mechanism for negative regulation of superoxide production. The
Journal of biological chemistry 282:30273-30284.
Chen Z, Lee H, Henle SJ, Cheever TR, Ekker SC, Henley JR (2013) Primary neuron
culture for nerve growth and axon guidance studies in zebrafish (Danio rerio).
PloS one 8:e57539.
Cheng G, Lambeth JD (2004) NOXO1, regulation of lipid binding, localization, and
activation of Nox1 by the Phox homology (PX) domain. The Journal of biological
chemistry 279:4737-4742.
Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD (2001) Homologs of gp91phox:
cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269:131-140.
Cheret C, Gervais A, Lelli A, Colin C, Amar L, Ravassard P, Mallet J, Cumano A,
Krause KH, Mallat M (2008) Neurotoxic activation of microglia is promoted by a
nox1-dependent NADPH oxidase. The Journal of neuroscience : the official
journal of the Society for Neuroscience 28:12039-12051.
Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S,
Galeotti T, Ramponi G (2003) Reactive oxygen species as essential mediators of
cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required
for cell adhesion. J Cell Biol 161:933-944.
Chiriaco M, Salfa I, Matteo GD, Rossi P, Finocchi A (2015) Chronic Granulomatous
Disease: clinical, molecular and therapeutic aspects. Pediatric allergy and
immunology : official publication of the European Society of Pediatric Allergy
and Immunology.
Choi DH, Cristovao AC, Guhathakurta S, Lee J, Joh TH, Beal MF, Kim YS (2012)
NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in
Parkinson's disease. Antioxidants & redox signaling 16:1033-1045.
Codutti L, van Ingen H, Vascotto C, Fogolari F, Corazza A, Tell G, Quadrifoglio F,
Viglino P, Boelens R, Esposito G (2008) The solution structure of DNA-free Pax8 paired box domain accounts for redox regulation of transcriptional activity in
the pax protein family. The Journal of biological chemistry 283:33321-33328.

174
Cole TS, McKendrick F, Cant AJ, Pearce MS, Cale CM, Goldblatt DR, Gennery AR,
Titman P (2013) Cognitive ability in children with chronic granulomatous
disease: a comparison of those managed conservatively with those who have
undergone hematopoietic stem cell transplant. Neuropediatrics 44:230-232.
Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L, Torre E, Migliore C,
Giordano S, Chiarugi P (2011) HIF-1alpha stabilization by mitochondrial ROS
promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma
cells. Free radical biology & medicine 51:893-904.
Coyoy A, Valencia A, Guemez-Gamboa A, Moran J (2008) Role of NADPH oxidase in
the apoptotic death of cultured cerebellar granule neurons. Free radical biology &
medicine 45:1056-1064.
Coyoy A, Olguin-Albuerne M, Martinez-Briseno P, Moran J (2013) Role of reactive
oxygen species and NADPH-oxidase in the development of rat cerebellum.
Neurochemistry international 62:998-1011.
Cristovao AC, Barata J, Je G, Kim YS (2013) PKCdelta mediates paraquat-induced Nox1
expression in dopaminergic neurons. Biochem Biophys Res Commun 437:380385.
Cui XL, Brockman D, Campos B, Myatt L (2006) Expression of NADPH oxidase
isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta
27:422-431.
D'Ambrosi N, Rossi S, Gerbino V, Cozzolino M (2014) Rac1 at the crossroad of actin
dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis. Frontiers in
cellular neuroscience 8:279.
Dalle-Donne I, Rossi R, Milzani A, Di Simplicio P, Colombo R (2001) The actin
cytoskeleton response to oxidants: from small heat shock protein phosphorylation
to changes in the redox state of actin itself. Free radical biology & medicine
31:1624-1632.
Dalle-Donne I, Giustarini D, Rossi R, Colombo R, Milzani A (2003) Reversible Sglutathionylation of Cys 374 regulates actin filament formation by inducing
structural changes in the actin molecule. Free radical biology & medicine 34:2332.
Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Di Simplicio P, Colombo R, Milzani
A (2002) Methionine oxidation as a major cause of the functional impairment of
oxidized actin. Free radical biology & medicine 32:927-937.

175
DalleDonne I, Milzani A, Colombo R (1995) H2O2-treated actin: assembly and polymer
interactions with cross-linking proteins. Biophysical journal 69:2710-2719.
Datla SR, McGrail DJ, Vukelic S, Huff LP, Lyle AN, Pounkova L, Lee M, Seidel-Rogol
B, Khalil MK, Hilenski LL, Terada LS, Dawson MR, Lassegue B, Griendling KK
(2014) Poldip2 controls vascular smooth muscle cell migration by regulating focal
adhesion turnover and force polarization. American journal of physiology Heart
and circulatory physiology 307:H945-957.
De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F
(2000) Cloning of two human thyroid cDNAs encoding new members of the
NADPH oxidase family. The Journal of biological chemistry 275:23227-23233.
de Oliveira S, Boudinot P, Calado A, Mulero V (2015) Duox1-derived H2O2 modulates
Cxcl8 expression and neutrophil recruitment via JNK/c-JUN/AP-1 signaling and
chromatin modifications. J Immunol 194:1523-1533.
de Rezende FF, Martins Lima A, Niland S, Wittig I, Heide H, Schroder K, Eble JA
(2012) Integrin alpha7beta1 is a redox-regulated target of hydrogen peroxide in
vascular smooth muscle cell adhesion. Free radical biology & medicine 53:521531.
Decourt B, Munnamalai V, Lee AC, Sanchez L, Suter DM (2009) Cortactin colocalizes
with filopodial actin and accumulates at IgCAM adhesion sites in Aplysia growth
cones. J Neurosci Res 87:1057-1068.
Deiner MS, Kennedy TE, Fazeli A, Serafini T, Tessier-Lavigne M, Sretavan DW (1997)
Netrin-1 and DCC mediate axon guidance locally at the optic disc: loss of
function leads to optic nerve hypoplasia. Neuron 19:575-589.
Detrich HI, M Westerfield M, Zon LI (2010) The Zebrafish: Cellular and Developmental
Biology, 3rd Edition, 3rd Edition. Burlington, MA: Elsevier.
Dickinson BC, Peltier J, Stone D, Schaffer DV, Chang CJ (2011) Nox2 redox signaling
maintains essential cell populations in the brain. Nature chemical biology 7:106112.
Diekmann D, Abo A, Johnston C, Segal AW, Hall A (1994) Interaction of Rac with
p67phox and regulation of phagocytic NADPH oxidase activity. Science 265:531533.
Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK
(2008) Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated
superoxide and hydrogen peroxide production. Free radical biology & medicine
45:1340-1351.

176
Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA (1987) The glycoprotein
encoded by the X-linked chronic granulomatous disease locus is a component of
the neutrophil cytochrome b complex. Nature 327:717-720.
Dixit R, Ross JL, Goldman YE, Holzbaur EL (2008) Differential regulation of dynein
and kinesin motor proteins by tau. Science 319:1086-1089.
Drummond GR, Sobey CG (2014) Endothelial NADPH oxidases: which NOX to target
in vascular disease? Trends Endocrinol Metab 25:452-463.
Dumont M, Stack C, Elipenhali C, Calingasan NY, Wille E, Beal MF (2011) Apocynin
administration does not improve behavioral and neuropathological deficits in a
transgenic mouse model of Alzheimer's disease. Neurosci Lett 492:150-154.
Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A (1999) Purification
of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the
porcine and human cdnas. The Journal of biological chemistry 274:37265-37269.
el Benna J, Ruedi JM, Babior BM (1994a) Cytosolic guanine nucleotide-binding protein
Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase.
Transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to
the submembranous actin cytoskeleton during oxidase activation. The Journal of
biological chemistry 269:6729-6734.
el Benna J, Faust LP, Babior BM (1994b) The phosphorylation of the respiratory burst
oxidase component p47phox during neutrophil activation. Phosphorylation of
sites recognized by protein kinase C and by proline-directed kinases. The Journal
of biological chemistry 269:23431-23436.
El Benna J, Dang PM, Andrieu V, Vergnaud S, Dewas C, Cachia O, Fay M, Morel F,
Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA (1999) P40phox associates
with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMAactivated membrane skeleton: a comparative study with P67phox and P47phox. J
Leukoc Biol 66:1014-1020.
Emmendorffer A, Roesler J, Elsner J, Raeder E, Lohmann-Matthes ML, Meier B (1993)
Production of oxygen radicals by fibroblasts and neutrophils from a patient with
x-linked chronic granulomatous disease. European journal of haematology
51:223-227.
Erskine L, Herrera E (2014) Connecting the retina to the brain. ASN neuro 6.
Erskine L, Reijntjes S, Pratt T, Denti L, Schwarz Q, Vieira JM, Alakakone B, Shewan D,
Ruhrberg C (2011) VEGF signaling through neuropilin 1 guides commissural
axon crossing at the optic chiasm. Neuron 70:951-965.

177
Fadool JM, Dowling JE (2008) Zebrafish: a model system for the study of eye genetics.
Progress in retinal and eye research 27:89-110.
Fiaschi T, Cozzi G, Raugei G, Formigli L, Ramponi G, Chiarugi P (2006) Redox
regulation of beta-actin during integrin-mediated cell adhesion. The Journal of
biological chemistry 281:22983-22991.
Fimbel SM, Montgomery JE, Burket CT, Hyde DR (2007) Regeneration of inner retinal
neurons after intravitreal injection of ouabain in zebrafish. The Journal of
neuroscience : the official journal of the Society for Neuroscience 27:1712-1724.
Finkel T (2001) Reactive oxygen species and signal transduction. IUBMB Life 52:3-6.
Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194:7-15.
Finkel T (2012) Signal transduction by mitochondrial oxidants. The Journal of biological
chemistry 287:4434-4440.
Fischer J, Weide T, Barnekow A (2005) The MICAL proteins and rab1: a possible link to
the cytoskeleton? Biochem Biophys Res Commun 328:415-423.
Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M,
van Horssen J, Lassmann H (2012) NADPH oxidase expression in active multiple
sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.
Brain : a journal of neurology 135:886-899.
Flint AJ, Tiganis T, Barford D, Tonks NK (1997) Development of "substrate-trapping"
mutants to identify physiological substrates of protein tyrosine phosphatases.
Proceedings of the National Academy of Sciences of the United States of America
94:1680-1685.
Fomenko DE, Xing W, Adair BM, Thomas DJ, Gladyshev VN (2007) High-throughput
identification of catalytic redox-active cysteine residues. Science 315:387-389.
Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J (2002) Phosphorylation of
p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox
and on NADPH oxidase activation. Biochemistry 41:7743-7750.
Forman HJ, Ursini F, Maiorino M (2014) An overview of mechanisms of redox
signaling. Journal of molecular and cellular cardiology 73:2-9.
Forsberg K, Di Giovanni S (2014) Cross Talk between Cellular Redox Status,
Metabolism, and p53 in Neural Stem Cell Biology. The Neuroscientist : a review
journal bringing neurobiology, neurology and psychiatry 20:326-342.

178
Forsberg K, Wuttke A, Quadrato G, Chumakov PM, Wizenmann A, Di Giovanni S
(2013) The tumor suppressor p53 fine-tunes reactive oxygen species levels and
neurogenesis via PI3 kinase signaling. The Journal of neuroscience : the official
journal of the Society for Neuroscience 33:14318-14330.
Frantz S, Brandes RP, Hu K, Rammelt K, Wolf J, Scheuermann H, Ertl G, Bauersachs J
(2006) Left ventricular remodeling after myocardial infarction in mice with
targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic research in
cardiology 101:127-132.
Frisen J, Yates PA, McLaughlin T, Friedman GC, O'Leary DD, Barbacid M (1998)
Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and
topographic mapping in the mammalian visual system. Neuron 20:235-243.
Fukuda M, Kanno E, Ishibashi K, Itoh T (2008) Large scale screening for novel rab
effectors reveals unexpected broad Rab binding specificity. Molecular & cellular
proteomics : MCP 7:1031-1042.
Fyhrquist F, Metsarinne K, Tikkanen I (1995) Role of angiotensin II in blood pressure
regulation and in the pathophysiology of cardiovascular disorders. Journal of
human hypertension 9 Suppl 5:S19-24.
Gao HM, Zhou H, Hong JS (2012) NADPH oxidases: novel therapeutic targets for
neurodegenerative diseases. Trends Pharmacol Sci.
Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz
F, Page P, Montet X, Michalik L, Arbiser J, Ruegg C, Krause KH, Imhof BA
(2011) Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through
a PPARalpha mediated mechanism. PloS one 6:e14665.
Gauss KA, Mascolo PL, Siemsen DW, Nelson LK, Bunger PL, Pagano PJ, Quinn MT
(2002) Cloning and sequencing of rabbit leukocyte NADPH oxidase genes reveals
a unique p67(phox) homolog. J Leukoc Biol 71:319-328.
Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H
oxidase in kidney. Proceedings of the National Academy of Sciences of the
United States of America 97:8010-8014.
Geiszt M, Lekstrom K, Witta J, Leto TL (2003) Proteins homologous to p47phox and
p67phox support superoxide production by NAD(P)H oxidase 1 in colon
epithelial cells. The Journal of biological chemistry 278:20006-20012.
Giannoni E, Fiaschi T, Ramponi G, Chiarugi P (2009) Redox regulation of anoikis
resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated
pro-survival signals. Oncogene 28:2074-2086.

179
Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P (2005) Intracellular reactive
oxygen species activate Src tyrosine kinase during cell adhesion and anchoragedependent cell growth. Molecular and cellular biology 25:6391-6403.
Gjetting KS, Ytting CK, Schulz A, Fuglsang AT (2012) Live imaging of intra- and
extracellular pH in plants using pHusion, a novel genetically encoded biosensor.
Journal of experimental botany 63:3207-3218.
Gordillo GM, Biswas A, Khanna S, Pan X, Sinha M, Roy S, Sen CK (2014) Dicer
knockdown inhibits endothelial cell tumor growth via microRNA 21a-3p
targeting of Nox-4. The Journal of biological chemistry 289:9027-9038.
Gorzalczany Y, Sigal N, Itan M, Lotan O, Pick E (2000) Targeting of Rac1 to the
phagocyte membrane is sufficient for the induction of NADPH oxidase assembly.
The Journal of biological chemistry 275:40073-40081.
Groemping Y, Lapouge K, Smerdon SJ, Rittinger K (2003) Molecular basis of
phosphorylation-induced activation of the NADPH oxidase. Cell 113:343-355.
Grogan A, Reeves E, Keep N, Wientjes F, Totty NF, Burlingame AL, Hsuan JJ, Segal
AW (1997) Cytosolic phox proteins interact with and regulate the assembly of
coronin in neutrophils. Journal of cell science 110 ( Pt 24):3071-3081.
Guemez-Gamboa A, Moran J (2009) NOX2 mediates apoptotic death induced by
staurosporine but not by potassium deprivation in cerebellar granule neurons. J
Neurosci Res 87:2531-2540.
Gulyani A, Vitriol E, Allen R, Wu J, Gremyachinskiy D, Lewis S, Dewar B, Graves LM,
Kay BK, Kuhlman B, Elston T, Hahn KM (2011) A biosensor generated via highthroughput screening quantifies cell edge Src dynamics. Nature chemical biology
7:437-444.
Gutscher M, Sobotta MC, Wabnitz GH, Ballikaya S, Meyer AJ, Samstag Y, Dick TP
(2009) Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases.
The Journal of biological chemistry 284:31532-31540.
Hadrava V, Kruppa U, Russo RC, Lacourciere Y, Tremblay J, Hamet P (1991) Vascular
smooth muscle cell proliferation and its therapeutic modulation in hypertension.
American heart journal 122:1198-1203.
Hall ED (2011) Antioxidant therapies for acute spinal cord injury. Neurotherapeutics :
the journal of the American Society for Experimental NeuroTherapeutics 8:152167.

180
Han CH, Freeman JL, Lee T, Motalebi SA, Lambeth JD (1998) Regulation of the
neutrophil respiratory burst oxidase. Identification of an activation domain in
p67(phox). The Journal of biological chemistry 273:16663-16668.
Harper RW, Xu C, McManus M, Heidersbach A, Eiserich JP (2006) Duox2 exhibits
potent heme peroxidase activity in human respiratory tract epithelium. FEBS
letters 580:5150-5154.
Hashimoto T, Zhang XM, Chen BY, Yang XJ (2006) VEGF activates divergent
intracellular signaling components to regulate retinal progenitor cell proliferation
and neuronal differentiation. Development 133:2201-2210.
He Y, Ren Y, Wu B, Decourt B, Lee AC, Taylor A, Suter DM (2015) Src and cortactin
promote lamellipodia protrusion and filopodia formation and stability in growth
cones. Mol Biol Cell 26:3229-3244.
Hensley MR, Leung YF (2010) A convenient dry feed for raising zebrafish larvae.
Zebrafish 7:219-231.
Hensley MR, Emran F, Bonilla S, Zhang L, Zhong W, Grosu P, Dowling JE, Leung YF
(2011) Cellular expression of Smarca4 (Brg1)-regulated genes in zebrafish
retinas. BMC Dev Biol 11:45.
Hernandes MS, Britto LR (2012) NADPH oxidase and neurodegeneration. Current
neuropharmacology 10:321-327.
Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP
(2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an
antioxidant. Hypertension 51:211-217.
Hilburger EW, Conte EJ, McGee DW, Tammariello SP (2005) Localization of NADPH
oxidase subunits in neonatal sympathetic neurons. Neurosci Lett 377:16-19.
Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK (2004) Distinct
subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol 24:677-683.
Hoffman SJ, Psaltis PJ, Clark KJ, Spoon DB, Chue CD, Ekker SC, Simari RD (2012) An
in vivo method to quantify lymphangiogenesis in zebrafish. PloS one 7:e45240.
Holmes B, Page AR, Good RA (1967) Studies of the metabolic activity of leukocytes
from patients with a genetic abnormality of phagocytic function. The Journal of
clinical investigation 46:1422-1432.

181
Holterman CE, Thibodeau JF, Kennedy CR (2015) NADPH oxidase 5 and renal disease.
Current opinion in nephrology and hypertension 24:81-87.
Hopker VH, Shewan D, Tessier-Lavigne M, Poo M, Holt C (1999) Growth-cone
attraction to netrin-1 is converted to repulsion by laminin-1. Nature 401:69-73.
Hu M, Easter SS (1999) Retinal neurogenesis: the formation of the initial central patch of
postmitotic cells. Dev Biol 207:309-321.
Hung RJ, Pak CW, Terman JR (2011) Direct redox regulation of F-actin assembly and
disassembly by Mical. Science 334:1710-1713.
Hung RJ, Spaeth CS, Yesilyurt HG, Terman JR (2013) SelR reverses Mical-mediated
oxidation of actin to regulate F-actin dynamics. Nat Cell Biol 15:1445-1454.
Hung RJ, Yazdani U, Yoon J, Wu H, Yang T, Gupta N, Huang Z, van Berkel WJ,
Terman JR (2010) Mical links semaphorins to F-actin disassembly. Nature
463:823-827.
Hutson LD, Chien CB (2002) Pathfinding and error correction by retinal axons: the role
of astray/robo2. Neuron 33:205-217.
Ibi M, Katsuyama M, Fan C, Iwata K, Nishinaka T, Yokoyama T, Yabe-Nishimura C
(2006) NOX1/NADPH oxidase negatively regulates nerve growth factor-induced
neurite outgrowth. Free radical biology & medicine 40:1785-1795.
Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev NA, Anwar GM, Quinn MT, UshioFukai M (2005) IQGAP1 regulates reactive oxygen species-dependent endothelial
cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol
25:2295-2300.
Imai F, Yoshizawa A, Matsuzaki A, Oguri E, Araragi M, Nishiwaki Y, Masai I (2014)
Stem-loop binding protein is required for retinal cell proliferation, neurogenesis,
and intraretinal axon pathfinding in zebrafish. Dev Biol 394:94-109.
Iyer GYN, Islam MF, Quastel JH (1961) Biochemical Aspects of Phagocytosis. Nature
192:535-541.
Janke C (2014) The tubulin code: molecular components, readout mechanisms, and
functions. J Cell Biol 206:461-472.
Jao LE, Wente SR, Chen W (2013) Efficient multiplex biallelic zebrafish genome editing
using a CRISPR nuclease system. Proceedings of the National Academy of
Sciences of the United States of America 110:13904-13909.

182
Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD (2009) Small-molecule NOX
inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxidants
& redox signaling 11:2535-2552.
Jaquet V, Marcoux J, Forest E, Leidal KG, McCormick S, Westermaier Y, Perozzo R,
Plastre O, Fioraso-Cartier L, Diebold B, Scapozza L, Nauseef WM, Fieschi F,
Krause KH, Bedard K (2011) NADPH oxidase (NOX) isoforms are inhibited by
celastrol with a dual mode of action. British journal of pharmacology 164:507520.
Jay DB, Papaharalambus CA, Seidel-Rogol B, Dikalova AE, Lassegue B, Griendling KK
(2008) Nox5 mediates PDGF-induced proliferation in human aortic smooth
muscle cells. Free radical biology & medicine 45:329-335.
Jimenez-Shahed J (2016) A review of current and novel levodopa formulations for the
treatment of Parkinson's disease. Therapeutic delivery 7:179-191.
Jones DP, Go YM (2011) Mapping the cysteine proteome: analysis of redox-sensing
thiols. Current opinion in chemical biology 15:103-112.
Kaji N, Ohashi K, Shuin M, Niwa R, Uemura T, Mizuno K (2003) Cell cycle-associated
changes in Slingshot phosphatase activity and roles in cytokinesis in animal cells.
The Journal of biological chemistry 278:33450-33455.
Kajla S, Mondol AS, Nagasawa A, Zhang Y, Kato M, Matsuno K, Yabe-Nishimura C,
Kamata T (2012) A crucial role for Nox 1 in redox-dependent regulation of Wntbeta-catenin signaling. FASEB journal : official publication of the Federation of
American Societies for Experimental Biology 26:2049-2059.
Kallenborn-Gerhardt W, Schroder K, Del Turco D, Lu R, Kynast K, Kosowski J,
Niederberger E, Shah AM, Brandes RP, Geisslinger G, Schmidtko A (2012)
NADPH oxidase-4 maintains neuropathic pain after peripheral nerve injury. The
Journal of neuroscience : the official journal of the Society for Neuroscience
32:10136-10145.
Kambe F, Nomura Y, Okamoto T, Seo H (1996) Redox regulation of thyroidtranscription factors, Pax-8 and TTF-1, is involved in their increased DNAbinding activities by thyrotropin in rat thyroid FRTL-5 cells. Molecular
endocrinology (Baltimore, Md) 10:801-812.
Kawahara BT, Quinn MT, Lambeth JD (2007a) Molecular evolution of the reactive
oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC
evolutionary biology 7:109.

183
Kawahara T, Lambeth JD (2007) Molecular evolution of Phox-related regulatory
subunits for NADPH oxidase enzymes. BMC evolutionary biology 7:178.
Kawahara T, Quinn MT, Lambeth JD (2007b) Molecular evolution of the reactive
oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC
evolutionary biology 7:109.
Kay JN, Link BA, Baier H (2005) Staggered cell-intrinsic timing of ath5 expression
underlies the wave of ganglion cell neurogenesis in the zebrafish retina.
Development 132:2573-2585.
Kay JN, Finger-Baier KC, Roeser T, Staub W, Baier H (2001) Retinal ganglion cell
genesis requires lakritz, a Zebrafish atonal Homolog. Neuron 30:725-736.
Kikuchi H, Hikage M, Miyashita H, Fukumoto M (2000) NADPH oxidase subunit,
gp91(phox) homologue, preferentially expressed in human colon epithelial cells.
Gene 254:237-243.
Kim JS, Huang TY, Bokoch GM (2009) Reactive oxygen species regulate a slingshotcofilin activation pathway. Mol Biol Cell 20:2650-2660.
Kim JS, Park EJ, Choi IG, Kim YS, Park JB (2011a) Neuregulin induces HaCaT
keratinocyte migration via Rac1-mediated NADPH-oxidase activation. Journal of
cellular physiology.
Kim JS, Bak EJ, Lee BC, Kim YS, Park JB, Choi IG (2011b) Neuregulin induces HaCaT
keratinocyte migration via Rac1-mediated NADPH-oxidase activation. Journal of
cellular physiology 226:3014-3021.
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of
embryonic development of the zebrafish. Dev Dyn 203:253-310.
Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, Klann E (2006) Synaptic plasticity
deficits and mild memory impairments in mouse models of chronic
granulomatous disease. Molecular and cellular biology 26:5908-5920.
Kiss PJ, Knisz J, Zhang Y, Baltrusaitis J, Sigmund CD, Thalmann R, Smith RJ, Verpy E,
Banfi B (2006) Inactivation of NADPH oxidase organizer 1 results in severe
imbalance. Current biology : CB 16:208-213.
Kita EM, Scott EK, Goodhill GJ (2015) Topographic wiring of the retinotectal
connection in zebrafish. Developmental neurobiology 75:542-556.
Kleinschnitz C et al. (2010) Post-stroke inhibition of induced NADPH oxidase type 4
prevents oxidative stress and neurodegeneration. PLoS biology 8.

184
Knaus UG, Heyworth PG, Evans T, Curnutte JT, Bokoch GM (1991) Regulation of
phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science
254:1512-1515.
Kokovay E, Wang Y, Kusek G, Wurster R, Lederman P, Lowry N, Shen Q, Temple S
(2012) VCAM1 is essential to maintain the structure of the SVZ niche and acts as
an environmental sensor to regulate SVZ lineage progression. Cell stem cell
11:220-230.
Kolodkin AL, Tessier-Lavigne M (2011) Mechanisms and molecules of neuronal wiring:
a primer. Cold Spring Harbor perspectives in biology 3.
Krijnen PA, Meischl C, Hack CE, Meijer CJ, Visser CA, Roos D, Niessen HW (2003)
Increased Nox2 expression in human cardiomyocytes after acute myocardial
infarction. Journal of clinical pathology 56:194-199.
Kuiper JW, Sun C, Magalhaes MA, Glogauer M (2011) Rac regulates PtdInsP(3)
signaling and the chemotactic compass through a redox-mediated feedback loop.
Blood 118:6164-6171.
Lambeth JD, Kawahara T, Diebold B (2007) Regulation of Nox and Duox enzymatic
activity and expression. Free radical biology & medicine 43:319-331.
Landino LM, Robinson SH, Skreslet TE, Cabral DM (2004) Redox modulation of tau and
microtubule-associated protein-2 by the glutathione/glutaredoxin reductase
system. Biochem Biophys Res Commun 323:112-117.
Landino LM, Koumas MT, Mason CE, Alston JA (2007) Modification of tubulin
cysteines by nitric oxide and nitroxyl donors alters tubulin polymerization
activity. Chemical research in toxicology 20:1693-1700.
Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD,
Griendling KK (2001) Novel gp91(phox) homologues in vascular smooth muscle
cells : nox1 mediates angiotensin II-induced superoxide formation and redoxsensitive signaling pathways. Circ Res 88:888-894.
Lassing I, Schmitzberger F, Bjornstedt M, Holmgren A, Nordlund P, Schutt CE,
Lindberg U (2007) Molecular and structural basis for redox regulation of betaactin. Journal of molecular biology 370:331-348.
Lawson ND, Weinstein BM (2002) In vivo imaging of embryonic vascular development
using transgenic zebrafish. Dev Biol 248:307-318.

185
Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, Wu H, Kornblum
HI (2011) Proliferative neural stem cells have high endogenous ROS levels that
regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell
stem cell 8:59-71.
Le Cabec V, Maridonneau-Parini I (1995) Complete and reversible inhibition of NADPH
oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane
translocation of the enzyme subunits. The Journal of biological chemistry
270:2067-2073.
Lee AC, Decourt B, Suter D (2008) Neuronal cell cultures from aplysia for highresolution imaging of growth cones. Journal of visualized experiments : JoVE.
Lee JE, Cho KE, Lee KE, Kim J, Bae YS (2014) Nox4-mediated cell signaling regulates
differentiation and survival of neural crest stem cells. Molecules and cells 37:907911.
Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E,
Krause KH, Banfi B, Lambeth JD, Lassegue B, Griendling KK (2009)
Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution
to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 29:480487.
Lee SR, Kwon KS, Kim SR, Rhee SG (1998) Reversible inactivation of protein-tyrosine
phosphatase 1B in A431 cells stimulated with epidermal growth factor. The
Journal of biological chemistry 273:15366-15372.
Levitan IB, Kaczmarek LK (2002) The Neuron: Cell and Molecular Biology: Oxford
University Press.
Li JM, Shah AM (2002) Intracellular localization and preassembly of the NADPH
oxidase complex in cultured endothelial cells. The Journal of biological chemistry
277:19952-19960.
Li L, Hutchins BI, Kalil K (2009) Wnt5a induces simultaneous cortical axon outgrowth
and repulsive axon guidance through distinct signaling mechanisms. The Journal
of neuroscience : the official journal of the Society for Neuroscience 29:58735883.
Li Q, Shirabe K, Thisse C, Thisse B, Okamoto H, Masai I, Kuwada JY (2005)
Chemokine signaling guides axons within the retina in zebrafish. The Journal of
neuroscience : the official journal of the Society for Neuroscience 25:1711-1717.

186
Li Y, Liu J, Zhan X (2000) Tyrosine phosphorylation of cortactin is required for H2O2mediated injury of human endothelial cells. The Journal of biological chemistry
275:37187-37193.
Li Y, Mouche S, Sajic T, Veyrat-Durebex C, Supale R, Pierroz D, Ferrari S, Negro F,
Hasler U, Feraille E, Moll S, Meda P, Deffert C, Montet X, Krause KH, Szanto I
(2012a) Deficiency in the NADPH oxidase 4 predisposes towards diet-induced
obesity. International journal of obesity (2005) 36:1503-1513.
Li Z, Ptak D, Zhang L, Walls EK, Zhong W, Leung YF (2012b) Phenylthiourea
specifically reduces zebrafish eye size. PloS one 7:e40132.
Lilienbaum A, Reszka AA, Horwitz AF, Holt CE (1995) Chimeric integrins expressed in
retinal ganglion cells impair process outgrowth in vivo. Molecular and cellular
neurosciences 6:139-152.
Lim JB, Langford TF, Huang BK, Deen WM, Sikes HD (2016) A reaction-diffusion
model of cytosolic hydrogen peroxide. Free radical biology & medicine 90:85-90.
Loosli F, Winkler S, Wittbrodt J (1999) Six3 overexpression initiates the formation of
ectopic retina. Genes Dev 13:649-654.
Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, Porru M, Leonetti C, Di
Carlo S, Visca P, Brizzi MF, Anichini A, Mortarini R, Falcioni R (2015) Sema6A
and Mical1 control cell growth and survival of BRAFV600E human melanoma
cells. Oncotarget 6:2779-2793.
Lowe J, Li H, Downing KH, Nogales E (2001) Refined structure of alpha beta-tubulin at
3.5 A resolution. Journal of molecular biology 313:1045-1057.
Lu XY, Wang HD, Xu JG, Ding K, Li T (2014) NADPH oxidase inhibition improves
neurological outcome in experimental traumatic brain injury. Neurochemistry
international 69:14-19.
Lukinavicius G, Reymond L, D'Este E, Masharina A, Gottfert F, Ta H, Guther A,
Fournier M, Rizzo S, Waldmann H, Blaukopf C, Sommer C, Gerlich DW, Arndt
HD, Hell SW, Johnsson K (2014) Fluorogenic probes for live-cell imaging of the
cytoskeleton. Nature methods 11:731-733.
Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P,
Papaharalambus C, Lassegue B, Griendling KK (2009) Poldip2, a novel regulator
of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res
105:249-259.

187
Macdonald R, Barth KA, Xu Q, Holder N, Mikkola I, Wilson SW (1995) Midline
signalling is required for Pax gene regulation and patterning of the eyes.
Development 121:3267-3278.
Maheswaranathan M, Gole HK, Fernandez I, Lassegue B, Griendling KK, San Martin A
(2011) Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase
activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular
smooth muscle cells. The Journal of biological chemistry 286:35430-35437.
Manuel M, Pratt T, Liu M, Jeffery G, Price DJ (2008) Overexpression of Pax6 results in
microphthalmia, retinal dysplasia and defective retinal ganglion cell axon
guidance. BMC Dev Biol 8:59.
Maraldi T, Prata C, Caliceti C, Vieceli Dalla Sega F, Zambonin L, Fiorentini D, Hakim G
(2010) VEGF-induced ROS generation from NAD(P)H oxidases protects human
leukemic cells from apoptosis. Int J Oncol 36:1581-1589.
Marrali G, Casale F, Salamone P, Fuda G, Caorsi C, Amoroso A, Brunetti M, Restagno
G, Barberis M, Bertuzzo D, Canosa A, Moglia C, Calvo A, Chio A (2014)
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. Journal of
neurology 261:2178-2183.
Marsick BM, Roche FK, Letourneau PC (2012) Repulsive axon guidance cues ephrin-A2
and slit3 stop protrusion of the growth cone leading margin concurrently with
inhibition of ADF/cofilin and ERM proteins. Cytoskeleton (Hoboken) 69:496505.
Marsick BM, Flynn KC, Santiago-Medina M, Bamburg JR, Letourneau PC (2010)
Activation of ADF/cofilin mediates attractive growth cone turning toward nerve
growth factor and netrin-1. Developmental neurobiology 70:565-588.
Martinez-Morales JR, Del Bene F, Nica G, Hammerschmidt M, Bovolenta P, Wittbrodt J
(2005) Differentiation of the vertebrate retina is coordinated by an FGF signaling
center. Developmental cell 8:565-574.
Masai I, Stemple DL, Okamoto H, Wilson SW (2000) Midline signals regulate retinal
neurogenesis in zebrafish. Neuron 27:251-263.
Masai I, Yamaguchi M, Tonou-Fujimori N, Komori A, Okamoto H (2005) The
hedgehog-PKA pathway regulates two distinct steps of the differentiation of
retinal ganglion cells: the cell-cycle exit of retinoblasts and their neuronal
maturation. Development 132:1539-1553.
Masu M (2015) Proteoglycans and axon guidance: a new relationship between old
partners. Journal of neurochemistry Epub ahead of print.

188
Meeker ND, Hutchinson SA, Ho L, Trede NS (2007) Method for isolation of PCR-ready
genomic DNA from zebrafish tissues. BioTechniques 43:610, 612, 614.
Meng D, Lv DD, Fang J (2008) Insulin-like growth factor-I induces reactive oxygen
species production and cell migration through Nox4 and Rac1 in vascular smooth
muscle cells. Cardiovascular research 80:299-308.
Meyer AJ, Dick TP (2010) Fluorescent protein-based redox probes. Antioxidants &
redox signaling 13:621-650.
Meyers JR, Hu L, Moses A, Kaboli K, Papandrea A, Raymond PA (2012) betacatenin/Wnt signaling controls progenitor fate in the developing and regenerating
zebrafish retina. Neural development 7:30.
Mills JE, Whitford PC, Shaffer J, Onuchic JN, Adams JA, Jennings PA (2007) A novel
disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic
activity. Journal of molecular biology 365:1460-1468.
Milzani A, DalleDonne I, Colombo R (1997) Prolonged oxidative stress on actin.
Archives of biochemistry and biophysics 339:267-274.
Miura GI, Yelon D (2011) A guide to analysis of cardiac phenotypes in the zebrafish
embryo. Methods in cell biology 101:161-180.
Miyano K, Ueno N, Takeya R, Sumimoto H (2006) Direct involvement of the small
GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1.
The Journal of biological chemistry 281:21857-21868.
Moldovan L, Moldovan NI, Sohn RH, Parikh SA, Goldschmidt-Clermont PJ (2000)
Redox changes of cultured endothelial cells and actin dynamics. Circ Res 86:549557.
Montezano AC, Touyz RM (2014) Reactive oxygen species, vascular Noxs, and
hypertension: focus on translational and clinical research. Antioxidants & redox
signaling 20:164-182.
Morinaka A, Yamada M, Itofusa R, Funato Y, Yoshimura Y, Nakamura F, Yoshimura T,
Kaibuchi K, Goshima Y, Hoshino M, Kamiguchi H, Miki H (2011) Thioredoxin
mediates oxidation-dependent phosphorylation of CRMP2 and growth cone
collapse. Science signaling 4:ra26.
Munnamalai V, Suter DM (2009) Reactive oxygen species regulate F-actin dynamics in
neuronal growth cones and neurite outgrowth. Journal of neurochemistry
108:644-661.

189
Munnamalai V, Weaver CJ, Weisheit CE, Venkatraman P, Agim ZS, Quinn MT, Suter
DM (2014) Bidirectional interactions between NOX2-type NADPH oxidase and
the F-actin cytoskeleton in neuronal growth cones. Journal of neurochemistry
130:526-540.
Murdoch CE, Bachschmid MM, Matsui R (2014) Regulation of neovascularization by Sglutathionylation via the Wnt5a/sFlt-1 pathway. Biochemical Society transactions
42:1665-1670.
Myers JP, Santiago-Medina M, Gomez TM (2011) Regulation of axonal outgrowth and
pathfinding by integrin-ECM interactions. Developmental neurobiology 71:901923.
Nadella M, Bianchet MA, Gabelli SB, Barrila J, Amzel LM (2005) Structure and activity
of the axon guidance protein MICAL. Proceedings of the National Academy of
Sciences of the United States of America 102:16830-16835.
Nakamoto C, Kuan SL, Findlay AS, Durward E, Ouyang Z, Zakrzewska ED, Endo T,
Nakamoto M (2014) Nel positively regulates the genesis of retinal ganglion cells
by promoting their differentiation and survival during development. Mol Biol Cell
25:234-244.
Nakanishi A, Wada Y, Kitagishi Y, Matsuda S (2014) Link between PI3K/AKT/PTEN
Pathway and NOX Proteinin Diseases. Aging and disease 5:203-211.
Nakanishi A, Imajoh-Ohmi S, Fujinawa T, Kikuchi H, Kanegasaki S (1992) Direct
evidence for interaction between COOH-terminal regions of cytochrome b558
subunits and cytosolic 47-kDa protein during activation of an O(2-)-generating
system in neutrophils. The Journal of biological chemistry 267:19072-19074.
Nauseef WM (2004) Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol
122:277-291.
Nauseef WM, Volpp BD, McCormick S, Leidal KG, Clark RA (1991) Assembly of the
neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and
membrane association of cytosolic oxidase components. The Journal of biological
chemistry 266:5911-5917.
Nayernia Z, Jaquet V, Krause KH (2014) New insights on NOX enzymes in the central
nervous system. Antioxidants & redox signaling 20:2815-2837.
Niethammer P, Grabher C, Look AT, Mitchison TJ (2009) A tissue-scale gradient of
hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459:996999.

190
Nimnual AS, Taylor LJ, Bar-Sagi D (2003) Redox-dependent downregulation of Rho by
Rac. Nat Cell Biol 5:236-241.
Nisimoto Y, Diebold BA, Cosentino-Gomes D, Lambeth JD (2014) Nox4: a hydrogen
peroxide-generating oxygen sensor. Biochemistry 53:5111-5120.
Niwa R, Nagata-Ohashi K, Takeichi M, Mizuno K, Uemura T (2002) Control of actin
reorganization by Slingshot, a family of phosphatases that dephosphorylate
ADF/cofilin. Cell 108:233-246.
Nogales E, Zhang R (2016) Visualizing microtubule structural transitions and
interactions with associated proteins. Current opinion in structural biology 37:9096.
Nornes S, Clarkson M, Mikkola I, Pedersen M, Bardsley A, Martinez JP, Krauss S,
Johansen T (1998) Zebrafish contains two pax6 genes involved in eye
development. Mech Dev 77:185-196.
Nunoi H, Rotrosen D, Gallin JI, Malech HL (1988) Two forms of autosomal chronic
granulomatous disease lack distinct neutrophil cytosol factors. Science 242:12981301.
O'Donnell M, Chance RK, Bashaw GJ (2009) Axon growth and guidance: receptor
regulation and signal transduction. Annual review of neuroscience 32:383-412.
Olguin-Albuerne M, Moran J (2015) ROS produced by NOX2 control in vitro
development of cerebellar granule neurons development. ASN neuro 7.
Omann GM, Harter JM, Burger JM, Hinshaw DB (1994) H2O2-induced increases in
cellular F-actin occur without increases in actin nucleation activity. Archives of
biochemistry and biophysics 308:407-412.
Pacal M, Bremner R (2014) Induction of the ganglion cell differentiation program in
human retinal progenitors before cell cycle exit. Dev Dyn 243:712-729.
Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U,
Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, Bergstrom DE
(2004) Vestibular defects in head-tilt mice result from mutations in Nox3,
encoding an NADPH oxidase. Genes Dev 18:486-491.
Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT (1997)
Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit
aortic adventitia: enhancement by angiotensin II. Proceedings of the National
Academy of Sciences of the United States of America 94:14483-14488.

191
Pan YA, Freundlich T, Weissman TA, Schoppik D, Wang XC, Zimmerman S, Ciruna B,
Sanes JR, Lichtman JW, Schier AF (2013) Zebrabow: multispectral cell labeling
for cell tracing and lineage analysis in zebrafish. Development 140:2835-2846.
Pao M, Wiggs EA, Anastacio MM, Hyun J, DeCarlo ES, Miller JT, Anderson VL,
Malech HL, Gallin JI, Holland SM (2004) Cognitive function in patients with
chronic granulomatous disease: a preliminary report. Psychosomatics 45:230-234.
Park HS, Lee SH, Park D, Lee JS, Ryu SH, Lee WJ, Rhee SG, Bae YS (2004) Sequential
activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth
factor-induced production of H2O2. Molecular and cellular biology 24:43844394.
Park KW, Jin BK (2008) Thrombin-induced oxidative stress contributes to the death of
hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res 86:10531063.
Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S,
Carlson G, McEwen BS, Iadecola C (2008) Nox2-derived radicals contribute to
neurovascular and behavioral dysfunction in mice overexpressing the amyloid
precursor protein. Proceedings of the National Academy of Sciences of the United
States of America 105:1347-1352.
Patel VB, Wang Z, Fan D, Zhabyeyev P, Basu R, Das SK, Wang W, Desaulniers J,
Holland SM, Kassiri Z, Oudit GY (2013) Loss of p47phox subunit enhances
susceptibility to biomechanical stress and heart failure because of dysregulation of
cortactin and actin filaments. Circ Res 112:1542-1556.
Pendyala S, Natarajan V (2010) Redox regulation of Nox proteins. Respiratory
physiology & neurobiology 174:265-271.
Poggi L, Vitorino M, Masai I, Harris WA (2005) Influences on neural lineage and mode
of division in the zebrafish retina in vivo. J Cell Biol 171:991-999.
Pollitt AY, Insall RH (2009) WASP and SCAR/WAVE proteins: the drivers of actin
assembly. Journal of cell science 122:2575-2578.
Poulain FE, Chien CB (2013) Proteoglycan-mediated axon degeneration corrects
pretarget topographic sorting errors. Neuron 78:49-56.
Prasov L, Glaser T (2012) Dynamic expression of ganglion cell markers in retinal
progenitors during the terminal cell cycle. Molecular and cellular neurosciences
50:160-168.

192
Prochniewicz E, Lowe DA, Spakowicz DJ, Higgins L, O'Conor K, Thompson LV,
Ferrington DA, Thomas DD (2008) Functional, structural, and chemical changes
in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers.
American journal of physiology Cell physiology 294:C613-626.
Quie PG, White JG, Holmes B, Good RA (1967) In vitro bactericidal capacity of human
polymorphonuclear leukocytes: diminished activity in chronic granulomatous
disease of childhood. The Journal of clinical investigation 46:668-679.
Quinn MT, Parkos CA, Walker L, Orkin SH, Dinauer MC, Jesaitis AJ (1989) Association
of a Ras-related protein with cytochrome b of human neutrophils. Nature
342:198-200.
Rees MD, Whitelock JM, Malle E, Chuang CY, Iozzo RV, Nilasaroya A, Davies MJ
(2010) Myeloperoxidase-derived oxidants selectively disrupt the protein core of
the heparan sulfate proteoglycan perlecan. Matrix biology : journal of the
International Society for Matrix Biology 29:63-73.
Ren F, Wang K, Zhang T, Jiang J, Nice EC, Huang C (2015) New insights into redox
regulation of stem cell self-renewal and differentiation. Biochimica et biophysica
acta 1850:1518-1526.
Rieger S, Sagasti A (2011) Hydrogen peroxide promotes injury-induced peripheral
sensory axon regeneration in the zebrafish skin. PLoS biology 9:e1000621.
Riehl R, Johnson K, Bradley R, Grunwald GB, Cornel E, Lilienbaum A, Holt CE (1996)
Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo.
Neuron 17:837-848.
Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE, Corvilain B,
Miot F, De Deken X (2009) Activation of dual oxidases Duox1 and Duox2:
differential regulation mediated by camp-dependent protein kinase and protein
kinase C-dependent phosphorylation. The Journal of biological chemistry
284:6725-6734.
Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S (2008)
Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal
tract. Seminars in immunopathology 30:315-327.
Roma LP, Duprez J, Takahashi HK, Gilon P, Wiederkehr A, Jonas JC (2012) Dynamic
measurements of mitochondrial hydrogen peroxide concentration and glutathione
redox state in rat pancreatic beta-cells using ratiometric fluorescent proteins:
confounding effects of pH with HyPer but not roGFP1. The Biochemical journal
441:971-978.

193
Rossi F, Zatti M (1964) Biochemical aspects of phagocytosis in polymorphonuclear
leucocytes. NADH and NADPH oxidation by the granules of resting and
phagocytizing cells. Experientia 20:21-23.
Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole
FS, Curnutte JT, Orkin SH (1986) Cloning the gene for an inherited human
disorder--chronic granulomatous disease--on the basis of its chromosomal
location. Nature 322:32-38.
Ruchhoeft ML, Ohnuma S, McNeill L, Holt CE, Harris WA (1999) The neuronal
architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases
in vivo. The Journal of neuroscience : the official journal of the Society for
Neuroscience 19:8454-8463.
Sadok A, Bourgarel-Rey V, Gattacceca F, Penel C, Lehmann M, Kovacic H (2008)
Nox1-dependent superoxide production controls colon adenocarcinoma cell
migration. Biochimica et biophysica acta 1783:23-33.
Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M,
Miyazono K, Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of
apoptosis signal-regulating kinase (ASK) 1. The EMBO journal 17:2596-2606.
Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D (2003)
Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide
intermediate. Nature 423:769-773.
Samuel A, Rubinstein AM, Azar TT, Ben-Moshe Livne Z, Kim SH, Inbal A (2016) Six3
regulates optic nerve development via multiple mechanisms. Scientific reports
6:20267.
Sandieson L, Hwang JT, Kelly GM (2014) Redox regulation of canonical Wnt signaling
affects extraembryonic endoderm formation. Stem cells and development
23:1037-1049.
Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC (2009) Redox control of
the cell cycle in health and disease. Antioxidants & redox signaling 11:29853011.
Schilling TF, Piotrowski T, Grandel H, Brand M, Heisenberg CP, Jiang YJ, Beuchle D,
Hammerschmidt M, Kane DA, Mullins MC, van Eeden FJ, Kelsh RN, FurutaniSeiki M, Granato M, Haffter P, Odenthal J, Warga RM, Trowe T, NussleinVolhard C (1996) Jaw and branchial arch mutants in zebrafish I: branchial arches.
Development 123:329-344.

194
Schmidt EF, Shim SO, Strittmatter SM (2008) Release of MICAL autoinhibition by
semaphorin-plexin signaling promotes interaction with collapsin response
mediator protein. The Journal of neuroscience : the official journal of the Society
for Neuroscience 28:2287-2297.
Schmidt R, Strahle U, Scholpp S (2013) Neurogenesis in zebrafish - from embryo to
adult. Neural development 8:3.
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of
image analysis. Nature methods 9:671-675.
Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP (2007) Nox1 mediates
basic fibroblast growth factor-induced migration of vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol 27:1736-1743.
Segal AW (1987) Absence of both cytochrome b-245 subunits from neutrophils in Xlinked chronic granulomatous disease. Nature 326:88-91.
Seong J, Ouyang M, Kim T, Sun J, Wen PC, Lu S, Zhuo Y, Llewellyn NM, Schlaepfer
DD, Guan JL, Chien S, Wang Y (2011) Detection of focal adhesion kinase
activation at membrane microdomains by fluorescence resonance energy transfer.
Nature communications 2:406.
Shacter E (2000) Quantification and significance of protein oxidation in biological
samples. Drug metabolism reviews 32:307-326.
Shadel GS, Horvath TL (2015) Mitochondrial ROS signaling in organismal homeostasis.
Cell 163:560-569.
Shao D, Segal AW, Dekker LV (2010) Subcellular localisation of the p40phox
component of NADPH oxidase involves direct interactions between the Phox
homology domain and F-actin. The international journal of biochemistry & cell
biology 42:1736-1743.
Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y,
Sumimoto H (2001) A novel superoxide-producing NAD(P)H oxidase in kidney.
The Journal of biological chemistry 276:1417-1423.
Siebold C, Berrow N, Walter TS, Harlos K, Owens RJ, Stuart DI, Terman JR, Kolodkin
AL, Pasterkamp RJ, Jones EY (2005) High-resolution structure of the catalytic
region of MICAL (molecule interacting with CasL), a multidomain flavoenzymesignaling molecule. Proceedings of the National Academy of Sciences of the
United States of America 102:16836-16841.

195
Sierra C, Coca A, Schiffrin EL (2011) Vascular mechanisms in the pathogenesis of
stroke. Current hypertension reports 13:200-207.
Sorce S, Krause KH (2009) NOX enzymes in the central nervous system: from signaling
to disease. Antioxidants & redox signaling 11:2481-2504.
Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM,
Piemonte F (2006) Protein glutathionylation in human central nervous system:
potential role in redox regulation of neuronal defense against free radicals. J
Neurosci Res 83:256-263.
Spencer NY, Zhou W, Li Q, Zhang Y, Luo M, Yan Z, Lynch TJ, Abbott D, Banfi B,
Engelhardt JF (2013) Hepatocytes produce TNF-alpha following hypoxiareoxygenation and liver ischemia-reperfusion in a NADPH oxidase- and c-Srcdependent manner. American journal of physiology Gastrointestinal and liver
physiology 305:G84-94.
St John JA, Key B (2012) HuC-eGFP mosaic labelling of neurons in zebrafish enables in
vivo live cell imaging of growth cones. Journal of molecular histology 43:615623.
St John JA, Scott S, Chua KY, Claxton C, Key B (2013) Growth cone dynamics in the
zebrafish embryonic forebrain are regulated by Brother of Cdo. Neurosci Lett
545:11-16.
Stacher Horndli C, Chien CB (2012) Sonic hedgehog is indirectly required for intraretinal
axon pathfinding by regulating chemokine expression in the optic stalk.
Development 139:2604-2613.
Stenkamp DL (2015) Development of the Vertebrate Eye and Retina. Progress in
molecular biology and translational science 134:397-414.
Stielow C, Catar RA, Muller G, Wingler K, Scheurer P, Schmidt HH, Morawietz H
(2006) Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation
in human endothelial cells. Biochem Biophys Res Commun 344:200-205.
Stone KE, Sakaguchi DS (1996) Perturbation of the developing Xenopus retinotectal
projection following injections of antibodies against beta1 integrin receptors and
N-cadherin. Dev Biol 180:297-310.
Stroissnigg H, Trancikova A, Descovich L, Fuhrmann J, Kutschera W, Kostan J, Meixner
A, Nothias F, Propst F (2007) S-nitrosylation of microtubule-associated protein
1B mediates nitric-oxide-induced axon retraction. Nat Cell Biol 9:1035-1045.

196
Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK,
Lambeth JD (1999) Cell transformation by the superoxide-generating oxidase
Mox1. Nature 401:79-82.
Sumimoto H (2008) Structure, regulation and evolution of Nox-family NADPH oxidases
that produce reactive oxygen species. The FEBS journal 275:3249-3277.
Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation
of H2O2 for platelet-derived growth factor signal transduction. Science 270:296299.
Suter DM (2011) Live cell imaging of neuronal growth cone motility and guidance in
vitro. Methods in molecular biology (Clifton, NJ) 769:65-86.
Suter DM, Forscher P (2001) Transmission of growth cone traction force through
apCAM-cytoskeletal linkages is regulated by Src family tyrosine kinase activity. J
Cell Biol 155:427-438.
Suter DM, Schaefer AW, Forscher P (2004) Microtubule dynamics are necessary for
SRC family kinase-dependent growth cone steering. Current biology : CB
14:1194-1199.
Suter DM, Errante LD, Belotserkovsky V, Forscher P (1998) The Ig superfamily cell
adhesion molecule, apCAM, mediates growth cone steering by substratecytoskeletal coupling. J Cell Biol 141:227-240.
Suzukawa K, Miura K, Mitsushita J, Resau J, Hirose K, Crystal R, Kamata T (2000)
Nerve growth factor-induced neuronal differentiation requires generation of Rac1regulated reactive oxygen species. The Journal of biological chemistry
275:13175-13178.
Tai K, Kubota M, Shiono K, Tokutsu H, Suzuki ST (2010) Adhesion properties and
retinofugal expression of chicken protocadherin-19. Brain Res 1344:13-24.
Tammariello SP, Quinn MT, Estus S (2000) NADPH oxidase contributes directly to
oxidative stress and apoptosis in nerve growth factor-deprived sympathetic
neurons. The Journal of neuroscience : the official journal of the Society for
Neuroscience 20:Rc53.
Tang R, Dodd A, Lai D, McNabb WC, Love DR (2007) Validation of zebrafish (Danio
rerio) reference genes for quantitative real-time RT-PCR normalization. Acta
biochimica et biophysica Sinica 39:384-390.
Taulet N, Delorme-Walker VD, DerMardirossian C (2012) Reactive oxygen species
regulate protrusion efficiency by controlling actin dynamics. PloS one 7:e41342.

197
Tauzin S, Starnes TW, Becker FB, Lam PY, Huttenlocher A (2014) Redox and Src
family kinase signaling control leukocyte wound attraction and neutrophil reverse
migration. J Cell Biol 207:589-598.
Teahan C, Rowe P, Parker P, Totty N, Segal AW (1987) The X-linked chronic
granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature
327:720-721.
Tejada-Simon MV, Serrano F, Villasana LE, Kanterewicz BI, Wu GY, Quinn MT, Klann
E (2005) Synaptic localization of a functional NADPH oxidase in the mouse
hippocampus. Molecular and cellular neurosciences 29:97-106.
ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M,
Bekhite MM, Wartenberg M, Sauer H, Rosenkranz S (2006) Novel Nox inhibitor
VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not
proliferation. Cardiovascular research 71:331-341.
Thiels E, Urban NN, Gonzalez-Burgos GR, Kanterewicz BI, Barrionuevo G, Chu CT,
Oury TD, Klann E (2000) Impairment of long-term potentiation and associative
memory in mice that overexpress extracellular superoxide dismutase. The Journal
of neuroscience : the official journal of the Society for Neuroscience 20:76317639.
Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish
embryos. Nat Protoc 3:59-69.
Thompson C, Lin CH, Forscher P (1996) An Aplysia cell adhesion molecule associated
with site-directed actin filament assembly in neuronal growth cones. Journal of
cell science 109 ( Pt 12):2843-2854.
Tirone F, Cox JA (2007) NADPH oxidase 5 (NOX5) interacts with and is regulated by
calmodulin. FEBS letters 581:1202-1208.
Touyz RM, Yao G, Schiffrin EL (2003) c-Src induces phosphorylation and translocation
of p47phox: role in superoxide generation by angiotensin II in human vascular
smooth muscle cells. Arterioscler Thromb Vasc Biol 23:981-987.
Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL (2005) p47phox associates with
the cytoskeleton through cortactin in human vascular smooth muscle cells: role in
NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol
25:512-518.
Tsatmali M, Walcott EC, Makarenkova H, Crossin KL (2006) Reactive oxygen species
modulate the differentiation of neurons in clonal cortical cultures. Molecular and
cellular neurosciences 33:345-357.

198
Tsukita S, Yonemura S (1997) ERM (ezrin/radixin/moesin) family: from cytoskeleton to
signal transduction. Current opinion in cell biology 9:70-75.
Ueyama T, Geiszt M, Leto TL (2006) Involvement of Rac1 in activation of
multicomponent Nox1- and Nox3-based NADPH oxidases. Molecular and
cellular biology 26:2160-2174.
Usatyuk PV, Romer LH, He D, Parinandi NL, Kleinberg ME, Zhan S, Jacobson JR,
Dudek SM, Pendyala S, Garcia JG, Natarajan V (2007) Regulation of hyperoxiainduced NADPH oxidase activation in human lung endothelial cells by the actin
cytoskeleton and cortactin. The Journal of biological chemistry 282:23284-23295.
Ushio-Fukai M (2006) Localizing NADPH oxidase-derived ROS. Science's STKE :
signal transduction knowledge environment 2006:re8.
Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ,
Johnson C, Alexander RW (2002) Novel role of gp91(phox)-containing
NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and
angiogenesis. Circ Res 91:1160-1167.
Van Battum EY, Gunput RA, Lemstra S, Groen EJ, Yu KL, Adolfs Y, Zhou Y,
Hoogenraad CC, Yoshida Y, Schachner M, Akhmanova A, Pasterkamp RJ (2014)
The intracellular redox protein MICAL-1 regulates the development of
hippocampal mossy fibre connections. Nature communications 5:4317.
Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG, Natarajan V (1999)
Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase
in vascular endothelial cells. Am J Physiol 277:L150-158.
Verrastro I, Pasha S, Jensen KT, Pitt AR, Spickett CM (2015) Mass spectrometry-based
methods for identifying oxidized proteins in disease: advances and challenges.
Biomolecules 5:378-411.
Vilas-Boas F, Bagulho A, Tenente R, Teixeira VH, Martins G, da Costa G, Jeronimo A,
Cordeiro C, Machuqueiro M, Real C (2016) Hydrogen peroxide regulates cell
adhesion through the redox sensor RPSA. Free radical biology & medicine
90:145-157.
Volpp BD, Nauseef WM, Clark RA (1988) Two cytosolic neutrophil oxidase components
absent in autosomal chronic granulomatous disease. Science 242:1295-1297.
Walker MB, Kimmel CB (2007) A two-color acid-free cartilage and bone stain for
zebrafish larvae. Biotechnic & histochemistry : official publication of the
Biological Stain Commission 82:23-28.

199
Wang HJ, Huang YL, Shih YY, Wu HY, Peng CT, Lo WY (2014) MicroRNA-146a
decreases high glucose/thrombin-induced endothelial inflammation by inhibiting
NAPDH oxidase 4 expression. Mediators of inflammation 2014:379537.
Wang K, Zhang T, Chen H, Jiang J, Nice EC, Huang C (2015) New insights into redox
regulation of stem cell self-renewal and differentiation. Biochimica et biophysica
acta.
Warburg O (1908) Beobachtungen über die Oxydationsprozesse im Seeigelei. In: HoppeSeyler´s Zeitschrift für physiologische Chemie, p 1.
Weaver CJ, Leung YF, Suter DM (2015) Expression dynamics of NADPH oxidases
during early zebrafish development. J Comp Neurol.
Weaver JR, Taylor-Fishwick DA (2013) Regulation of NOX-1 expression in beta cells: a
positive feedback loop involving the Src-kinase signaling pathway. Mol Cell
Endocrinol 369:35-41.
Weaver JR, Holman TR, Imai Y, Jadhav A, Kenyon V, Maloney DJ, Nadler JL, Rai G,
Simeonov A, Taylor-Fishwick DA (2012) Integration of pro-inflammatory
cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.
Mol Cell Endocrinol 358:88-95.
Westerfield M (2000) The zebrafish book. A guide for the laboratory use of zebrafish
(Danio rerio), 4th ed Edition. Eugene, OR: Univ. of Oregon Press.
Wientjes FB, Hsuan JJ, Totty NF, Segal AW (1993) p40phox, a third cytosolic
component of the activation complex of the NADPH oxidase to contain src
homology 3 domains. The Biochemical journal 296 ( Pt 3):557-561.
Wientjes FB, Reeves EP, Soskic V, Furthmayr H, Segal AW (2001) The NADPH
oxidase components p47(phox) and p40(phox) bind to moesin through their PX
domain. Biochem Biophys Res Commun 289:382-388.
Wilkinson RN, Elworthy S, Ingham PW, van Eeden FJ (2013) A method for highthroughput PCR-based genotyping of larval zebrafish tail biopsies.
BioTechniques 55:314-316.
Wilson C, Gonzalez-Billault C (2015) Regulation of cytoskeletal dynamics by redox
signaling and oxidative stress: implications for neuronal development and
trafficking. Frontiers in cellular neuroscience 9:381.
Wilson C, Nunez MT, Gonzalez-Billault C (2015) Contribution of NADPH oxidase to
the establishment of hippocampal neuronal polarity in culture. Journal of cell
science 128:2989-2995.

200
Wind S, Beuerlein K, Eucker T, Muller H, Scheurer P, Armitage ME, Ho H, Schmidt
HH, Wingler K (2010) Comparative pharmacology of chemically distinct
NADPH oxidase inhibitors. British journal of pharmacology 161:885-898.
Winterbourn CC (2008) Reconciling the chemistry and biology of reactive oxygen
species. Nature chemical biology 4:278-286.
Wojciak-Stothard B, Tsang LY, Haworth SG (2005) Rac and Rho play opposing roles in
the regulation of hypoxia/reoxygenation-induced permeability changes in
pulmonary artery endothelial cells. American journal of physiology Lung cellular
and molecular physiology 288:L749-760.
Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG (2010) Inactivation of
peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for
cell signaling. Cell 140:517-528.
Wozniak MA, Modzelewska K, Kwong L, Keely PJ (2004) Focal adhesion regulation of
cell behavior. Biochimica et biophysica acta 1692:103-119.
Wright KM, Lyon KA, Leung H, Leahy DJ, Ma L, Ginty DD (2012) Dystroglycan
organizes axon guidance cue localization and axonal pathfinding. Neuron 76:931944.
Wu DC, Re DB, Nagai M, Ischiropoulos H, Przedborski S (2006) The inflammatory
NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic
lateral sclerosis mice. Proceedings of the National Academy of Sciences of the
United States of America 103:12132-12137.
Wu RF, Gu Y, Xu YC, Nwariaku FE, Terada LS (2003) Vascular endothelial growth
factor causes translocation of p47phox to membrane ruffles through WAVE1. The
Journal of biological chemistry 278:36830-36840.
Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA, Jr., Terada LS (2005) Subcellular
targeting of oxidants during endothelial cell migration. J Cell Biol 171:893-904.
Xu S, Chamseddine AH, Carrell S, Miller FJ, Jr. (2014) Nox4 NADPH oxidase
contributes to smooth muscle cell phenotypes associated with unstable
atherosclerotic plaques. Redox biology 2:642-650.
Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, Sadoshima
J (2003) Inhibition of endogenous thioredoxin in the heart increases oxidative
stress and cardiac hypertrophy. The Journal of clinical investigation 112:13951406.

201
Yan B, Han P, Pan L, Lu W, Xiong J, Zhang M, Zhang W, Li L, Wen Z (2014) IL-1beta
and reactive oxygen species differentially regulate neutrophil directional
migration and Basal random motility in a zebrafish injury-induced inflammation
model. J Immunol 192:5998-6008.
Yan Y, Wladyka C, Fujii J, Sockanathan S (2015) Prdx4 is a compartment-specific H2O2
sensor that regulates neurogenesis by controlling surface expression of GDE2.
Nature communications 6:7006.
Yang S, Madyastha P, Bingel S, Ries W, Key L (2001) A new superoxide-generating
oxidase in murine osteoclasts. The Journal of biological chemistry 276:54525458.
Yawn BP, Wollan PC, Weingarten TN, Watson JC, Hooten WM, Melton LJ, 3rd (2009)
The prevalence of neuropathic pain: clinical evaluation compared with screening
tools in a community population. Pain medicine (Malden, Mass) 10:586-593.
Yin L, Maddison LA, Li M, Kara N, LaFave MC, Varshney GK, Burgess SM, Patton JG,
Chen W (2015) Multiplex Conditional Mutagenesis Using Transgenic Expression
of Cas9 and sgRNAs. Genetics 200:431-441.
Yoo SK, Starnes TW, Deng Q, Huttenlocher A (2011) Lyn is a redox sensor that
mediates leukocyte wound attraction in vivo. Nature 480:109-112.
Yoo SK, Freisinger CM, LeBert DC, Huttenlocher A (2012) Early redox, Src family
kinase, and calcium signaling integrate wound responses and tissue regeneration
in zebrafish. J Cell Biol 199:225-234.
Zhan Y, He D, Newburger PE, Zhou GW (2004) p47(phox) PX domain of NADPH
oxidase targets cell membrane via moesin-mediated association with the actin
cytoskeleton. Journal of cellular biochemistry 92:795-809.
Zhang J-M, An J (2007) Cytokines, Inflammation and Pain. International anesthesiology
clinics 45:27-37.
Zhang L, Wu J, Duan X, Tian X, Shen H, Sun Q, Chen G (2016) NADPH Oxidase: A
Potential Target for Treatment of Stroke. Oxidative medicine and cellular
longevity 2016:5026984.
Zhang XF, Forscher P (2009) Rac1 Modulates Stimulus-Evoked Ca2+ Release in
Neuronal Growth Cones via Parallel Effects on Microtubule/ER Dynamics and
ROS Production. Mol Biol Cell.

202
Zhao J, Yu S, Zheng Y, Yang H, Zhang J (2016) Oxidative Modification and Its
Implications for the Neurodegeneration of Parkinson's Disease. Molecular
neurobiology.
Zhu K, Kakehi T, Matsumoto M, Iwata K, Ibi M, Ohshima Y, Zhang J, Liu J, Wen X,
Taye A, Fan C, Katsuyama M, Sharma K, Yabe-Nishimura C (2015) NADPH
oxidase NOX1 is involved in activation of protein kinase C and premature
senescence in early-stage diabetic kidney. Free radical biology & medicine.
Zhu X, Xu Y, Yu S, Lu L, Ding M, Cheng J, Song G, Gao X, Yao L, Fan D, Meng S,
Zhang X, Hu S, Tian Y (2014) An efficient genotyping method for genomemodified animals and human cells generated with CRISPR/Cas9 system.
Scientific reports 4:6420.
Zimmerman MC, Takapoo M, Jagadeesha DK, Stanic B, Banfi B, Bhalla RC, Miller FJ,
Jr. (2011) Activation of NADPH oxidase 1 increases intracellular calcium and
migration of smooth muscle cells. Hypertension 58:446-453.
Zolessi FR, Poggi L, Wilkinson CJ, Chien CB, Harris WA (2006) Polarization and
orientation of retinal ganglion cells in vivo. Neural development 1:2.

VITA

203

VITA

Cory was born in Galveston, Indiana in 1986. He graduated from Lewis Cass
High School in 2005, and began studying at Purdue University in the fall of the same
year. In August of 2009, he earned a bachelor’s degree from Purdue in Cell,
Developmental and Molecular biology. Prior to the completion of his degree, he began
working as a lab technician at Purdue. The following year, he began his graduate work
under the supervision of Dr. Daniel M. Suter. Upon completion of his Ph.D. in 2016,
Cory will begin a post-doctoral research position at the University of South Carolina
under the co-supervision of Dr. Fabienne Poulain and Dr. Jeff Twiss.

